TW201807165A - Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium - Google Patents

Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium Download PDF

Info

Publication number
TW201807165A
TW201807165A TW106111896A TW106111896A TW201807165A TW 201807165 A TW201807165 A TW 201807165A TW 106111896 A TW106111896 A TW 106111896A TW 106111896 A TW106111896 A TW 106111896A TW 201807165 A TW201807165 A TW 201807165A
Authority
TW
Taiwan
Prior art keywords
nanocapsules
composition
mixture
phe
cyc
Prior art date
Application number
TW106111896A
Other languages
Chinese (zh)
Inventor
凱文 艾德蘭
派翠西亞 愛琳 賽克斯頓
瑞秋 杜賓
班傑明 史諾
馬利安 那姆提比
詹姆斯 艾倫
薇琪 庫克
韓森 阿拉希
馬克 傑貝爾
Original Assignee
馬克專利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 馬克專利公司 filed Critical 馬克專利公司
Publication of TW201807165A publication Critical patent/TW201807165A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/14Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
    • C09K19/18Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/60Pleochroic dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3025Cy-Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K2019/525Solvents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K2019/528Surfactants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2219/00Aspects relating to the form of the liquid crystal [LC] material, or by the technical area in which LC material are used

Abstract

The present invention relates to compositions for nanoencapsulation which comprise the mesogenic medium as set forth in claim 1, one or more polymerizable compounds and one or more surfactants, to nanocapsules containing the mesogenic medium and to their use in electro-optical devices.

Description

包含液晶介質之用於奈米膠囊化的組合物及奈米膠囊Nanocapsule-containing composition and nanocapsule containing liquid crystal medium

本發明係關於用於奈米膠囊化之組合物,其包含如下文所述之液晶原介質、一或多種可聚合化合物及一或多種表面活性劑;係關於含有該液晶原介質之奈米膠囊;係關於其製備方法及其在光電裝置中之用途。The present invention relates to a composition for nanocapsule encapsulation, which comprises a mesogen, one or more polymerizable compounds and one or more surfactants as described below; and a nanocapsule containing the mesogen. ; About its preparation method and its use in photovoltaic devices.

液晶(LC)介質廣泛用於液晶顯示器(LCD)中、尤其用於具有主動矩陣或被動矩陣定址之光電顯示器中以展示資訊。在主動矩陣顯示器之情形下,個別像素通常藉由諸如電晶體(例如薄膜電晶體(TFT))之積體非線性主動元件定址,而在被動矩陣顯示器之情形下,個別像素通常藉由多工方法定址,如自先前技術所已知。 TN (「扭曲向列型」)型之LCD仍常使用,然而,該等具有對比度之強視角依賴性之缺點。另外,已知所謂的VA (「垂直配向」)顯示器,其具有較寬之視角。此外,已知OCB (「光學補償彎曲」)顯示器,其係基於雙折射效應且含有具有所謂「彎曲」配向之LC層。亦已知所謂的IPS (「平面內切換」)顯示器,其在兩個基板之間含有LC層,其中兩個電極僅配置在該兩個基板中之一者上且較佳具有相互嚙合之梳形結構。此外,已提供所謂的FFS (「邊緣場切換」)顯示器,其在同一基板上含有兩個電極,其中一個電極以梳形方式結構化且另一者未經結構化。藉此產生強的所謂「邊緣場」,即靠近電極邊緣並貫穿單元之強電場,一種具有強垂直分量以及強水平分量二者之電場。 另一發展係所謂的PS (「聚合物持續」)或PSA (「聚合物持續配向」)型顯示器,對於該等顯示器亦偶爾使用術語「聚合物穩定」。在該等顯示器中,將少量(例如0.3重量%、通常< 1重量%)之一或多種可聚合化合物、較佳地一或多種可聚合單體化合物添加至LC介質,且在將LC介質填充至顯示器中之後,通常藉由UV光聚合在視情況向顯示器之電極施加電壓時在原位聚合或交聯。聚合係在其中LC介質展現液晶相之溫度下、通常在室溫下實施。將可聚合之液晶原或液晶化合物(亦稱為反應性液晶原或「RM」)添加至LC混合物已證明尤其適當。 另外,已闡述基於聚合物分散液晶(PDLC)膜之顯示器,例如,參見US 4,688,900。在此等PDLC膜中,通常將微米級之LC介質液滴(微滴)隨機分佈在聚合物基質中。該等相分離系統中之LC域具有可導致光強烈散射之大小。PDLC膜通常使用聚合誘導相分離(PIPS)之方法來製備,其中相分離係反應誘導的。或者,PDLC膜可基於溫度誘導相分離(TIPS)或溶劑誘導相分離(SIPS)來製備。除PDLC膜以外,亦已知所謂的聚合物網絡液晶(PNLC)系統,其中聚合物網絡係在連續LC相中形成。 此外,已闡述用於顯示器中之微米級膠囊化LC材料(微膠囊),其中微膠囊係藉由與用作膠囊化介質之不可混溶黏合劑(例如聚乙烯醇(PVA))一起形成LC材料之水性乳液來製備,例如參見US 4,435,047。 WO 2013/110564 A1中闡述使用將至少部分溶解之聚合物前體聚合並交聯將光電流體微膠囊化之方法。 除以上顯示器類型之外,近期已提出包括包含奈米膠囊之層之LCD,其中奈米膠囊含有液晶分子。舉例而言,US 2014/0184984 A1中闡述配置有在所謂的緩衝材料中含有此等奈米膠囊之層之LCD裝置之構形。 US 2012/0113363 A1中闡述其中配置有奈米膠囊之另一LCD裝置。 Kang及Kim在Optics Express, 2013, 第21卷, 第15719-15727頁中闡述基於克爾(Kerr)效應及平面內切換用於顯示器中之光學各向同性奈米膠囊化LC。平均直徑為大約110 nm之奈米膠囊係藉由以下來製備:將向列型LC添加至非離子聚合表面活性劑與溶解於水溶液中之PVA (其用作殼形成聚合物及水溶性乳化劑)之混合物,形成奈米乳液,將該奈米乳液加熱至濁點並攪拌以使圍繞LC奈米液滴之PVA相分離,並使聚合殼與交聯劑(例如二醛)交聯。此外,闡述含有所製備LC奈米膠囊、作為黏合劑之親水性PVA及作為塑化劑之乙二醇之塗層溶液。 WO 2009/085082 A1中闡述由交聯聚合物製得之多孔性奈米顆粒,其可像海綿一樣起作用以吸收LC物質,該等多孔性奈米顆粒在LCD中具有作為相位延遲膜之可能應用。 業內需要具有改良及視情況可調之光電及物理性質、尤其用於光電裝置中之奈米膠囊。此外,業內需要提供易於製作此等奈米膠囊之經改良簡便製程。另外,業內需要可用於該製程中之組合物。Liquid crystal (LC) media are widely used in liquid crystal displays (LCDs), especially in optoelectronic displays with active matrix or passive matrix addressing to display information. In the case of active matrix displays, individual pixels are usually addressed by integrated non-linear active elements such as transistors (such as thin film transistors (TFTs)), while in the case of passive matrix displays, individual pixels are usually Method addressing, as known from the prior art. TN ("Twisted Nematic") LCDs are still commonly used, however, these have the disadvantage of strong viewing angle dependence of contrast. In addition, a so-called VA ("vertical alignment") display is known, which has a wide viewing angle. In addition, OCB ("optically compensated bending") displays are known, which are based on the birefringence effect and contain an LC layer with a so-called "bending" alignment. A so-called IPS ("In-Plane Switching") display is also known, which contains an LC layer between two substrates, where the two electrodes are arranged only on one of the two substrates and preferably have a comb that engages each other形 结构。 Shaped structure. In addition, so-called FFS ("Frequency Field Switching") displays have been provided, which contain two electrodes on the same substrate, one of which is structured in a comb shape and the other is unstructured. This produces a strong so-called "fringe field", that is, a strong electric field near the electrode edge and penetrating the cell, an electric field with both a strong vertical component and a strong horizontal component. Another development is the so-called PS ("Polymer Sustain") or PSA ("Polymer Sustaining Alignment") type display, for which the term "Polymer Stable" is also occasionally used. In such displays, a small amount (for example, 0.3% by weight, usually <1% by weight) of one or more polymerizable compounds, preferably one or more polymerizable monomer compounds is added to the LC medium, and the LC medium is filled. After entering the display, it is usually polymerized or crosslinked in situ by applying UV light polymerization to the electrodes of the display as appropriate. The polymerization is performed at a temperature where the LC medium exhibits a liquid crystal phase, usually at room temperature. The addition of a polymerizable mesogen or a liquid crystal compound (also known as a reactive mesogen or "RM") to an LC mixture has proven to be particularly suitable. In addition, displays based on polymer dispersed liquid crystal (PDLC) films have been described, for example, see US 4,688,900. In these PDLC membranes, micron-scale LC medium droplets (droplets) are usually randomly distributed in the polymer matrix. The LC domains in these phase separation systems are of a size that can cause strong light scattering. PDLC membranes are usually prepared using a polymerization-induced phase separation (PIPS) method, in which a phase separation system is induced by a reaction. Alternatively, PDLC membranes can be prepared based on temperature-induced phase separation (TIPS) or solvent-induced phase separation (SIPS). In addition to PDLC films, so-called polymer network liquid crystal (PNLC) systems are also known, in which polymer networks are formed in a continuous LC phase. In addition, micron-sized encapsulated LC materials (microcapsules) for use in displays have been described, where microcapsules form an LC by using an immiscible adhesive such as polyvinyl alcohol (PVA) as an encapsulation medium Aqueous emulsions of materials are prepared, for example, see US 4,435,047. WO 2013/110564 A1 describes a method for microencapsulating photovoltaic fluids by polymerizing and crosslinking at least partially dissolved polymer precursors. In addition to the above display types, LCDs including layers containing nanocapsules have recently been proposed, where nanocapsules contain liquid crystal molecules. For example, US 2014/0184984 A1 describes the configuration of an LCD device configured with a layer containing these nanocapsules in a so-called cushioning material. US 2012/0113363 A1 describes another LCD device with a nanocapsule configured therein. Kang and Kim in Opticals Express, 2013, Volume 21, pages 15719-15727 describe an optically isotropic nano-encapsulated LC for use in displays based on the Kerr effect and in-plane switching. Nanocapsules with an average diameter of about 110 nm are prepared by adding nematic LC to a non-ionic polymeric surfactant and PVA dissolved in an aqueous solution (which is used as a shell-forming polymer and a water-soluble emulsifier) ) To form a nanoemulsion. The nanoemulsion is heated to the cloud point and stirred to separate the PVA phase around the LC nanodroplets, and the polymeric shell is crosslinked with a crosslinking agent (such as a dialdehyde). In addition, a coating solution containing the prepared LC nanocapsules, hydrophilic PVA as a binder, and ethylene glycol as a plasticizer is explained. WO 2009/085082 A1 describes porous nano particles made from cross-linked polymers, which can act as sponges to absorb LC substances. These porous nano particles have the potential to act as phase retardation films in LCDs application. There is a need in the industry for nanocapsules with improved optoelectronic and physical properties, especially for use in optoelectronic devices. In addition, there is a need in the industry to provide an improved and simple process for making such nanocapsules. In addition, there is a need in the industry for compositions that can be used in this process.

因此,本發明之目標係提供改良之組合物,其在膠囊化期間具有有利性能,同時在所得奈米膠囊中進一步提供有利特性,以及提供包含液晶原介質之改良之奈米膠囊。另一目標係提供製備包含液晶原介質之奈米膠囊之改良方法。特定而言,本發明之目標係提供組合物及奈米膠囊使得奈米膠囊中所含之液晶原介質具有適當高的De及高電阻以及適當高的Dn及光電參數之有利值,同時此外特別提供相對較低之旋轉黏度及有利之可靠性。此外,本發明之目標係奈米膠囊中所包含之液晶原介質展現寬且穩定之LC、尤其向列型相範圍、低熔點及相對較高之澄清點及適當高之電壓保持率。本發明之另一目標係提供可用於光調變元件及光電裝置中之穩定且可靠之奈米膠囊及包含奈米膠囊與黏合劑之複合系統,尤其具有適當低之臨限電壓、有利之快速反應時間、改良之低溫度行為及在低溫下操作性質之改良、光電參數(例如臨限電壓)之最小溫度依賴性及高對比度者。此外,本發明之目標係提供光調變元件及光電裝置中之奈米膠囊及複合系統,該等光調變元件及光電裝置具有有利之寬視角範圍且對外力(例如觸摸)實質上不敏感。熟習此項技術者自以下詳細闡述即刻明瞭本發明之其他目標。 該等目標由獨立請求項中所定義之標的物來解決,而較佳實施例則闡述於各別附屬請求項中並於下文進一步闡述。 本發明尤其提供包括主要態樣、較佳實施例及特定特徵之以下項目,其各別地單獨且以組合形式有助於解決以上目標且最終提供額外優點。 本發明之第一態樣提供用於奈米膠囊化之組合物,其中該組合物包含 (i) 液晶原介質,其包含一或多種式I化合物 R-A-Y-A’-R’ I 其中 R及R’ 彼此獨立地表示選自以下之基團:F、CF3 、OCF3 、CN及具有1至15個碳原子之直鏈或具支鏈烷基或烷氧基或具有2至15個碳原子之直鏈或具支鏈烯基,其未經取代、由CN或CF3 單取代或由鹵素、較佳地F單取代或多取代,且其中一或多個CH2 基團在每一情形下可彼此獨立地以使得氧原子彼此不直接連接之方式由-O-、-S-、-CO-、-COO-、-OCO-、-OCOO-或-C≡C-替代, A及A’ 彼此獨立地表示選自以下之基團:-Cyc-、-Phe-、-Cyc-Cyc-、-Cyc-Phe-、-Phe-Phe-、-Cyc-Cyc-Cyc-、-Cyc-Cyc-Phe-、-Cyc-Phe-Cyc-、-Cyc-Phe-Phe-、-Phe-Cyc-Phe-、-Phe-Phe-Phe-及其各別鏡像, 其中Cyc係反式-1,4-伸環己基,其中一或兩個非毗鄰CH2 基團可由O替代,且其中Phe係1,4-伸苯基,其中一或兩個非毗鄰CH基團可由N替代且其可由一或兩個F取代,且 Y 表示單鍵、-COO-、-CH2 CH2 -、-CF2 CF2 -、-CH2 O-、-CF2 O-、-CH=CH-、-CF=CF-或-C≡C-, (ii) 一或多種可聚合化合物,及 (iii) 一或多種表面活性劑。 已令人驚訝地發現,藉由提供根據本發明之組合物(其包含如上文所述之組份(i)、(ii)及(iii)之組合),可在改良且令人驚訝之簡單製程中製備含有液晶原介質之奈米膠囊,其中該等組合物在該製程中展現有利性能。另外,該等組合物容許獲得就其物理及化學屬性而言、尤其就其光電性質及其在光調變元件及光電裝置中之適當性而言提供顯著益處之奈米膠囊。 本發明之另一態樣係關於奈米膠囊,其各別地包含聚合殼及含有液晶原介質之核心,該液晶原介質包含一或多種如上文所述之式I化合物。 已令人驚訝地發現,可提供穩定且可靠之奈米膠囊,其含有具有有利光電性質以及適當可靠性之液晶原介質。已認識到,根據本發明之奈米膠囊可藉由在奈米乳液中基於原位聚合且尤其基於PIPS之製程獲得或可各別地自其獲得。因此,出人意料地可提供光調變材料,其包含由聚合殼膠囊化之LC奈米級液滴(奈米液滴)作為核心,其中奈米膠囊作為整體以及其中所含之液晶原介質具有適當且甚至改良之性質。 因此,可將離散量之LC材料侷限於奈米體積中,其穩定地含有並可個別地定址且其可安裝或分散在不同環境中。由聚合殼奈米膠囊化之LC材料可容易地施加至單一基板並自單一基板支撐,該基板可係撓性的且其中層或膜厚度可改變或各別地進行改變。由聚合壁包圍(即包封)之LC介質可以至少兩種狀態進行操作。 然而,奈米液滴各自僅提供相對較小體積之LC。由此目前實現較佳且有利地提供具有適當大之Dn同時此外展現良好透射及良好可靠性、包括尤其適當電壓保持率(VHR)及熱及UV穩定性以及相對較小之旋轉黏度之LC組份。此外,LC組份可有利地具有適當且合理高之介電各向異性De之值以在光電裝置應用中獲得相對較小之臨限電壓。 此外有利地認識到,在奈米膠囊中,LC核心與聚合殼之間之界面面積與所提供之奈米體積相比相對較大,且因此需要尤其慮及聚合殼組份及LC核心組份之各別性質及其相互關係。在根據本發明之奈米膠囊中,聚合物與LC組份之間之相互作用可有利地且適當地設定及調整,可獲得此之主要原因在於所提供之本發明之用於奈米膠囊化之組合物以及所提供之製備製程之控制及適應性。 舉例而言,界面相互作用可有助於或阻止在LC奈米液滴中形成任何配向或定向。 慮及奈米膠囊之大小較小(其可係可見光之亞波長且甚至小於可見光之λ/4),膠囊可有利地僅係極弱之可見光散射體。 此外,在電場不存在下且端視界面相互作用而定,在一種情形下LC介質可形成在奈米級體積中具有極少或無定向之無序相、尤其各向同性相,其可提供(例如)優良之視角行為。此外,在未供電或非定址狀態下固有地具有各向同性相在裝置應用中、尤其在使用偏振器時由於可實現極佳之暗狀態而可係有利的。 與出現(例如)徑向或雙極性定向相反,據信在一種情形下由於奈米膠囊中所提供之小體積此定向可不發生或至少受到限制。 或者,且在特定實施例中較佳,可進行配置,其中尤其可使用界面相互作用來誘導或影響LC介質中之配向及定向,例如藉由設定或調整與膠囊壁之錨定強度來實施。在此一情形下可產生均勻平面徑向或雙極性配向。當各別地具有及個別地具有LC定向或配向之此等奈米膠囊隨機分散時,總體上可觀察到光學各向同性。 球形或類球形幾何學連同曲率一起設定對於向列型構形以及液晶分子之配向之約束或邊界條件,此可進一步取決於LC在膠囊表面之錨定、膠囊之彈性性質及主體及表面能量學以及大小。光電反應進而取決於奈米膠囊中之LC排序及定向。 此外,膠囊化LC介質之配向及定向之任何可能之不存在或存在與基板無關,使得不需要在基板上提供配向層。 特定而言,當膠囊中之LC具有徑向構形且粒徑低於光波長時,奈米膠囊係實質上光學各向同性的。此使得當使用兩個交叉偏振器時實現優良暗狀態。當使用電場切換、尤其平面內切換時,可獲得為光學各向異性之軸向構形,其中誘導雙折射引起光透射。 在本發明之另一態樣中,提供製備奈米膠囊之方法,其包含以下步驟 (a) 提供包含根據本發明之組合物之水性混合物, (b) 攪動、較佳地機械攪動所提供之水性混合物以獲得包含分散於水相中之根據本發明之組合物且尤其液晶原介質之奈米液滴,及 (c) 在步驟(b)之後,將一或多種根據本發明之可聚合化合物聚合以獲得奈米膠囊,其每一者包含聚合殼及含有如上文及下文所述之液晶原介質之核心。 視情況,在獲得奈米膠囊之後,可將水相耗盡、去除或交換,其中可使用(例如)離心或過濾方法。 雖然根據本發明之奈米膠囊之製備不限於此且其亦可藉由其他方法(例如藉由用預成型聚合物膠囊化或藉由溶質共擴散方法)來製備,但在本發明中有利地認識到,包含LC介質之奈米膠囊可有利地藉由使用原位聚合之製程來製備,且其尤其基於聚合誘導相分離。 此外,已認識到,代替提供現成聚合物來使LC介質膠囊化,在奈米級上將液晶原介質膠囊化可有利地自聚合物前體原位開始進行。因此,可有利地避免使用預成型聚合物以及與其一起具體提供之乳化劑。就此而言,使用既定預製聚合物可使奈米乳液之形成及穩定化困難,同時此外其可限制整個製程之可調整性。 在根據本發明之製程中,一或多種可聚合化合物至少部分可溶或各別地至少部分地溶解於包含液晶原介質之相中,較佳地該一或多種可聚合化合物及液晶原介質充分混合、尤其均質混合,其中此混合物在後期階段藉助PIPS (即聚合誘導相分離)進行奈米相分離。可設定並調整溫度以有利地影響溶解性。 為設定並影響溶解性、溶解及/或混合,可視情況且較佳地將有機溶劑添加至組合物,此可進一步有利地在聚合期間影響相分離。 有利地觀察到,所提供之如上文及下文所述之LC介質對於膠囊化製程、尤其聚合及與其相關聯之條件(例如暴露於熱或UV光(例如來自波長範圍為300 nm至380 nm之UV燈))係適當穩定的。考慮到不需要在玻璃基板之間進行聚合,波長之選擇有利地不受玻璃之UV截止限制,但可(例如)慮及材料性質及組合物之穩定性來設定。亦可使用包括UV及可見光譜兩者之光,例如藉由使用波長範圍為300 nm至600 nm之燈。 本製程係基於奈米分散液與PIPS之組合,且其在提供受控及可調適製備方法方面提供顯著優點。由此製程獲得或可各別地自此製程獲得之奈米膠囊顯示適當及可調之粒徑,同時給出有利高粒徑均勻性(即有利低多分散性)及進而有利均質產物性質。令人驚訝發現,設定適當膠囊奈米大小同時此外觀察並達成低多分散性可對操作電壓具有有利影響。考慮到製程之可控性及適應性,可有利地設定並調諧所獲得奈米膠囊及尤其其中所含LC介質之光電參數。 已認識到,各種成分、或可能缺乏的成分、尤其LC材料、一或多種可聚合化合物以及分散介質及正形成及已形成聚合物之各別可混溶性、溶解性及相容性起重要作用,尤其混合自由能與混合相互作用能及混合熵。 此外,應注意,膠囊化製程係基於聚合反應,即具體動態製程係膠囊形成之基礎。特定而言,目前通常觀察到用於膠囊化之一或多種可聚合化合物具有與LC介質之適當可混溶性,而已形成之膠囊殼聚合物展現與LC材料之適當低之溶解性。 在根據本發明之製程中,聚合轉化或完成可令人驚訝地高且殘餘未反應之可聚合化合物之量有利地低。此可確保已形成之膠囊中LC介質之性質及性能不受或僅最低限度地受殘餘反應性單體影響。 此外已發現,在聚合之前,提供表面活性劑可有利地促進分散介質、尤其水性分散介質中離散奈米液滴之形成及後續穩定化、尤其離子及/或立體穩定化,其中奈米液滴包含LC介質及一或多種可聚合化合物。機械攪動、尤其高剪切混合可適當地產生或進一步實現分散液、尤其乳液及均質化,且同樣地促進奈米液滴形成。 因此,機械攪動及提供表面活性劑兩者可在獲得奈米液滴及進而奈米級膠囊、尤其具有實質上均勻粒徑分佈或各別地低多分散性之奈米膠囊方面起有利作用。 奈米膠囊之小且均勻大小在獲得因應所施加電場之快速且均勻切換方面可係有益的,較佳地給出低毫秒或甚至亞毫秒反應時間。 此外,相分離及已形成之聚合殼之性質、尤其穩定性及與LC組份之不可混溶性可藉由視情況且較佳地交聯正形成或各別地已形成之聚合物鏈而有利地受影響。然而,在無此交聯之情形下,膠囊性質亦可已經足夠良好。 本發明之另一態樣係關於複合系統,其包含根據本發明之奈米膠囊及一或多種黏合劑。 已發現,奈米膠囊與一或多種黏合劑材料之組合尤其鑒於基板上之塗層或印刷及膜形成可適當地影響並增加光調變材料之可加工性及適用性。一或多種黏合劑可用作分散劑及黏附劑或黏合劑(binding agent)兩者,且此外可在維持或甚至促進撓性的同時提供適當物理及機械穩定性。此外,可藉由改變所提供之黏合劑之量有利地調整膠囊之密度或濃度。 由於可將如所製備之奈米顆粒或膠囊濃縮(例如藉由離心、過濾或乾燥)並將其再分散,因此可獨立於如自原始產生製程獲得之濃度來設定或調整膜或層中顆粒之密度或比例。 本發明之另一態樣提供光電裝置,其包含根據本發明之奈米膠囊或根據本發明之複合系統。 藉由提供根據本發明之奈米膠囊化之LC介質,視情況與黏合劑材料組合,可在光電裝置中獲得若干顯著優點。該等優點包括(例如)良好機械穩定性、撓性及對外部所施加力或各別地壓力(例如來自接觸)之不敏感性以及關於切換速度、透射率、暗狀態、視角行為及臨限電壓之其他有利性質。其他優點在於可使用撓性基板且改變膜或層厚度之可能性及膜厚度偏差或方差之容忍度。就此而言,可使用簡單的滴下、塗覆或印刷方法將光調變材料施加至基板。 此外,不需要在基板上提供配向層(例如習用聚醯亞胺(PI)配向層)及/或摩擦基板表面。 當裝置中之兩個電極提供於同一基板上(例如在IPS或FFS之情形下)時,單一基板可足以提供功能性及穩定性或各別地支撐,使得提供相對基板僅係可選的。然而,此相對基板在(例如)提供其他光學元件或物理或化學保護方面仍可係有益的。It is therefore an object of the present invention to provide improved compositions which have advantageous properties during encapsulation, while further providing advantageous properties in the resulting nanocapsules, and to provide improved nanocapsules containing a mesogen. Another object is to provide an improved method for preparing nanocapsules containing a mesogen. In particular, the object of the present invention is to provide a composition and a nanocapsule so that the mesogen in the nanocapsule has a suitably high De and high resistance, and a suitably high value of Dn and photoelectric parameters. Provides relatively low rotational viscosity and favorable reliability. In addition, the object of the present invention is that the liquid crystal precursor medium contained in the nanocapsules exhibits a wide and stable LC, especially a nematic phase range, a low melting point, a relatively high clarification point, and a suitably high voltage retention rate. Another object of the present invention is to provide stable and reliable nanocapsules and composite systems including nanocapsules and adhesives, which can be used in light modulation elements and optoelectronic devices, and particularly have a suitably low threshold voltage, which is advantageous and fast Response time, improved low temperature behavior and improved operating properties at low temperature, minimum temperature dependence of photoelectric parameters (such as threshold voltage) and high contrast. In addition, the object of the present invention is to provide nanocapsules and composite systems in light modulation elements and optoelectronic devices, which light modulation elements and optoelectronic devices have a favorable wide viewing angle range and are substantially insensitive to external forces (such as touch). . Those skilled in the art will immediately understand other objects of the present invention from the following detailed description. These objectives are solved by the subject matter defined in the independent claims, while the preferred embodiments are set out in the respective subsidiary claims and further explained below. In particular, the present invention provides the following items including main aspects, preferred embodiments, and specific features, which individually and in combination help to solve the above objectives and ultimately provide additional advantages. A first aspect of the present invention provides a composition for nano-encapsulation, wherein the composition comprises (i) a mesogen, which comprises one or more compounds of formula I RAY-A'-R 'I wherein R and R 'Indicates independently of each other a group selected from the group consisting of: F, CF 3 , OCF 3 , CN and a straight or branched chain alkyl or alkoxy group having 1 to 15 carbon atoms or having 2 to 15 carbon atoms Unbranched or branched alkenyl, unsubstituted, mono-substituted by CN or CF 3 or mono- or poly-substituted by halogen, preferably F, and one or more of the CH 2 groups in each case The following can be replaced by -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-, or -C≡C- independently of each other in such a way that the oxygen atoms are not directly connected to each other, A and A 'Independently of one another represents a group selected from -Cyc-, -Phe-, -Cyc-Cyc-, -Cyc-Phe-, -Phe-Phe-, -Cyc-Cyc-Cyc-, -Cyc-Cyc -Phe-, -Cyc-Phe-Cyc-, -Cyc-Phe-Phe-, -Phe-Cyc-Phe-, -Phe-Phe-Phe- and their respective mirror images, where Cyc is trans-1,4 - cyclohexylene, in which one or two non-adjacent CH 2 O group can be replaced and wherein based Phe 1,4-phenylene, in which one or two non-adjacent CH Groups may be replaced by N and which may be substituted by one or two F, and Y represents a single bond, -COO -, - CH 2 CH 2 -, - CF 2 CF 2 -, - CH 2 O -, - CF 2 O-, -CH = CH-, -CF = CF-, or -C≡C-, (ii) one or more polymerizable compounds, and (iii) one or more surfactants. It has surprisingly been found that by providing a composition according to the invention, which comprises a combination of components (i), (ii) and (iii) as described above, it can be improved and surprisingly simple Nanocapsules containing a liquid crystal precursor are prepared during the manufacturing process, and the compositions exhibit advantageous properties during the manufacturing process. In addition, these compositions allow obtaining nanocapsules that provide significant benefits in terms of their physical and chemical properties, especially their optoelectronic properties and their suitability in light modulation elements and optoelectronic devices. Another aspect of the present invention relates to nanocapsules, each of which includes a polymeric shell and a core containing a mesogen, which comprises one or more compounds of formula I as described above. It has surprisingly been found that stable and reliable nanocapsules can be provided that contain a liquid crystal precursor medium with favorable optoelectronic properties and appropriate reliability. It has been recognized that nanocapsules according to the present invention can be obtained by a process based on in situ polymerization and especially based on PIPS in a nanoemulsion or can be obtained separately therefrom. Therefore, it is unexpectedly possible to provide a light modulation material including LC nano-sized droplets (nano droplets) encapsulated by a polymer shell as a core, wherein the nano capsules as a whole and the original liquid crystal medium contained therein have proper And even improved properties. Therefore, discrete amounts of LC materials can be confined to nanometer volumes, which are stably contained and can be individually addressed and can be installed or dispersed in different environments. The LC material encapsulated by the polymeric shell nano can be easily applied to and supported from a single substrate, which can be flexible and its layer or film thickness can be changed or individually changed. The LC medium surrounded (ie, encapsulated) by the polymer wall can be operated in at least two states. However, nano droplets each only provide a relatively small volume of LC. As a result, it is currently possible to better and advantageously provide LC groups with appropriately large Dn while also exhibiting good transmission and good reliability, including particularly suitable voltage retention (VHR) and thermal and UV stability, and relatively small rotational viscosity. Serving. In addition, the LC component may advantageously have an appropriate and reasonably high value of the dielectric anisotropy De to obtain a relatively small threshold voltage in the application of photovoltaic devices. In addition, it is advantageously recognized that in nanocapsules, the interface area between the LC core and the polymeric shell is relatively large compared to the nanovolume provided, and therefore the polymeric shell component and the LC core component need to be particularly considered Their individual properties and their interrelationships. In the nanocapsules according to the present invention, the interaction between the polymer and the LC component can be advantageously and appropriately set and adjusted. The main reason for this is that the nanocapsules for nanoencapsulation of the present invention are provided The composition and the control and adaptability of the provided manufacturing process. For example, interfacial interactions can help or prevent the formation of any alignment or orientation in LC nanodroplets. Considering the small size of the nanocapsules (which may be a sub-wavelength of visible light and even smaller than λ / 4 of visible light), the capsule may advantageously be only a very weak visible light scatterer. In addition, in the absence of an electric field and depending on the interface interaction, in one case the LC medium can form a disordered phase with little or no orientation in the nanoscale volume, especially an isotropic phase, which can provide ( For example) Excellent perspective behavior. In addition, having an isotropic phase inherently in an unpowered or non-addressed state can be advantageous in device applications, especially when using a polarizer, since an excellent dark state can be achieved. In contrast to the occurrence of, for example, a radial or bipolar orientation, it is believed that in some cases this orientation may not occur or at least be limited due to the small volume provided in the nanocapsules. Alternatively, and it is better in a specific embodiment, it can be configured, in particular, interfacial interaction can be used to induce or affect the orientation and orientation in the LC medium, for example, by setting or adjusting the anchoring strength with the capsule wall. In this case, a uniform planar radial or bipolar alignment can be produced. When these nanocapsules, which individually and individually have LC orientation or alignment, are randomly dispersed, optical isotropy is generally observed. Spherical or quasi-spherical geometry, together with the curvature, sets constraints or boundary conditions for the nematic configuration and the alignment of the liquid crystal molecules, which may further depend on the anchoring of the LC on the capsule surface, the elastic properties of the capsule, and the body and surface energy As well as size. The photoelectric response in turn depends on the LC ordering and orientation in the nanocapsules. In addition, any possible absence or existence of the orientation and orientation of the encapsulated LC medium is independent of the substrate, so that it is not necessary to provide an alignment layer on the substrate. In particular, when the LC in the capsule has a radial configuration and the particle size is below the wavelength of light, the nanocapsules are essentially optically isotropic. This makes it possible to achieve an excellent dark state when using two crossed polarizers. When using electric field switching, especially in-plane switching, an axial configuration that is optically anisotropic can be obtained, in which induced birefringence causes light transmission. In another aspect of the present invention, a method for preparing a nanocapsule is provided, comprising the steps of (a) providing an aqueous mixture comprising a composition according to the present invention, (b) agitating, preferably mechanically agitating, the provided An aqueous mixture to obtain nano droplets comprising a composition according to the invention and especially a mesogen in a water phase, and (c) after step (b), one or more polymerizable compounds according to the invention Polymerize to obtain nanocapsules, each of which includes a polymeric shell and a core containing a mesogen as described above and below. Optionally, after the nanocapsules are obtained, the aqueous phase can be depleted, removed or exchanged, where, for example, centrifugation or filtration methods can be used. Although the preparation of nanocapsules according to the present invention is not limited thereto and it can also be prepared by other methods, such as by encapsulation with a preformed polymer or by a solute co-diffusion method, it is advantageous in the present invention It is recognized that nanocapsules containing LC media can be advantageously prepared by a process using in situ polymerization, and which is based in particular on polymerization-induced phase separation. In addition, it has been recognized that instead of providing ready-made polymers to encapsulate the LC media, encapsulation of the liquid crystal precursor media on the nanometer scale can advantageously begin in situ from the polymer precursor. Therefore, the use of preformed polymers and the emulsifiers specifically provided with them can be advantageously avoided. In this regard, the use of established pre-made polymers can make the formation and stabilization of nanoemulsions difficult, and in addition, it can limit the adjustability of the entire process. In the process according to the present invention, the one or more polymerizable compounds are at least partially soluble or individually at least partially dissolved in the phase containing the mesogen, preferably the one or more polymerizable compounds and the mesogen are sufficient Mixing, especially homogeneous mixing, where this mixture is subjected to nanophase separation at a later stage by means of PIPS (ie, polymerization-induced phase separation). The temperature can be set and adjusted to favorably affect solubility. To set and influence solubility, dissolution and / or mixing, organic solvents may be added to the composition as appropriate and preferably, which may further advantageously affect phase separation during polymerization. It is advantageously observed that the LC media provided as described above and below are useful for encapsulation processes, especially polymerization and conditions associated therewith (e.g. exposure to heat or UV light (e.g. from wavelengths in the range 300 nm to 380 nm) UV lamp)) is suitably stable. Considering that it is not necessary to perform polymerization between the glass substrates, the selection of the wavelength is advantageously not limited by the UV cutoff of the glass, but can be set, for example, considering the material properties and the stability of the composition. Light including both UV and visible spectrum can also be used, for example by using lamps with a wavelength range of 300 nm to 600 nm. This process is based on a combination of nano-dispersion and PIPS, and it offers significant advantages in providing controlled and adaptable manufacturing methods. The nanocapsules obtained by this process or separately obtainable from this process show suitable and adjustable particle sizes, while giving favorable high particle size uniformity (ie, favorable low polydispersity) and thus favorable homogeneous product properties. It was surprisingly found that setting an appropriate capsule nanometer size while also observing and achieving low polydispersity can have a beneficial effect on operating voltage. Considering the controllability and adaptability of the manufacturing process, it is advantageous to set and tune the photoelectric parameters of the obtained nanocapsules and especially the LC medium contained therein. It has been recognized that various ingredients, or possibly missing ingredients, especially LC materials, one or more polymerizable compounds, and dispersion media and the respective miscibility, solubility, and compatibility of the forming and formed polymers play an important role , Especially mixed free energy and mixed interaction energy and mixed entropy. In addition, it should be noted that the encapsulation process is based on the polymerization reaction, that is, the specific dynamic process is the basis of capsule formation. In particular, it is currently generally observed that one or more polymerizable compounds used for encapsulation have a proper miscibility with the LC medium, and the formed capsule shell polymer exhibits a suitably low solubility with the LC material. In the process according to the invention, the polymerization conversion or completion can be surprisingly high and the amount of residual unreacted polymerizable compound is advantageously low. This ensures that the properties and performance of the LC medium in the formed capsules are not affected or are only minimally affected by residual reactive monomers. In addition, it has been found that prior to polymerization, the provision of a surfactant can advantageously promote the formation and subsequent stabilization, especially ionic and / or steric stabilization, of discrete nanodroplets in a dispersion medium, especially an aqueous dispersion medium. Contains an LC medium and one or more polymerizable compounds. Mechanical agitation, especially high-shear mixing, can appropriately produce or further effect dispersions, especially emulsions and homogenization, and similarly promote nano-droplet formation. Therefore, both mechanical agitation and the provision of surfactants can play an advantageous role in obtaining nano droplets and thus nano-grade capsules, especially nano capsules with substantially uniform particle size distribution or individually low polydispersity. The small and uniform size of the nanocapsules can be beneficial in obtaining fast and uniform switching in response to the applied electric field, preferably giving low millisecond or even sub-millisecond response times. In addition, the properties of phase separation and the formed polymeric shells, especially their stability and immiscibility with the LC component, can be facilitated by cross-linking the polymer chains that are being formed or formed individually, as appropriate and preferably The land is affected. However, without this cross-linking, the capsule properties can also be good enough. Another aspect of the invention relates to a composite system comprising a nanocapsule according to the invention and one or more adhesives. It has been found that the combination of nanocapsules with one or more adhesive materials, in particular in view of the coating or printing and film formation on the substrate, can appropriately influence and increase the processability and applicability of the light modulating material. One or more adhesives can be used as both dispersants and adhesives or binding agents, and in addition can provide proper physical and mechanical stability while maintaining or even promoting flexibility. In addition, the density or concentration of the capsule can be advantageously adjusted by changing the amount of the provided adhesive. Since the nano particles or capsules as prepared can be concentrated (e.g., by centrifugation, filtration or drying) and redispersed, the particles in the film or layer can be set or adjusted independently of the concentration as obtained from the original production process Density or proportion. Another aspect of the present invention provides a photovoltaic device comprising a nanocapsule according to the present invention or a composite system according to the present invention. By providing a nano-encapsulated LC medium according to the present invention, optionally combined with a binder material, several significant advantages can be obtained in photovoltaic devices. These advantages include, for example, good mechanical stability, flexibility and insensitivity to externally applied forces or individual pressures (e.g. from contact), as well as regarding switching speed, transmission, dark state, viewing angle behavior and threshold Other advantageous properties of voltage. Other advantages are that flexible substrates can be used and the possibility of changing the thickness of the film or layer and the tolerance of film thickness deviations or variances. In this regard, the light modulation material may be applied to the substrate using a simple dropping, coating, or printing method. In addition, it is not necessary to provide an alignment layer (such as a conventional polyimide (PI) alignment layer) on the substrate and / or rub the surface of the substrate. When the two electrodes in the device are provided on the same substrate (such as in the case of IPS or FFS), a single substrate may be sufficient to provide functionality and stability or separate support, so that providing the opposite substrate is only optional. However, this opposing substrate may still be beneficial in, for example, providing other optical elements or physical or chemical protection.

不由此限制本發明,在下文中,藉由態樣、實施例及特定特徵之詳細闡述來說明本發明,且更詳細地闡述特定實施例。 術語「液晶(LC)」係關於在一些溫度範圍內(熱致型LC)或在一些溶液濃度範圍內(溶致型LC)具有液晶中間相之材料或媒介。其含有液晶原化合物。 術語「液晶原化合物」及「液晶化合物」意指包含一或多個棒狀(棒形或板形/條形)或盤形(圓盤形)液晶原基團(即具有誘導液晶相或中間相行為之能力之基團)之化合物。 包含液晶原基團之LC化合物或材料及液晶原化合物或材料自身不一定需要展現液晶相。其亦可僅在與其他化合物之混合物中顯示液晶相行為。此包括低分子量非反應性液晶化合物、反應性或可聚合液晶化合物及液晶聚合物。 棒狀液晶原化合物通常包含由一或多個彼此直接連接或經由鏈接基團連接之芳香族或非芳香族環狀基團組成之液晶原核心、視情況包含附接至該液晶原核心之末端之端基及視情況包含一或多個附接至該液晶原核心之長邊之側基,其中該等端基及側基通常選自(例如)碳基或烴基、極性基團(如鹵素、硝基、羥基等)或可聚合基團。 為簡明起見,術語「液晶」材料或介質針對液晶材料或介質及液晶原材料或介質兩者使用,且反之亦然,術語「液晶原」針對材料之液晶原基團使用。 術語「非液晶原化合物或材料」意指不含如上文所定義之液晶原基團之化合物或材料。 如本文中所使用,術語「聚合物」應理解為意指涵蓋一或多種不同類型之重複單元(分子之最小構成單元)之骨架的分子,且包括通常已知之術語「寡聚物」、「共聚物」、「均聚物」及諸如此類。另外應瞭解,術語聚合物除聚合物本身以外包括來自起始劑、觸媒之殘餘物及伴隨此一聚合物合成之其他要素,其中此等殘餘物應理解為並非共價納入其中。此外,此等殘餘物及其他要素儘管通常在聚合後純化製程期間去除,但其通常與聚合物混合或共混,使得在容器之間或溶劑或分散介質之間轉移聚合物時其通常與聚合物保持在一起。 如本發明中所使用之術語「(甲基)丙烯酸聚合物」包括自丙烯酸單體獲得之聚合物、可自甲基丙烯酸單體獲得之聚合物及可自此等單體之混合物獲得之對應共聚物。 術語「聚合」意指藉由將多個可聚合基團或含有此等可聚合基團之聚合物前體(可聚合化合物)鍵結在一起而形成聚合物之化學過程。 具有一個可聚合基團之可聚合化合物亦稱作「單反應性」化合物,具有兩個可聚合基團之化合物亦稱作「二反應性」化合物,且具有兩個以上可聚合基團之化合物亦稱作「多反應性」化合物。不具可聚合基團之化合物亦稱作「非反應性」或「非可聚合」化合物。 術語「膜」及「層」包括具有或多或少明顯機械穩定性之剛性或撓性、自支撐或獨立式膜或層,以及於支撐基板上或兩個基板之間之塗層或層。 可見光係波長在約400 nm至約745 nm範圍內之電磁輻射。紫外(UV)光係波長在約200 nm至400 nm範圍內之電磁輻射。 在第一態樣中,本發明係關於用於奈米膠囊化(即用於形成奈米膠囊)之組合物,其中每一膠囊之已形成之膠囊殼含有呈奈米級體積之LC介質。組合物包含如上文所定義之組份(i)、(ii)及(iii)。特定而言,其中尤其提供包含一或多種式I化合物之液晶原介質。 令人驚訝發現,如根據本發明所提供之組合物容許在有利製程、尤其使用原位聚合之製程、特別基於PIPS之製程中製備含有液晶原介質之有利奈米膠囊,其中組合物在該製程中具有有利性能。此外,該等組合物容許獲得在其物理及化學屬性方面、尤其就其光電性質及其在光電裝置中之適當性而言提供顯著益處之奈米膠囊。因此,本發明組合物可用於製備奈米膠囊。 組合物可藉由適當地將組份混合或摻和來提供。 在較佳實施例中,根據本發明之組合物基於整體組合物佔LC介質以下之量:5重量%至95重量%、更佳地15重量%至75重量%、尤其25重量%至65重量%。 在較佳實施例中,根據本發明之組合物進一步包含一或多種有機溶劑。已發現,提供有機溶劑可在用於製備本發明奈米膠囊之製程中提供額外益處。特定而言,一或多種有機溶劑可有助於設定或調適各組份溶解性或各別地可混溶性。溶劑可用作適當共溶劑,其中其他有機成分之溶劑能力可增強或受影響。此外,該(等)有機溶劑可在由一或多種可聚合化合物之聚合誘導之相分離期間具有有利影響。提供該(等)有機溶劑可有助於獲得LC材料與所製備之聚合物組份之改良分離,且其可進一步影響、尤其降低界面處之錨定能。 就此而言,可使用作為有機溶劑標準之有機溶劑。該(等)溶劑可選自(例如)脂肪族烴、鹵化脂肪族烴、芳香族烴、鹵化芳香族烴、醇(包括氟化醇、二醇(glycol)或其酯)、醚、酯、內酯、酮及諸如此類,更佳地選自二醇(diol)及正烷烴。亦可使用以上溶劑之二元、三元或更多元混合物。 在較佳實施例中,溶劑係選自以下各項之一或多者:環己烷、十四氟己烷、十二烷、十三烷、十四烷、十五烷、十六烷、全氟十六烷、1,5-二甲基四氫萘、3-苯氧基甲苯、十七烷2-異丙氧基乙醇、辛基十二烷醇、全氟辛醇、五氟辛醇、十五氟辛醇、1,2-乙二醇、1,2-丙二醇、1,3-丁二醇、1,4-丁二醇、戊二醇(尤其1,4-戊二醇)、己二醇(尤其1,6-己二醇)、庚二醇、辛二醇、羥基-2-戊酮、三乙醇胺、辛酸甲酯、乙酸乙酯、三氟乙酸三甲基矽基酯及乙酸丁酯。尤佳地,所使用之有機溶劑包含十六烷、辛酸甲酯、乙酸乙酯或1,4-戊二醇,尤其係十六烷、辛酸甲酯、乙酸乙酯或1,4-戊二醇。在另一實施例中,使用包含十六烷及1,4-戊二醇之組合。 該(等)有機溶劑、尤其十六烷較佳地以基於整體組合物以下之量添加:0.1重量%至35重量%、更佳地1重量%至25重量%、尤其3重量%至17重量%。 有機溶劑可增強溶解性或各別地溶解或稀釋其他有機組份且可有助於調節黏度。 在實施例中,有機溶劑用作疏水劑。將其添加至奈米乳液或細乳液之分散相可影響、尤其增加奈米液滴中之滲透壓。此可藉由阻抑奧斯瓦爾德(Ostwald)熟化促成「水包油」乳液穩定化。用作疏水劑之較佳有機溶劑之水中溶解性低於液晶於水中之溶解性,而其可溶於液晶中。 在根據本發明之組合物中,提供一或多種可聚合化合物作為含有或各別地包圍LC介質之聚合殼或壁之前體。 可聚合化合物具有至少一個可聚合基團。可聚合基團較佳地選自CH2 =CW1 -COO-、、CH2 =CW2 -(O)k1 -、CH3 -CH=CH-O-、(CH2 =CH)2 CH-OCO-、(CH2 =CH-CH2 )2 CH-OCO-、(CH2 =CH)2 CH-O-、(CH2 =CH-CH2 )2 N-、HO-CW2 W3 -、HS-CW2 W3 -、HW2 N-、HO-CW2 W3 -NH-、CH2 =CW1 -CO-NH-、CH2 =CH-(COO)k1 -Phe-(O)k2 -、Phe-CH=CH-、HOOC-、OCN-,其中W1 係H、Cl、CN、苯基或具有1至5個C原子之烷基,尤其H、Cl或CH3 ,W2 及W3 各自獨立地係H或具有1至5個C原子之烷基,尤其H、甲基、乙基或正丙基,Phe係1,4-伸苯基且k1 及k2 各自獨立地係0或1。 選擇一或多種可聚合化合物使得其在LC組份或相中具有適當及足夠溶解性。此外,其需要易受聚合條件及環境影響。特定而言,該(等)可聚合化合物可經歷具有高轉化率之適當聚合,使得在反應之後殘餘未反應之可聚合化合物之量有利地低。此可在LC介質之穩定性及性能方面提供益處。此外,選擇可聚合組份使得自其形成之聚合物適當相分離或各別地使得已自其形成之聚合物相分離以構成聚合膠囊殼。特定而言,有利地避免或各別地使LC組份於殼聚合物中之溶解性及已形成之聚合物殼之溶脹或膠凝最小化,其中LC介質之量以及構成在已形成之膠囊中保持實質上恆定。因此,有利地最小化或避免LC材料之任一LC化合物在壁中之優先溶解性。 藉由提供適當堅韌之聚合物殼,可有利地最小化或甚至完全避免奈米膠囊之溶脹或甚至破裂及LC材料自膠囊之不期望洩漏。 聚合或固化時間尤其取決於可聚合材料之反應性及量、已形成之膠囊殼之厚度及聚合起始劑(若存在)之類型及量以及反應溫度及/或輻射(例如UV燈)功率。可選擇聚合或固化時間及條件以(例如)獲得用於聚合之快速製程或者以(例如)獲得然而其中聚合物之轉化及分離之完全性可受有益影響之較慢製程。因此,可較佳具有較短之聚合及固化時間,例如5分鐘以下,而在替代實施例中較長之聚合時間可較佳,例如1小時以上或甚至至少3小時。 在實施例中,使用非液晶原可聚合化合物,即不含液晶原基團之化合物。然而,其展現足夠且適當之溶解性或各別地與LC組份之可混溶性。在較佳實施例中,額外提供有機溶劑。 在另一態樣中,使用可聚合液晶原或液晶化合物(亦稱為反應性液晶原(RM))。該等化合物含有液晶原基團及一或多種可聚合基團(即適於聚合之官能基)。 視情況,在實施例中,根據本發明之可聚合化合物僅包含反應性液晶原,即所有反應性單體係液晶原。或者,RM可與一或多種非液晶原可聚合化合物組合提供。RM可係單反應性或二反應性或多反應性的。RM可展現有利地溶解性或各別地與LC介質之可混溶性。然而,進一步可設計出自其形成或各別地由其形成之聚合物顯示適當相分離行為。較佳可聚合液晶原化合物包含至少一個可聚合基團作為末端基團及液晶原基團作為核心基團,進一步較佳地在可聚合基團與液晶原基團之間包含間隔集團及/或鏈接基團。在實施例中,使用雙[4[3(丙烯醯基氧基)丙基氧基]苯甲酸2-甲基-1,4-伸苯基酯(RM 257, Merck KGaA)。替代地或另外地,液晶原基團之一或多個側向取代基亦可係可聚合基團。 在另一實施例中,避免使用液晶原可聚合化合物。 在較佳實施例中,一或多種可聚合化合物係選自氯乙烯、二氯亞乙烯、丙烯腈、甲基丙烯腈、丙烯醯胺、甲基丙烯醯胺、四氫糠基丙烯酸之甲基酯、乙基酯、正或第三丁基酯、環己基酯、2-乙基己基酯、苯基氧基乙基酯、羥基乙基酯、羥基丙基酯、2-5 C-烷氧基乙基酯或甲基丙烯酸之甲基酯、乙基酯、正或第三丁基酯、環己基酯、2-乙基己基酯、苯基氧基乙基酯、羥基乙基酯、羥基丙基酯、2-5 C-烷氧基乙基酯、乙酸乙烯酯、丙酸乙烯酯、丙烯酸乙烯酯、琥珀酸乙烯酯、N-乙烯基吡咯啶酮、N-乙烯基咔唑、苯乙烯、二乙烯基苯、二丙烯酸伸乙基酯、1,6-己二醇丙烯酸酯、雙酚A二丙烯酸酯及雙酚A二甲基丙烯酸酯、三羥甲基丙烷二丙烯酸酯、三羥甲基丙烷三丙烯酸酯、新戊四醇三丙烯酸酯、三乙二醇二丙烯酸酯、乙二醇二甲基丙烯酸酯、三丙二醇三丙烯酸酯、新戊四醇三丙烯酸酯、新戊四醇四丙烯酸酯、二三甲基丙烷四丙烯酸酯或二新戊四醇五丙烯酸酯或二新戊四醇六丙烯酸酯。硫醇-烯亦較佳,例如市售產品Norland 65 (Norland Products)。亦可使用基於矽烷或基於矽氧烷之反應性單體。 可聚合或反應性基團較佳地選自乙烯基、丙烯酸酯基團、甲基丙烯酸酯基團、氟丙烯酸酯基團、氧雜環丁烷基團或環氧基,尤其較佳地丙烯酸酯基團或甲基丙烯酸酯基團。 較佳地,一或多種可聚合化合物係選自丙烯酸酯、甲基丙烯酸酯、氟丙烯酸酯及乙酸乙烯酯,其中組合物更佳地進一步包含一或多種二反應性及/或三反應性可聚合化合物,較佳地選自二丙烯酸酯、二甲基丙烯酸酯、三丙烯酸酯及三甲基丙烯酸酯。在較佳實施例中,可聚合化合物之一或多種可聚合化合物經氟化,其中尤佳地丙烯酸酯化合物及甲基丙烯酸酯化合物係氟化丙烯酸酯及氟化甲基丙烯酸酯。 在實施例中,如上文所述之一或多種可聚合化合物(ii)包含選自一種、兩種或更多種丙烯酸酯、甲基丙烯酸酯及乙酸乙烯酯基團之可聚合基團,其中該等化合物較佳係非液晶原化合物。 在較佳實施例中,根據本發明之組合物包含一或多種單丙烯酸酯,其較佳地以以下之量添加:基於整體組合物0.1重量%至75重量%、更佳地0.5重量%至50重量%、尤其2.5重量%至25重量%。尤佳之單反應性化合物係選自丙烯酸甲基酯、丙烯酸乙基酯、丙烯酸丙基酯、丙烯酸異丙基酯、丙烯酸丁基酯、丙烯酸第三丁基酯、丙烯酸戊基酯、丙烯酸己基酯、丙烯酸壬基酯、丙烯酸2-乙基-己基酯、丙烯酸2-羥基-乙基酯、丙烯酸2-羥基-丁基酯、丙烯酸2,3-二羥基丙基酯、丙烯酸六氟異丙基酯、丙烯酸1,1-二氫全氟丙基酯、丙烯酸全氟癸基酯、丙烯酸五氟丙基酯、丙烯酸七氟丁基酯、丙烯酸1H,1H,2H,2H-全氟癸基酯、丙烯酸3-參(三甲基矽氧基)矽基丙基酯、丙烯酸硬脂醯基酯及丙烯酸縮水甘油基酯。 另外地或替代地可添加乙酸乙烯酯。 在另一較佳實施例中,根據本發明之組合物視情況除以上單丙烯酸酯以外包含一或多種單甲基丙烯酸酯,其較佳地以基於整體組合物以下之量添加:0.1重量%至75重量%、更佳地0.5重量%至50重量%、尤其2.5重量%至25重量%。尤佳之單反應性化合物係選自甲基丙烯酸甲基酯、甲基丙烯酸乙基酯、甲基丙烯酸丙基酯、甲基丙烯酸異丙基酯、甲基丙烯酸丁基酯、甲基丙烯酸第三丁基酯、甲基丙烯酸戊基酯、甲基丙烯酸己基酯、甲基丙烯酸壬基酯、甲基丙烯酸2-乙基-己基酯、甲基丙烯酸2-羥基-乙基酯、甲基丙烯酸2-羥基-丁基酯、甲基丙烯酸2,3-二羥基丙基酯、甲基丙烯酸六氟異丙基酯、甲基丙烯酸1,1-二氫全氟丙基酯、甲基丙烯酸全氟癸基酯、甲基丙烯酸五氟丙基酯、甲基丙烯酸七氟丁基酯、甲基丙烯酸1H,1H,2H,2H-全氟癸基酯、甲基丙烯酸3-參(三甲基矽氧基)矽基丙基酯、甲基丙烯酸硬脂醯基酯、甲基丙烯酸縮水甘油基酯、甲基丙烯酸金剛烷基酯及甲基丙烯酸異莰基酯。 尤佳地將至少一種交聯劑(即含有兩個或更多個可聚合基團之可聚合化合物)添加至組合物。將所製備顆粒中之聚合殼交聯可提供額外益處,尤其就進一步改良穩定性及容納性及調節或各別地降低對溶脹之易感性、尤其因溶劑引起之溶脹而言。就此而言,二反應性及多反應性化合物可用於形成其自身之聚合物網絡及/或使實質上自聚合單反應性化合物形成之聚合物鏈交聯。 可使用業內已知之習用交聯劑。尤佳地額外提供二反應性或多反應性丙烯酸酯及/或甲基丙烯酸酯,其較佳地以基於整體組合物以下之量添加:0.1重量%至75重量%、更佳地0.5重量%至50重量%、尤其2.5重量%至25重量%。尤佳化合物係選自二丙烯酸伸乙基酯、二丙烯酸伸丙基酯、二丙烯酸伸丁基酯、二丙烯酸伸戊基酯、二丙烯酸伸己基酯、二醇二丙烯酸酯、甘油二丙烯酸酯、新戊四醇四丙烯酸酯、二甲基丙烯酸伸乙基酯(亦稱為乙二醇二甲基丙烯酸酯)、二甲基丙烯酸伸丙基酯、二甲基丙烯酸伸丁基酯、二甲基丙烯酸伸戊基酯、二甲基丙烯酸伸己基酯、三丙二醇二丙烯酸酯、二醇二甲基丙烯酸酯、甘油二甲基丙烯酸酯、三甲基丙烷三甲基丙烯酸酯及新戊四醇三丙烯酸酯。 可有利地設定並調整單反應性單體與二反應性或多反應性單體之比率以影響殼之聚合物組成及其性質。 根據本發明之組合物包含一或多種表面活性劑。在實施例中,該(等)表面活性劑可在初始步驟中單獨製備或提供,且然後添加至其他組份。特定而言,該(等)表面活性劑可作為水性混合物或組合物製備或提供,其然後添加至包含如上文及下文所述之液晶原介質及一或多種可聚合化合物之其他組份。尤佳地,一或多種表面活性劑作為水性表面活性劑提供。 該(等)表面活性劑可用於降低表面或界面張力並促進乳化及分散。 可使用業內已知之習用表面活性劑,包括陰離子表面活性劑,例如硫酸鹽(例如月桂基硫酸鈉)、磺酸鹽、磷酸鹽及羧酸鹽表面活性劑;陽離子表面活性劑,例如二級或三級胺及四級銨鹽表面活性劑;兩性離子表面活性劑,例如甜菜鹼、磺酸甜菜鹼及磷脂表面活性劑;及非離子表面活性劑,例如長鏈醇及酚、醚、酯或醯胺非離子表面活性劑。 在根據本發明之較佳實施例中,使用非離子表面活性劑。在製備奈米膠囊之製程期間、尤其就分散液形成及穩定化而言以及在PIPS中使用非離子表面活性劑可提供益處。此外認識到,在表面活性劑(例如殘餘表面活性劑)包含於已形成之奈米膠囊中之情形下,避免帶電之表面活性劑可係有利的。因此,就奈米膠囊之穩定性、可靠性及光電特性及性能而言,使用非離子表面活性劑且避免離子表面活性劑在複合系統及光電裝置中亦可係有益的。 尤佳者係聚乙氧基化之非離子表面活性劑。較佳化合物係選自以下之群:聚氧乙烯二醇烷基醚表面活性劑、聚氧丙烯二醇烷基醚表面活性劑、葡萄糖苷烷基醚表面活性劑、聚氧乙烯二醇辛基酚醚表面活性劑(例如Triton X-100)、聚氧乙烯二醇烷基酚醚表面活性劑、甘油烷基酯表面活性劑、聚氧乙烯二醇去水山梨醇烷基酯表面活性劑(例如聚山梨醇酯)、去水山梨醇烷基酯表面活性劑、椰油醯胺單乙醇胺、椰油醯胺二乙醇胺及十二烷基二甲基氧化胺。 在尤佳實施例中,所使用之表面活性劑係選自聚氧乙烯二醇烷基醚表面活性劑,其包含市售Brij® 試劑。尤佳者係包含二十三(乙二醇)單十二烷基醚、更佳由其組成之表面活性劑。在極佳實施例中,使用市售Brij® L23 (Sigma-Aldrich),其亦稱為Brij 35或聚氧乙烯(23)月桂基醚。 較佳地,表面活性劑以基於整體組合物以下之量提供於組合物中:少於25重量%、更佳地少於20重量%且尤其少於15重量%。 根據較佳實施例,當表面活性劑作為製備之水性混合物提供時,水之量就重量而言不視為佔整體組成,即就此而言水除外。 在製備根據本發明之奈米膠囊之製程中,亦可使用聚合表面活性劑或表面活性聚合物或嵌段共聚物。 然而在特定實施例中,避免使用此等聚合表面活性劑或表面活性聚合物。 根據本發明之態樣,可使用可聚合表面活性劑,即包含一或多個可聚合基團之表面活性劑。 此可聚合表面活性劑可單獨使用(即作為唯一提供之表面活性劑)或與不可聚合之表面活性劑組合。在實施例中,另外提供可聚合表面活性劑並與不可聚合之表面活性劑組合。可聚合表面活性劑之此可選提供可提供有助於適當液滴形成及穩定化以及穩定聚合膠囊殼形成之合併益處。因此,該等化合物同時作為表面活性劑及可聚合化合物起作用。尤佳者係可聚合非離子表面活性劑、尤其額外具有一或多個丙烯酸酯及/或甲基丙烯酸酯基團之非離子表面活性劑。此包括使用可聚合表面活性劑之實施例可具有之優點在於兩親性界面處之模板性質在聚合期間可尤其好地得以保持。此外,可聚合表面活性劑不僅可參與聚合反應,而且可有利地作為構建單元併入至聚合物殼中以及更佳地殼表面處,使得其可有利地影響界面相互作用。在尤佳實施例中,聚矽氧聚醚丙烯酸酯、更佳地可交聯聚矽氧聚醚丙烯酸酯係用作可聚合表面活性劑。亦可添加聚(乙二醇)甲醚甲基丙烯酸酯。 在較佳實施例中,根據本發明之組合物係作為水性混合物提供,其中更佳地,包含組份(i)、(ii)及(iii)之該組合物分散於水相中。就此而言,所提供之該(等)表面活性劑可有利地有助於形成及穩定分散液、尤其乳液,並促進均質化。 在提供水性混合物之情形下,水之量就重量而言不視為佔整體組成,即就此而言水除外。 較佳地,水作為純化水、尤其去離子水提供。 在尤佳實施例中,根據本發明之組合物係作為分散於水相中之奈米液滴提供。 組合物可含有其他化合物,例如一或多種多色性染料(尤其一或多種二色性染料)、一或多種手性化合物及/或其他習用及適當添加劑。 多色性染料較佳係二色性染料且可選自(例如)偶氮染料及噻二唑染料。 適當手性化合物係(例如)標準手性摻雜劑,如R-或S-811、R-或S-1011、R-或S-2011、R-或S-3011、R-或S-4011、R-或S-5011或CB 15 (所有可自Merck KGaA, DaRMtadt, Germany獲得);如WO 98/00428中所闡述之山梨醇;如GB 2,328,207中所闡述之氫化安息香;如WO 02/94805中所闡述之手性聯萘酚;如WO 02/34739中所闡述之手性聯萘酚縮醛;如WO 02/06265中所闡述之手性TADDOL;或如WO 02/06196或WO 02/06195中所闡述之具有氟化鏈接基團之手性化合物。 此外,可添加物質以改變LC材料之光電參數對介電各向異性、光學各向異性、黏度及/或溫度之依賴性。 根據本發明之液晶原介質包含一或多種如上文所述之式I化合物。 在較佳實施例中,液晶介質係由2至25種、較佳地3至20種化合物組成,該等之至少一者係式I化合物。介質較佳包含一或多種、更佳兩種或更多種且最佳三種或更多種根據本發明之式I化合物。介質較佳地包含選自向列型或向列態物質之低分子量液晶化合物,例如選自以下之已知類別:氧偶氮苯、亞苄基-苯胺、聯苯、聯三苯、苯甲酸苯基酯或苯甲酸環己基酯、環己烷甲酸之苯基酯或環己基酯、環己基苯甲酸之苯基酯或環己基酯、環己基環己烷甲酸之苯基酯或環己基酯、苯甲酸之環己基苯基酯、環己烷甲酸之環己基苯基酯及環己基環己烷甲酸之環己基苯基酯、苯基環己烷、環己基聯苯、苯基環己基環己烷、環己基環己烷、環己基環己烯、環己基環己基環己烯、1,4-雙環己基苯、4,4’-雙環己基聯苯、苯基嘧啶或環己基嘧啶、苯基吡啶或環己基吡啶、苯基嗒嗪或環己基嗒嗪、苯基二噁烷或環己基二噁烷、苯基-1,3-二噻烷或環己基-1,3-二噻烷、1,2-二苯基-乙烷、1,2-二環己基乙烷、1-苯基-2-環己基乙烷、1-環己基-2-(4-苯基環己基)-乙烷、1-環己基-2-聯苯-乙烷、1-苯基2-環己基-苯基乙烷,視情況鹵化二苯乙烯、苄基苯基醚、二苯乙炔、經取代之肉桂酸及其他類別之向列型或向列態物質。該等化合物中之1,4-伸苯基亦可側向地經單氟化或二氟化。液晶混合物較佳地基於此類型之非手性化合物。 在較佳實施例中,LC主體混合物係向列型LC混合物,其較佳地不具有手性LC相。 適當LC混合物可具有正介電各向異性。此等混合物闡述於(例如)JP 07-181 439 (A)、EP 0 667 555、EP 0 673 986、DE 195 09 410、DE 195 28 106、DE 195 28 107、WO 96/23 851、WO 96/28 521及WO2012/079676中。 在另一實施例中,LC介質具有負介電各向異性。此等介質闡述於(例如) EP 1 378 557 A1中。 在尤佳實施例中,一或多種式I化合物係選自一或多種式Ia、Ib及Ic化合物,其中 R1 、R2 、R3 、R4 及R5 彼此獨立地表示具有1至15個碳原子之直鏈或具支鏈烷基或烷氧基或具有2至15個碳原子之直鏈或具支鏈烯基,其未經取代、由CN或CF3 單取代或由鹵素、較佳地F單取代或多取代,且其中一或多個CH2 基團在每一情形下可彼此獨立地以使得氧原子彼此不直接連接之方式由-O-、-S-、-CO-、-COO-、-OCO-、-OCOO-或-C≡C-替代, X1 表示F、CF3 、OCF3 或CN, L1 、L2 、L3 及L4 彼此獨立地係H或F, i 係1或2,且 j及k 彼此獨立地係0或1。 如上文所闡述之根據本發明之組合物可用於根據本發明之奈米膠囊之製備方法中並提供特定優點。 令人驚訝地發現,根據本發明,可最終在奈米級上實施高效且受控之製程以產生通常係球形或類球形之包封LC材料之奈米級容器。製程利用分散液、尤其奈米乳液(亦稱為細乳液),其中包含LC材料及一或多種反應性可聚合化合物之奈米級相分散於適當分散介質中。 特定而言,分散相在分散介質中展現較差之溶解性,此意味著其顯示低溶解性或甚至實際上不溶於形成連續相之分散介質中。有利地,使用水、基於水或水溶液或混合物來形成連續或外部相。 藉助分散,個別奈米液滴彼此去耦合之方式使得每一液滴構成用於隨後聚合之單獨奈米級反應體積。 製程便捷地利用原位聚合。特定而言,聚合與相分離組合。就此而言,奈米液滴給出之大小設定該等轉變之長度標度或體積或導致聚合誘導之奈米相分離之各別地分離。 此外,液滴界面可用作膠囊化聚合殼之模板。在奈米液滴中形成或開始形成之聚合物鏈或網絡可隔離或經驅動以在與水相之界面處累積,聚合可在此處進行以及終止以形成封閉之膠囊化層。就此而言,正形成或各別地已形成之聚合殼實質上不可混溶於水相以及LC介質兩者中。 因此,在本發明之態樣中,可在水相與包含LC介質之相之間之界面處接著發生、促進及/或繼續聚合。就此而言,界面可用作擴散障壁及作為反應位點。 此外,膠囊之正形成及已形成界面之特性、尤其聚合物之結構及構建單元可藉助(例如)垂面錨定、錨定能及因應電場之切換行為而影響材料性質、尤其LC配向。在一個實施例中,降低錨定能或強度以有利地影響光電切換,其中可適當地設定及調整(例如)聚合物表面形態及極性。 特定而言,製程之組合要素可有利地產生大量個別、分散或可各別地分散之液奈米膠囊之製備,其各自具有聚合殼及包含LC材料之核心。 在製程之第一步驟中,製備或提供水性混合物,其包含根據本發明之組合物。在實施例中,可製備較佳於水中之表面活性劑溶液或混合物並添加至組合物之其他組份。然後攪動、尤其機械攪動所提供之水性混合物以獲得分散於水相中之包含一或多種可聚合化合物及根據本發明之LC介質之奈米液滴。可使用高剪切混合來實施攪動或混合。舉例而言,可使用使用轉子-定子原理之高性能分散裝置,例如市售Turrax (IKA)。視情況可由音波處理替代此高剪切混合。亦可組合音波處理與高剪切混合,其中較佳地音波處理在高剪切混合之前進行。 如上文所闡述之攪動之組合及提供表面活性劑可有利得使得分散液、尤其乳液適當形成且穩定化。使用高壓均質器(除上文所闡述之混合以外視情況且較佳地使用)可藉由設定或調整及各別地降低液滴大小且亦藉由使液滴大小分佈更窄(即改良粒徑之均勻性)進一步有利地影響奈米分散液、尤其奈米乳液之製備。此在高壓均質化重複進行、尤其若干次(例如三次、四次或五次)時尤佳。舉例而言,可使用市售微射流均質機(Microfluidics)。 然後使分散奈米液滴經受聚合步驟。特定而言,將奈米液滴中所含有或與其各別地混合之一或多種可聚合化合物聚合。此聚合引起PIPS及如上文及下文所闡述之具有核心-殼結構之奈米膠囊之形成。所獲得或可各別地獲得之奈米膠囊通常呈球形、實質上球形或類球形。就此而言,一些形狀不對稱或小的變形可係有益的,例如就操作電壓而言。 在乳液液滴中及每一液滴界面處之聚合可使用習用方法來實施。可以一或多個步驟來實施聚合。特定而言,在奈米液滴中一或多種可聚合化合物之聚合較佳地藉由暴露於熱或光化輻射來達成,其中暴露於光化輻射意味著用光(如UV光、可見光或IR光)輻照、用X射線或γ射線輻照或用高能粒子(例如離子或電子)輻照。在較佳實施例中,實施自由基聚合。 聚合可在適當溫度下實施。在實施例中,聚合係在低於液晶原混合物之澄清點之溫度下進行。然而,在替代實施例中,亦可在澄清點下或高於澄清點下實施聚合。 在實施例中,聚合係藉由將乳液加熱來實施,即藉由熱聚合、例如藉由熱聚合一或多種丙烯酸酯及/或甲基丙烯酸酯化合物來實施。尤佳者係反應性可聚合前體之熱起始自由基聚合,使得LC材料奈米膠囊化。 在另一實施例中,聚合係藉由光輻照來實施,即用光、較佳地UV光來實施。作為光化輻射之來源,可使用(例如)單一UV燈或一套UV燈。當使用高燈功率時,可縮短固化時間。光輻射之另一可能來源係雷射,如(例如) UV雷射、可見雷射或IR雷射。 可將適當及習用之熱起始劑或光起始劑添加至組合物以促進反應,例如偶氮化合物或有機過氧化物(例如Luperox型起始劑)。此外,聚合之適當條件及起始劑之適當類型及量為業內所已知並闡述於文獻中。 例如,當藉助UV光聚合時,可使用光起始劑,其在UV輻照下分解從而產生起始聚合反應之自由基或離子。對於聚合丙烯酸酯或甲基丙烯酸酯基團而言,較佳地使用自由基光起始劑。為使乙烯基、環氧化物或氧雜環丁烷基團聚合,較佳使用陽離子光起始劑。亦可使用熱聚合起始劑,其在加熱時分解從而產生起始聚合之自由基或離子。典型自由基光起始劑係(例如)市售Irgacure®或Darocure® (Ciba Geigy AG, Basel, Switzerland)。典型陽離子光起始劑係(例如) UVI 6974 (Union Carbide)。 在實施例中,使用可很好地溶於奈米液滴中但不溶於水中或至少實質上不溶於水中之起始劑。舉例而言,在製備奈米膠囊之製程中,可使用偶氮二異丁腈(AIBN),其在特定實施例中進一步包含於根據本發明之組合物中。 替代地亦或另外地,可提供水溶性起始劑,例如2,2’-偶氮雙(2-甲基丙醯胺)二鹽酸鹽(AIBA)。 在實施例中,尤佳地使用非離子性起始劑、尤其非離子性光起始劑。 亦可添加其他添加劑。特定而言,可聚合材料可額外包含一或多種添加劑,例如觸媒、敏化劑、穩定劑、抑制劑及鏈轉移劑。 舉例而言,可聚合材料亦可包含一或多種穩定劑或抑制劑以防止不期望之自發聚合,如(例如)市售Irganox® (Ciba Geigy AG, Basel, Switzerland)。 藉由將一或多種鏈轉移劑添加至可聚合材料,可調節所獲得或可各別地獲得之聚合物之性質。藉由使用鏈轉移劑,可調整聚合物中游離聚合物鏈之長度及/或兩個交聯之間之聚合物鏈之長度,其中當鏈轉移劑之量增加時,聚合物中之聚合物鏈長度通常降低。 聚合較佳在惰性氣體氣氛(例如氮或氬)、更佳地在加熱之氮氣氛下進行。但亦可在空氣中聚合。 此外,較佳地,聚合在上文所闡述之有機溶劑存在下實施。使用有機溶劑(例如十六烷)就調整一或多種反應性化合物與LC材料之溶解性及穩定奈米液滴而言可係有利的,且其在影響相分離方面亦可係有益的。然而較佳地,有機溶劑之量(假若使用)基於整體組合物通常限於低於25重量%、更佳地少於20重量%且尤其少於15重量%。 已形成之聚合物殼關於LC材料以及水兩者適當地展現低溶解性,即實質上不溶。此外,在製程中,所產生之奈米膠囊之凝結或各別地聚集可適當且有利地受到限制或甚至避免。 亦較佳地,殼中正形成之聚合物或各別地已形成之聚合物交聯。此交聯可在形成穩定聚合殼及給出適當容納性及障壁功能性方面提供益處,同時維持足夠之機械撓性。 因此,根據本發明之製程提供液晶原介質之膠囊化及侷限,同時維持LC材料之光電性能及尤其電反應性。特定而言,提供組合物以及製程條件使得LC材料之穩定性得以維持。因此,LC可在已形成之奈米膠囊中展現有利特性,例如適當高的De、適當高的Dn、高的有利澄清點及低熔點。特定而言,所提供之LC材料可在聚合中顯示(例如)關於暴露於熱或UV光之適當且有利的穩定性。 在製程中,有利地使用水或水溶液作為分散介質。然而,就此而言,此外亦觀察到所提供之組合物以及所產生之奈米膠囊對水之存在(例如關於水解)顯示適當穩定性及耐化學性。在實施例中,藉由提供或添加含有(例如)甲醯胺或乙二醇之極性介質、較佳地非水性極性介質可降低或甚至實質上最小化水之量。 因此,在製程中產生適當分散之穩定奈米膠囊。在可選且較佳之隨後步驟中,可去除水相或可各別地降低或耗盡水之量,或者可將水相交換為另一分散介質。 在實施例中,(例如)藉由過濾或離心,分散或可各別地分散之液奈米膠囊自水相實質或完全分離。可使用習用過濾(例如膜過濾)、透析、交叉流過濾及尤其交叉流過濾與透析之組合及/或離心技術。過濾及/或離心可藉由(例如)去除過量或不希望之或甚至殘餘之表面活性劑來提供其他益處。因此,例如藉由去除污染物、雜質或不希望之離子不僅可提供奈米膠囊之濃度亦可提供純化。 較佳地且有利地,將膠囊之表面電荷之量保持在最小。基於機械穩定性,奈米膠囊可相對容易地經受分離技術。亦可將奈米膠囊乾燥,其中乾燥意指去除分散介質但將所含有之LC材料留在膠囊內部。可使用習用技術,例如空氣中乾燥、臨界點乾燥及冷凍乾燥、尤其冷凍乾燥。 有利地,根據本發明之製程提供大量可分散且甚至可再分散之個別奈米膠囊。因此,其可進一步容易且靈活地使用並施加至各種環境。由於膠囊之其穩定性儲存,故在用於各種應用之前尤其具有適當的長儲放壽命亦係可能的。然而,立即進一步處理亦係有利提供之選擇。就此而言,膠囊在處理期間、尤其對於塗覆應用適當地穩定。 如上文所闡述之製程以受控及可調適之方式提供便利之產生奈米膠囊之方法。特定而言,在將多分散性保持較低的同時可適當地調整膠囊粒徑,例如藉由調整組合物中表面活性劑之量來實施。令人驚訝發現,考慮到降低光電應用中之操作電壓,適當設定之均勻膠囊大小可尤其有利。 在實施例中,組合物中所提供之表面活性劑可至少部分地併入聚合膠囊殼中,且尤其併入與膠囊內部中LC之界面處。此等在界面處併入之表面活性劑分子尤其藉由設定或調節界面性質及相互作用可有利地影響光電性能並降低操作電壓。在一種情形下,表面活性劑可有利地影響LC分子之配向,例如促進垂直配向從而產生徑向構形。另外地或替代地,表面活性劑分子可影響內部聚合物表面之形態及物理化學屬性,使得錨定強度降低。因此,組合物中所提供之表面活性劑不僅有助於根據本發明之有利製程,而且其亦可在所獲得之奈米膠囊中提供益處。 在本發明之另一態樣中,提供根據本發明之有利奈米膠囊。特定而言,該等奈米膠囊構成填充有LC材料之具有視情況且較佳地交聯之聚合殼之奈米容器。膠囊係個別的且單獨的,即具有核心-殼結構之離散及可分散之顆粒。膠囊可個別地亦或共同地作為光調變材料。其可施加至各種環境且端視分散介質而定,可再分散於不同介質中。舉例而言,其可分散於水或水相中,乾燥,並分散於黏合劑、較佳地聚合物黏合劑中。奈米膠囊亦可稱為奈米顆粒。特定而言,奈米顆粒包含由聚合物殼包圍之奈米級LC材料。該等奈米膠囊化之液晶可視情況另外地嵌入聚合黏合劑中。 在其中相分離不太明顯或不太完全之替代情形下,聚合物網絡可在液滴內部中形成使得獲得展現海綿狀或多孔性內部之膠囊,其中LC材料填充空隙。在此情形下,LC材料填充海綿狀結構或網絡中之孔,而殼包封LC材料。 在另一替代情形下,LC材料與聚合物之間之分離可處於中間程度,其中LC內部與壁之間之界面或邊界僅不太明顯且顯示梯度行為。 然而,較佳地獲得殼聚合物與LC材料之高效且完全之分離,尤其給出具有光滑內部表面之殼。 視情況,所包含之液晶原介質可進一步含有一或多種手性摻雜劑及/或一或多種多色性染料及/或其他習用添加劑。 有利地,根據本發明之奈米膠囊係藉由本發明組合物之聚合獲得或可自其獲得,且尤其自本文中所闡述之高效且受控之製程獲得。令人驚訝地,在奈米膠囊中尤其可藉由將上文所闡述之一或多種前體化合物聚合來提供殼聚合物,此相對於LC組份充分匹配且與LC性能相容。較佳地,膠囊聚合物之電阻抗至少等於且更佳地大於LC材料之電阻抗。 另外,殼聚合物就可分散性及避免不希望之聚集而言可係有利的。此外,殼聚合物可與黏合劑組合並與黏合劑良好地起作用,例如在膜形成複合系統及尤其光電應用中。 根據本發明之膠囊(其中液晶藉由殼材料組份膠囊化)之特徵在於其係奈米級的。較佳者係平均大小不大於400 nm之奈米膠囊。 較佳地,如藉由動態光散射分析所測定,奈米膠囊之平均大小不大於400 nm、更佳地不大於250 nm。動態光散射(DLS)係眾所周知之技術,其可用於測定亞微米區域中顆粒之大小以及大小分佈。舉例而言,可使用市售Zetasizer (Malvern)用於DLS分析。 甚至更佳地,奈米膠囊之平均大小低於200 nm、尤其不大於150 nm,如較佳地藉由DLS所測定。在尤佳實施例中,平均奈米膠囊大小低於可見光之波長、尤其小於可見光之λ/4。有利地發現,根據本發明之在至少一種狀態下、尤其具有適當LC配向或構形之奈米膠囊可係極弱之可見光散射體,即其不或實質上不散射可見光。在此情形下,膠囊可用於調變光之兩個偏振分量之間之相移(即相位延遲),同時在任何狀態下不顯示或實質上不顯示不希望之光之散射。 對於光電應用而言,聚合物膠囊化之液晶原介質較佳地展現以下侷限大小:15 nm至400 nm、更佳地50 nm至250 nm且尤其75 nm至150 nm。 若膠囊大小變得極小、尤其接近LC分子之分子大小,考慮到所包封LC材料之量減少並且LC分子之遷移率變得更加受限,膠囊之功能性可變得不太高效。 選擇形成離散個別結構之聚合殼或各別地壁之厚度使得其有效地含有並穩定地侷限所含有之LC介質,同時容許相對撓性並仍能夠實現LC材料之優良電反應性。考慮到電容及光電性能,殼較佳地應儘可能地薄,同時仍提供足夠的容納強度。因此,典型膠囊殼或壁厚度低於100 nm。較佳地,聚合殼之厚度小於50 nm、更佳地低於25 nm且尤其低於15 nm。在較佳實施例中,聚合殼之厚度為1 nm至15 nm、更佳地3 nm至10 nm且尤其5 nm至8 nm。 可使用顯微鏡技術、尤其SEM及TEM來觀察奈米膠囊大小、結構及形態。可(例如)藉由在冷凍斷裂樣品上之TEM來測定壁厚度。或者,可使用中子散射技術。此外,舉例而言,AFM、NMR、橢圓偏光及和頻產生技術可用於研究奈米膠囊結構。根據本發明之奈米膠囊通常具有球形或類球形形狀,其中中空球形或類球形殼填充有或各別地含有根據本發明之LC介質。 較佳地,奈米膠囊實質上不含表面活性劑,使得較佳地甚至殘餘表面活性劑保持在最小值或甚至完全避免。 因此,在態樣中提供實質上不含表面活性劑之奈米膠囊。 因此,本發明提供複數個LC之離散球形或類球形體或顆粒,其各自由聚合殼奈米膠囊化且其可各自個別地以及共同地以至少兩種狀態在光電裝置中操作。 LC組份提供如上文所闡述之有益化學、物理及光電特性,例如良好之可靠性及穩定性及較低之旋轉黏度。在較佳實施例中,根據本發明之LC介質具有Dn ³ 0.15、更佳地³ 0.20且最佳地³ 0.25之雙折射。當根據本發明之LC介質額外具有De³ 10之介電各向異性時甚至更佳。 令人驚訝地,根據本發明藉由適當地提供及設定雙折射以及介電各向異性,甚至小奈米體積之LC足以有效且高效地調變光,其中僅中等電場或各別地僅中等驅動電壓即可用來實現或各別地改變奈米膠囊中LC分子之配向。 此外,本發明之另一優點在於可獲得實質上均勻之膠囊大小,即達成低多分散性。此均勻性可有利地在裝置應用中提供膠囊之均勻光電性能。 此外,由根據本發明之受控且可調適之製程獲得或可各別地自其獲得之膠囊可關於膠囊大小進行調整及調節,此進而容許根據期望、尤其基於克爾效應調節光電性能。 在本發明之另一態樣中,提供包含根據本發明之奈米膠囊及一或多種黏合劑之複合系統。 已發現,離散奈米膠囊可與黏合劑材料混合,其中混合之奈米膠囊實質上維持、較佳地完全維持其在複合物中之完整性,而同時結合、固持或安裝於黏合劑中。就此而言,黏合劑材料可係與聚合殼材料相同之材料或不同材料。因此,根據本發明,奈米膠囊可分散於自與奈米膠囊殼之材料相同之材料製得或與其不同之材料製得之黏合劑中。較佳地,黏合劑係不同或至少經改質之材料。 黏合劑由於其可分散奈米膠囊而可係有用的,其中可設定並調整膠囊之量或濃度。令人驚訝地,藉由獨立地提供膠囊及適當黏合劑,不僅可調整組合複合物中膠囊之量,且若期望亦可尤其獲得極高含量亦及或者極低含量之膠囊。通常,奈米膠囊以約2重量%至約95重量%之比例含於複合物中。較佳地,複合物含有10重量%至85重量%、更佳30重量%至70重量%範圍內之奈米膠囊。在較佳實施例中,所使用之黏合劑與奈米膠囊之量大約相同。 此外,黏合劑材料可改良或影響膠囊之可塗覆性或可印刷性及膜形成能力及性能。較佳地,黏合劑可在維持適當程度之撓性的同時提供機械支撐,且其可用作基質。此外,黏合劑展現適當及足夠之透明度。 在實施例中,黏合劑可選自(例如)如(例如) US 4,814,211中所闡述之無機玻璃整料或其他無機材料。 然而,黏合劑較佳係聚合材料。適當材料可係合成樹脂,例如環氧樹脂及聚胺基甲酸酯,其(例如)可熱固化。此外,可使用乙烯基化合物及丙烯酸酯、尤其聚丙烯酸乙烯酯及聚乙酸乙烯酯。此外,可使用或添加聚甲基丙烯酸甲基酯、聚脲、聚胺基甲酸酯、脲甲醛、三聚氰胺甲醛、三聚氰胺脲甲醛。亦可使用基於硫醇-烯之系統,例如市售產品Norland光學黏著劑65 (Norland Products)。 尤佳使用水溶性聚合物,例如聚乙烯醇(PVA)、澱粉、羧甲基纖維素、甲基纖維素、乙基纖維素、聚乙烯吡咯啶、明膠、海藻酸鹽、酪蛋白、阿拉伯膠或乳膠狀乳液。就設定各別疏水性或親水性而言,可(例如)選擇黏合劑。 在較佳實施例中,黏合劑、尤其乾黏合劑極少吸收水或不吸收水。 在尤佳實施例中,一或多種黏合劑包含聚乙烯醇,其包括部分及完全水解之PVA。有利地,可藉由改變水解度來調整水溶性及親水性。因此,可控制或降低水吸收。PVA之性質(例如機械強度或黏度)可藉由(例如)調整PVA之分子量、水解度或藉由化學修飾來有利地設定。 黏合劑性質亦可藉由交聯黏合劑而有利地受影響。因此,尤其當PVA作為黏合劑提供時,在實施例中,較佳地藉由諸如二醛(例如戊二醛、甲醛及乙二醛)之交聯劑將黏合劑交聯。此交聯可(例如)有利地降低任何不期望裂紋形成之傾向。 複合物可進一步包含習用添加劑,例如穩定劑、抗氧化劑、自由基清除劑及/或塑化劑。 對於黏合劑、尤其PVA而言,可使用乙二醇作為較佳塑化劑。亦可將甘油添加至黏合劑、尤其基於PVA之黏合劑。添加至黏合劑、尤其至PVA之該等添加劑亦可用於有利地影響或調整其他材料性質,例如操作電壓或介電容率。 此外,為有利地影響膜形成性質,可添加成膜劑(例如聚丙烯酸)及消泡劑。 此等試劑可用於改良膜形成及基板可潤濕性。視情況,可進行塗料組合物之脫氣及/或過濾以進一步改良膜性質。同樣地,設定並調整黏合劑黏度可對正形成或各別地已形成之膜具有有利影響。 黏合劑可作為液體或糊狀物提供,其中可(例如)在膜形成期間或之後尤其藉由在升高溫度下蒸發將載劑介質或溶劑(例如水、水性溶劑或有機溶劑)自複合物混合物去除。 黏合劑較佳地與奈米膠囊良好地混合及組合,同時進一步避免膠囊之聚集,使得可避免或最小化(例如)光洩漏,此進而可使極佳暗狀態成為可能。此外,黏合劑可經選擇使得可在複合物中(例如在由複合物所形成之膜中)提供高密度之奈米膠囊。此外,在複合物中,黏合劑之結構及機械優點可與LC膠囊之有利光電性質組合。 根據本發明之奈米膠囊可尤其藉由將其(再)分散而施加至各種各樣之不同環境。其可有利地分散於黏合劑中或各別地與黏合劑混合。黏合劑不僅可改良膜形成行為亦可改良膜性質,其中尤其黏合劑可相對於基板固持膠囊。通常,膠囊在黏合劑中隨機分佈或各別地隨機定向。 可將包含黏合劑材料之複合物以及以其自身之奈米膠囊適當地施加或層壓至基板。舉例而言,可藉由習用塗覆技術(例如旋塗、刮塗或滴塗)將複合物或僅奈米膠囊施加至基板上。或者,亦可藉由習用及已知印刷方法(例如噴墨印刷)將其施加至基板。亦可將膠囊或複合物溶解於適當溶劑中。然後藉由(例如)旋塗或印刷或其他已知技術將此溶液塗覆或印刷至基板上,並將溶劑蒸發掉。在許多情形下,適當地將混合物加熱以促進溶劑之蒸發。可使用(例如)水、水性混合物或標準有機溶劑作為溶劑。 較佳地,施加至基板之材料係複合物(即其亦含有黏合劑)。通常,形成厚度為低於25 µm、較佳地低於15 µm之膜。在較佳實施例中,由複合物所製得之膜之厚度為0.5 µm至10 μm、極佳地1 µm至7 μm、尤其2 µm至5 μm。 可使用(例如)玻璃、矽、石英薄片或塑膠膜作為基板。亦可將第二基板置於經施加、較佳地塗覆或印刷之材料之頂部。可使用各向同性或雙折射基板。亦可施加光學塗層、尤其與光學黏著劑一起。 在較佳實施例中,基板可係撓性材料。鑒於由複合物所提供之撓性,因此整體上可獲得撓性系統或裝置。 適當且較佳之塑膠基板係(例如)聚酯(例如,聚對苯二甲酸乙二酯(PET)或聚萘二甲酸乙二酯(PEN))、聚乙烯醇(PVA)、聚碳酸酯(PC)或三乙醯纖維素(TAC)之膜,更佳為PET或TAC膜。可使用(例如)單軸拉伸之塑膠膜作為雙折射基板。PET膜可(例如)以商標名Melinex® 自DuPont Teijin Films購得。 基板可係透明及透射或反射的。為了光電可定址性,基板可展現一或多個電極。在典型實施例中,提供具有ITO電極之玻璃基板。 就相容性而言且鑒於各別應用,LC材料、聚合膠囊殼及黏合劑之電學及光學性質有利地且較佳地匹配或配向。根據本發明之複合物可提供適當及有利之光電行為及性能。 此外,藉由(例如)較佳地且有利地降低水吸收可獲得優良物理及化學穩定性。特定而言,可達成良好穩定性及對熱或機械應力之耐受性而同時仍提供適當之機械撓性。 較佳地,黏合劑且較佳地以及聚合物殼鑒於LC之電反應性具有相對較大之阻抗以及與LC材料接近之適當介電常數以限制界面處之充電。觀察到黏合劑之介電常數足夠高以確保電場有效地施加於膠囊中之LC介質上。較佳地使該等材料中之任何電荷或離子含量最小化以將導電性保持極低。就此而言,已發現,所提供之黏合劑、較佳PVA之性質可藉由純化、尤其藉由去除或減少雜質及帶電污染物之量來改良。舉例而言,黏合劑、尤其PVA可溶解於去離子水或醇中並在其中洗滌,且其可藉由透析或索格斯利特(soxhlet)純化進行處理。 此外,考慮到各別應用中之最佳性能,LC材料、聚合膠囊殼及黏合劑之折射率有利地且較佳地匹配或配向。特定而言,LC材料與黏合劑之折射率相協調。特定而言,可慮及LC之非常折射率(ne )、LC之尋常折射率(no )或LC之平均折射率(navg )設定或調整黏合劑之折射率以及可能地膠囊聚合物之折射率。特定而言,黏合劑以及殼聚合物之折射率可與LC材料之ne 、no 或navg 緊密匹配。 在實施例中,奈米膠囊分散於黏合劑中,其中黏合劑中之膠囊相對於彼此展現隨機定向。不管每一個別膠囊內LC材料之配向或定向不存在或存在之任何可能性,膠囊相對於彼此之此隨機定向可導致LC材料作為整體給出觀察到之平均折射率(navg )。慮及膠囊之奈米大小及其用作僅極弱之光散射體之有利潛能,在此實施例中電場之施加(其中電場迫使LC材料(再)配向)可調變透射或反射光之相移或延遲,然而並不改變表觀散射(假若存在)。在此一情形下,且尤其當膠囊之大小顯著小於光波長時,黏合劑且較佳地以及聚合膠囊殼之折射率可(例如)適當且有利地相對於LC材料之navg 進行調整或匹配。因此,奈米膠囊可作為高效奈米級相位調變器。 考慮到膠囊之奈米大小且在電場不存在下,可實質上阻抑、較佳地完全阻抑光散射,尤其對於大小小於400 nm者而言。此外,可藉由匹配或調整LC材料及一或多種聚合材料之折射率來控制散射及折射。 當膠囊及各別LC指向矢在黏合劑中隨機定位時,在實施例中,對於正常入射光,相移可與偏振無關。 在另一實施例中,膠囊在黏合劑中配向或定向。 尤其就調諧光電性質及功能性而言,根據本發明之複合系統有利地容許高適應度且容許設定及調整若干個自由度。舉例而言,在能夠獨立地改變膜中奈米級LC材料之密度的同時,可設定、調試或改變層或膜厚度,其中此外奈米膠囊之大小(即每一個別膠囊中LC材料之量)可預先設定且因此亦可調整。此外,可選擇LC介質以具有特定性質,例如適當高的De及Dn值。 在較佳實施例中,適當地最大化組合物中、奈米膠囊中及複合物中LC之量以達成有利的高光電性能。 根據本發明,可有利地以相對產生容易性及高可加工性提供複合物,其可使得良好透射率、低操作電壓、改良之VHR及良好暗狀態成為可能。令人驚訝地,可獲得強健之有效及高效系統,其適用於無任何配向層或無表面摩擦之單一基板且其可對層厚度偏差或對外力(例如觸摸)以及在光洩漏方面展現相對不敏感性。此外,可在不提供配向層或額外延遲層之情形下獲得寬視角。 較佳地且有利地,所提供之奈米膠囊及複合系統顯示足夠的可加工性,使得在膠囊之濃縮及過濾、與黏合劑混合、膜形成及膜之可選乾燥期間聚集保持在最小。 根據本發明之奈米膠囊及複合物可用於顯示器及其他光學及光電應用中。 特定而言,含有LC介質之較佳與黏合劑混合之奈米膠囊適於光之高效控制及調變。其可用於(例如)濾光器、可調偏振器及透鏡及相位板中。作為相位調變器,其可用於光子裝置、光通訊及資訊處理及三維顯示器中。另一用途在於可切換之智能窗或防窺窗中。 因此,本發明有利地提供光調變元件及光電調變器。該等元件及調變器包含根據本發明之奈米膠囊,其中較佳地該等膠囊混合並分散於黏合劑中。 此外,提供光電裝置、尤其光電顯示器,其有利地利用如上文及下文所闡述之奈米膠囊及/或複合系統。在裝置中,提供複數個奈米膠囊。 上文及下文所闡述之許多液晶原化合物或其混合物可購得。所有該等化合物已知或可藉由本身已知之方法來製備,如文獻(例如在標準著作中,例如Houben-Weyl, Methoden der Organischen Chemie [methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart)中所闡述,確切而言係在已知且適於該等反應之反應條件下進行。此處亦可使用本身已知之變化形式,但此處不再更詳細地提及。 根據本發明之介質以係本身習用之方式來製備。一般而言,較佳地在升高溫度下,組份彼此溶解。藉助適當添加劑,本發明之液晶相可以使得其可用於液晶顯示器元件中之方式進行調節。此類型之添加劑為熟習此項技術者所已知並詳細闡述於文獻中(H. Kelker/ R. Hatz,Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980)。舉例而言,可添加多色性染料用於產生有色之客體-主體系統或可添加物質以調節介電各向異性、黏度及/或向列相之配向。 根據本發明,術語「烷基」較佳地涵蓋具有1至7個碳原子之直鏈及具支鏈烷基,尤其直鏈基團甲基、乙基、丙基、丁基、戊基、己基及庚基。具有2至5個碳原子之基團通常較佳。 烷氧基可係直鏈或具支鏈,且其較佳係直鏈的且具有1、2、3、4、5、6或7個碳原子,且因此較佳係甲氧基、乙氧基、丙氧基、丁氧基、戊氧基、己氧基或庚氧基。 根據本發明,術語「烯基」較佳地涵蓋具有2至7個碳原子之直鏈及具支鏈烯基,尤其直鏈基團。尤佳烯基係C2 -C7 -1E-烯基、C4 -C7 -3E-烯基、C5 -C7 -4E-烯基、C6 -C7 -5E-烯基及C7 -6E-烯基,尤其C2 -C7 -1E-烯基、C4 -C7 -3E-烯基及C5 -C7 -4E-烯基。較佳烯基之實例係乙烯基、1E-丙烯基、1E-丁烯基、1E-戊烯基、1E-己烯基、1E-庚烯基、3-丁烯基、3E-戊烯基、3E-己烯基、3E-庚烯基、4-戊烯基、4Z-己烯基、4E-己烯基、4Z-庚烯基、5-己烯基及6-庚烯基。具有最多5個碳原子之基團通常較佳。 氟化烷基或烷氧基較佳地包含CF3 、OCF3 、CFH2 、OCFH2 、CF2 H、OCF2 H、C2 F5 、OC2 F5 、CFHCF3 、CFHCF2 H、CFHCFH2 、CH2 CF3 、CH2 CF2 H、CH2 CFH2 、CF2 CF2 H、CF2 CFH2 、OCFHCF3 、OCFHCF2 H、OCFHCFH2 、OCH2 CF3 、OCH2 CF2 H、OCH2 CFH2 、OCF2 CF2 H、OCF2 CFH2 、C3 F7 或OC3 F7 ,尤其CF3 、OCF3 、CF2 H、OCF2 H、C2 F5 、OC2 F5 、CFHCF3 、CFHCF2 H、CFHCFH2 、CF2 CF2 H、CF2 CFH2 、OCFHCF3 、OCFHCF2 H、OCFHCFH2 、OCF2 CF2 H、OCF2 CFH2 、C3 F7 或OC3 F7 ,尤佳OCF3 或OCF2 H。在較佳實施例中氟烷基涵蓋具有末端氟之直鏈基團,即氟甲基、2-氟乙基、3-氟丙基、4-氟丁基、5-氟戊基、6-氟己基及7-氟庚基。然而,不排除氟之其他位置。 氧雜烷基較佳地涵蓋式Cn H2n+1 -O-(CH2 )m 之直鏈基團,其中n及m各自彼此獨立地係1至6。較佳地,n = 1且m係1至6。 氧雜烷基較佳係直鏈2-氧雜丙基(=甲氧基甲基)、2-(=乙氧基甲基)或3-氧雜丁基(= 2-甲氧基乙基)、2-、3-或4-氧雜戊基、2-、3-、4-或5-氧雜己基、2-、3-、4-、5-或6-氧雜庚基、2-、3-、4-、5-、6-或7-氧雜辛基、2-、3-、4-、5-、6-、7-或8-氧雜壬基、或2-、3-、4-、5-、6-、7-、8-或9-氧雜癸基。 鹵素較佳係F或Cl,尤其係F。 若以上所提及之基團中之一者係其中一個CH2 基團已由-CH=CH-替代之烷基,則此基團可係直鏈或具支鏈。其較佳係直鏈且具有2至10個碳原子。因此,其尤其係乙烯基、丙-1-或丙-2-烯基、丁-1-、-2-或丁-3-烯基、戊-1-、-2-、-3-或戊-4-烯基、己-1-、-2-、-3-、-4-或己-5-烯基、庚-1-、-2-、-3-、-4-、-5-或庚-6-烯基、辛-1-、-2-、-3-、-4-、-5-、-6-或辛-7-烯基、壬1-、-2-、-3-、-4-、-5-、-6-、-7-或壬-8-烯基、癸-1-、-2-、-3-、-4-、-5-、-6-、-7-、-8-或癸-9-烯基。 若以上所提及之基團中之一者係其中一個CH2 基團已由-O-替代且一個已由-CO-替代之烷基,則該等基團較佳毗鄰。因此,該等基團含有醯氧基-CO-O-或氧基羰基-O-CO-。該等基團較佳係直鏈且具有2至6個碳原子。 因此,其尤其係乙醯氧基、丙醯氧基、丁醯氧基、戊醯氧基、己醯氧基、乙醯氧基甲基、丙醯氧基甲基、丁醯氧基甲基、戊醯氧基甲基、2-乙醯氧基乙基、2-丙醯氧基乙基、2-丁醯氧基乙基、3-乙醯氧基丙基、3-丙醯氧基丙基、4-乙醯氧基丁基、甲氧基羰基、乙氧基羰基、丙氧基羰基、丁氧基羰基、戊氧基羰基、甲氧基羰基甲基、乙氧基羰基甲基、丙氧基羰基甲基、丁氧基羰基甲基、2-(甲氧基羰基)乙基、2-(乙氧基羰基)乙基、2-(丙氧基羰基)乙基、3-(甲氧基羰基)丙基、3-(乙氧基羰基)丙基或4-(甲氧基羰基)-丁基。 若以上所提及之基團中之一者係其中一個CH2 基團已由未經取代或經取代之-CH=CH-替代且毗鄰CH2 基團已由CO、CO-O或O-CO替代之烷基,則此基團可係直鏈或具支鏈。其較佳係直鏈且具有4至13個碳原子。因此,其尤其係丙烯醯基氧基甲基、2-丙烯醯基氧基乙基、3-丙烯醯基氧基丙基、4-丙烯醯基氧基丁基、5-丙烯醯基氧基戊基、6-丙烯醯基氧基己基、7-丙烯醯基氧基庚基、8-丙烯醯基氧基辛基、9-丙烯醯基氧基壬基、10-丙烯醯基氧基癸基、甲基丙烯醯基氧基甲基、2-甲基丙烯醯基氧基乙基、3-甲基丙烯醯基氧基丙基、4-甲基丙烯醯基氧基丁基、5-甲基丙烯醯基氧基戊基、6-甲基丙烯醯基氧基己基、7-甲基丙烯醯基氧基庚基、8-甲基丙烯醯基氧基辛基或9-甲基丙烯醯基氧基壬基。 若以上所提及之基團中之一者係由CN或CF3 單取代之烷基或烯基,則此基團較佳係直鏈的。由CN或CF3 之取代係在任一位置處。 若以上所提及之基團中之一者係至少由鹵素單取代之烷基或烯基,則此基團較佳係直鏈且鹵素較佳係F或Cl、更佳F。在多取代之情形下,鹵素較佳係F。所得基團亦包括全氟化基團。在單取代之情形下,氟或氯取代基可在任一期望位置,但較佳在ω位上。 含有具支鏈基團之化合物由於在一些習用液晶基礎材料中之更佳溶解性而可偶爾具重要性。然而,若其具光學活性,則其尤其適於作為手性摻雜劑。 此類型之具支鏈基團通常含有不超過一個之鏈分支。較佳具支鏈基團係異丙基、2-丁基(= 1-甲基丙基)、異丁基(= 2-甲基丙基)、2-甲基丁基、異戊基(= 3-甲基丁基)、2-甲基戊基、3-甲基戊基、2-乙基己基、2-丙基戊基、異丙氧基、2-甲基丙氧基、2-甲基丁氧基、3-甲基丁氧基、2-甲基戊氧基、3-甲基戊氧基、2-乙基己氧基、1-甲基己氧基或1-甲基庚氧基。 若以上所提及之基團中之一者係其中兩個或更多個CH2 基團已由-O-及/或-CO-O-替代之烷基,則此基團可係直鏈或具支鏈。其較佳係具支鏈且具有3至12個碳原子。因此,其尤其係雙羧基甲基、2,2-雙羧基乙基、3,3-雙羧基丙基、4,4-雙羧基丁基、5,5-雙羧基戊基、6,6-雙羧基己基、7,7-雙羧基庚基、8,8-雙羧基辛基、9,9-雙羧基壬基、10,10-雙羧基癸基、雙(甲氧基羰基)甲基、2,2-雙(甲氧基羰基)乙基、3,3-雙(甲氧基羰基)丙基、4,4-雙(甲氧基羰基)丁基、5,5-雙(甲氧基羰基)戊基、6,6-雙(甲氧基羰基)己基、7,7-雙(甲氧基羰基)庚基、8,8-雙(甲氧基羰基)辛基、雙(乙氧基羰基)甲基、2,2-雙(乙氧基羰基)乙基、3,3-雙(乙氧基羰基)丙基、4,4-雙(乙氧基羰基)丁基或5,5-雙(乙氧基羰基)戊基。 根據本發明之LC介質較佳地具有-10℃與+70℃之間之向列相範圍。LC介質甚至更佳地具有-20℃與+80℃之間之向列相範圍。當根據本發明之LC介質具有-20℃與+90℃之間之向列相範圍時最佳。 根據本發明之LC介質較佳地具有Dn ³ 0.15、更佳³ 0.20且最佳³ 0.25之雙折射。 根據本發明之LC介質較佳地具有De³ +10、更佳³ +15且最佳³ +20之介電各向異性。 根據本發明之LC介質較佳且有利地展現高可靠性及高電電阻率(亦稱為比電阻率(SR))。根據本發明之LC介質之SR值較佳係³ 1×1013 W cm、極佳³ 1×1014 W cm。除非另有闡述,否則SR之量測係如G. Weber等人,Liquid Crystals 5, 1381 (1989)中所闡述來實施。 根據本發明之LC介質亦較佳且有利地展現高電壓保持率(VHR),參見S. Matsumoto等人,Liquid Crystals 5, 1320 (1989);K. Niwa等人,Proc. SID Conference, San Francisco, 1984年6月, 第304頁(1984);T. Jacob及U. Finkenzeller,「Merck Liquid Crystals - Physical Properties of Liquid Crystals」, 1997。根據本發明之LC介質之VHR較佳係³ 90 %、極佳³ 95 %。除非另有闡述,否則VHR之量測係如T. Jacob、U. Finkenzeller,「Merck Liquid Crystals - Physical Properties of Liquid Crystals」, 1997中所闡述來實施。 除非另有明確說明,否則在整個本申請案中,所有濃度係以重量%給出且係關於各別完全混合物,但不包括如上文所指示之水溶劑或水相。 所有溫度均係以攝氏度(攝氏(Celsius),℃)給出且所有溫度差均係以攝氏度給出。除非另有明確說明,否則所有物理性質及物理化學或光電參數係藉由通常已知之方法、尤其根據「Merck Liquid Crystals, Physical Properties of Liquid Crystals」, Status 1997年11月, Merck KGaA, Germany來測定且針對20℃之溫度給出。 上文及下文中,Dn表示光學各向異性,其中Dn = ne - no ,且Δe表示介電各向異性,其中Δe=e÷÷ -e^ 。介電各向異性Δe係在20℃及1 kHz下測定。光學各向異性Dn係在20℃及589.3 nm之波長下測定。 根據本發明之化合物之De及Dn值及旋轉黏度(γ1 )係藉由自液晶混合物之線性外推法來獲得,該等液晶混合物係由5%至10%之根據本發明之各別化合物及90%至95%之市售液晶混合物ZLI-2857或ZLI-4792 (兩種混合物均來自Merck KGaA)組成。 除了通常及熟知之縮寫以外,亦使用以下縮寫:C:晶相;N:向列相;Sm:層列相;I:各向同性相。該等符號之間之數字顯示所關注物質之轉變溫度。 在本發明中且尤其在以下實例中,液晶原化合物之結構係藉助縮寫(亦稱為首字母縮略詞)來指示。在該等首字母縮略詞中,使用下表A至C將化學式縮寫如下。所有基團Cn H2n+1 、Cm H2m+1 及C1 H2l+1 或Cn H2n-1 、Cm H2m-1 及Cl H2l-1 均表示直鏈烷基或烯基,較佳地1E-烯基,其各自分別具有n個、m個及l個C原子。表A列示用於化合物核心結構之環元素之代碼,而表B顯示鏈接基團。表C給出左手側或右手側末端基團之代碼之含義。首字母縮略詞係由具有可選鏈接基團之環元素之代碼、隨後第一連字符及左手側末端基團之代碼及第二連字符以及右手側末端基團之代碼構成。表D顯示化合物之說明性結構以及其各別縮寫。 A :環元素 B :鏈接基團 C 末端基團 其中n及m各自表示整數,且三個點「...」係來自此表之其他縮寫之佔位符。 下表顯示說明性結構以及其各別縮寫。顯示該等結構以說明縮寫規則之含義。此外,其代表可較佳使用之化合物。 D :說明性結構 其中n、m及l較佳地彼此獨立地表示1至7。 下表顯示可用作根據本發明之液晶原介質中之其他穩定劑之說明性化合物。 E 表E 顯示可添加至根據本發明之LC介質之可能穩定劑,其中n表示1至12之整數,較佳地1、2、3、4、5、6、7或8,末端甲基未示出。 LC介質較佳地包含0至10重量%、尤其1ppm至5重量%、尤佳1 ppm至1重量%之穩定劑。 下表F顯示可較佳地用作根據本發明之液晶原介質中之手性摻雜劑之說明性化合物。 F 在本發明之較佳實施例中,液晶原介質包含一或多種選自表F中所示化合物之化合物。 根據本發明之液晶原介質較佳地包含兩種或更多種、較佳地四種或更多種選自上表D至F中所示化合物之化合物。 根據本發明之LC介質較佳地包含三種或更多種、更佳五種或更多種表D中所示之化合物。 以下實例僅說明本發明且其不應視為以任何方式限制本發明之範圍。根據本揭示內容,熟習此項技術者將明瞭實例及其修改形式或其他等效形式。實例 在實例中, Vo 表示在20℃下之電容性臨限電壓[V], ne 表示在20℃及589 nm下之非常折射率, no 表示在20℃及589 nm下之尋常折射率 Dn 表示在20℃及589 nm下之光學各向異性, e÷÷ 表示在20℃及1 kHz下之平行於指向矢之介電容率, e^ 表示在20℃及1 kHz下之垂直於指向矢之介電容率, De 表示在20℃及1 kHz下之介電各向異性, cl.p., T(N,I) 表示澄清點[℃], g1 表示在20℃下量測之旋轉黏度[mPa×s],藉由磁場中之旋轉方法測定, K1 表示在20℃下「展開」變形之彈性常數[pN], K2 表示在20℃下「扭轉」變形之彈性常數[pN], K3 表示在20℃下「彎曲」變形之彈性常數[pN], 除非另有明確指示,否則本發明之術語「臨限電壓」係關於電容性臨限值(V0 ),。在實例中,按通常慣例,光學臨限值亦可指示為10%相對對比度(V10 )。參考實例 1 製備液晶混合物B-1並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-1 參考實例 2 製備液晶混合物B-2並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-2 參考實例 3 製備液晶混合物B-3並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-3 參考實例 4 製備液晶混合物B-4並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-4 參考實例 5 製備液晶混合物B-5並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-5 參考實例 6 製備液晶混合物B-6並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-6 參考實例 7 製備液晶混合物B-7並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-7 參考實例 8 製備液晶混合物B-8並對於其一般物理性質進行表徵,其具有如下表中所指示之組成及性質。 基礎混合物B-8 實例 1 奈米膠囊之製備 將LC混合物B-1 (2.66 g)、十六烷(0.66 g)及甲基丙烯酸甲基酯(3.30 g)稱重至250 ml高燒杯中。 將Brij L23 (0.83 g)稱重至250 ml錐形燒瓶中並添加水(100 ml)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合5分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下經過高壓均質器4次。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加AIBN (35 mg)之後加熱至70℃持續3小時。將反應混合物冷卻,過濾,且然後在Zetasizer (Malvern Zetasizer Nano ZS)儀器上實施材料之大小分析。 所獲得膠囊之平均大小為85 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。30% 固體含量 PVA 黏合劑之製備 首先將PVA (PVA之分子量Mw :31k;88%水解)在索格斯利特裝置中洗滌3天以去除離子。 將46.66 g無離子水添加至150 ml瓶,添加大的磁力攪拌棒並將瓶置於50℃攪拌器熱板上並使其達到溫度。將20.00 g經洗滌之31k PVA固體稱重至燒杯中。在瓶中產生渦旋並經大約5分鐘逐漸添加31k PVA,停止使浮動之PVA分散至混合物中。將熱板升至90℃並繼續攪拌2-3小時。將瓶置於80℃下之烘箱中20小時。將混合物在仍溫暖時藉助50 μm布過濾器在0.5巴(bar)之空氣壓力下進行過濾。用Millipore 5 μm SVPP過濾器代替該過濾器並重複過濾。 藉由以下將所過濾黏合劑之固體含量量測3次並計算平均數:使用DSC微量天平稱量空DSC盤,將大約40 mg黏合劑混合物添加至DSC盤並記錄質量,將盤置於60℃熱板上1小時隨後置於110℃熱板上10 min,將盤自熱板移除並使其冷卻,記錄乾盤質量且計算固體含量。複合系統之製備 首先藉由顯微鏡術針對不希望之凝結或結塊對所獲得之奈米膠囊樣品進行檢查且在膜形成之後亦檢查。量測所濃縮奈米膠囊懸浮液之固體含量,其中將樣品之固體含量量測3次並計算平均數。使用DSC微量天平在空DSC盤中稱重樣品。將大約40 mg樣品添加至DSC盤並記錄質量。將盤置於60℃熱板上1小時隨後置於110℃熱板上10 min。將盤自熱板移除並使其冷卻。記錄乾盤質量,並計算固體含量。 將所製備之PVA添加至濃縮奈米膠囊樣品,其中將大約30%經洗滌之31k PVA混合物添加於2.5 ml小瓶中,且然後將奈米膠囊添加至小瓶。添加無離子水以使大約0.5 g混合物之總固體含量為20%。使用渦旋攪拌器攪拌混合物並將混合物置於輥上過夜以使PVA分散。基板上膜製備 所使用之基板係IPS (平面內切換)玻璃,其具有經ITO塗覆之叉指式電極,其中電極寬度為4 μm且間隙為8 μm。將基板置於擱架及塑膠盒中用於洗滌。添加去離子水並將樣品置於音波振動器中10分鐘。自水移除基板並用紙巾吸乾以去除過量水。用丙酮、2-丙醇(IPA)及最終用於離子層析之水重複洗滌。然後使用壓縮空氣槍乾燥基板。用UV-臭氧將基板處理10分鐘。 然後將包含奈米膠囊及黏合劑之複合系統塗覆於基板上。使用塗覆機(K Control Coater,RK PrintCoat Instruments,用k棒1進行棒塗,塗覆速度為7)將40 µL之混合物塗覆為膜。將樣品於熱板上在60℃下乾燥10分鐘,其在蓋子下以防止吃水並阻止污染物掉落至膜上。記錄膜之外觀。在量測之間使所製備之膜儲存在乾燥箱中。 藉由用剃鬚刀片自電觸點上方去除膜來量測膜厚度。使用輪廓儀(Dektak XT表面輪廓儀,Bruker)以5 mg之觸針力及3000 nm之掃描長度及30 s之時間在中間電極之區域中量測膜厚度。觀察到4.0-5.5微米之期望膜厚度。光電性質之量測 藉由眼睛針對均勻性及缺陷檢查膜之外觀。將兩個電極焊接至玻璃。使用動態散射模式(DSM)量測電壓-透射曲線。 亦使用顯微鏡在所需電壓下記錄10%及90%透射之暗狀態及亮狀態之影像。 切換速度係在40℃及25℃下在150 Hz調變頻率以及若適當10 Hz下量測。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 2 將LC混合物B-1 (2.0 g)、二甲基丙烯酸伸乙基酯(0.60 g)、甲基丙烯酸2-羥基乙基酯(0.07 g)、甲基丙烯酸甲基酯(0.15 g)及十六烷(0.10 g)稱重至250 ml高燒杯中。 如上文實例1中所闡述處理並研究此混合物。 所獲得膠囊之平均大小為124 nm,如藉由DLS (Zetasizer)分析所測定。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 如上文實例1中所闡述製備包含所獲得之膠囊及黏合劑之複合系統及膜。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 3 將LC混合物B-1 (2.0 g)、二甲基丙烯酸伸乙基酯(0.66 g)、甲基丙烯酸羥基乙基酯(0.08 g)、甲基丙烯酸甲基酯(0.16 g)及2-異丙氧基乙醇(0.10 g)稱重至250 ml高燒杯中。 如上文實例1中所闡述處理並研究此混合物。 所獲得膠囊之平均大小為204 nm,如藉由DLS (Zetasizer)分析所測定。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 如上文實例1中所闡述製備包含所獲得之膠囊及黏合劑之複合系統及膜。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 4 將LC混合物B-1 (1.0g)、己二醇二丙烯酸酯(0.03 g)、甲基丙烯酸羥基乙基酯(0.03 g)、甲基丙烯酸異莰基酯(0.110 g)及丙烯酸2-乙基己基酯(0.250 g)稱重至250 ml高燒杯中。 如上文實例1中所闡述處理並研究此混合物。 所獲得膠囊之平均大小為114 nm,如藉由DLS (Zetasizer)分析所測定。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 如上文實例1中所闡述製備包含所獲得之膠囊及黏合劑之複合系統及膜。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 5 將LC混合物B-2 (2.0 g)、二甲基丙烯酸伸乙基酯(0.66 g)、甲基丙烯酸2-羥基乙基酯(0.075 g)、甲基丙烯酸甲基酯(0.175 g)及十六烷(0.10 g)稱重至250 ml高燒杯中。 如上文實例1中所闡述處理並研究此混合物。 所獲得膠囊之平均大小為148 nm,如藉由DLS (Zetasizer)分析所測定。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 如上文實例1中所闡述製備包含所獲得之膠囊及黏合劑之複合系統及膜。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 6 將LC混合物B-3 (1.0 g)、二甲基丙烯酸伸乙基酯(0.34 g)、甲基丙烯酸2-羥基乙基酯(0.07 g)及十六烷(0.25 g)稱重至250 ml高燒杯中。 如上文實例1中所闡述處理並研究此混合物。 所獲得膠囊之平均大小為145 nm,如藉由DLS (Zetasizer)分析所測定。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 如上文實例1中所闡述製備包含所獲得之膠囊及黏合劑之複合系統及膜。 所製備之包含奈米膠囊及黏合劑之膜之經量測光電參數於下表中給出。 光電參數 實例 7 如上文實例2中所闡述處理LC混合物B-4以製備奈米膠囊、具有黏合劑之複合系統及塗覆膜。實例 8 如上文實例2中所闡述處理LC混合物B-5以製備奈米膠囊、具有黏合劑之複合系統及塗覆膜。實例 9 如上文實例2中所闡述處理LC混合物B-6以製備奈米膠囊、具有黏合劑之複合系統及塗覆膜。實例 10 如上文實例2中所闡述處理LC混合物B-7以製備奈米膠囊、具有黏合劑之複合系統及塗覆膜。實例 11 將LC混合物B-1 (2.00 g)、1,4-戊二醇(102 mg)、二甲基丙烯酸伸乙基酯(658 mg)、甲基丙烯酸2-羥基乙基酯(77 mg)及甲基丙烯酸甲基酯(162 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為180 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.6 µm。 經量測之光電參數V50 (即50%相對對比度之中灰電壓)係55 V。 所製備之樣品在24℃、40℃及60℃下顯示有利性能,展現適當溫度依賴性及穩定性。實例 12 將LC混合物B-1 (1.00 g)、1,4-戊二醇(175 mg)、二甲基丙烯酸伸乙基酯(300 mg)、甲基丙烯酸2-羥基乙基酯(40 mg)及甲基丙烯酸甲基酯(100 mg)稱重至250 ml高燒杯中。 將Brij L23 (50 mg)稱重至250 ml錐形燒瓶中並添加水(150 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達10分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(10 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為175 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。樣品尤其顯示有利溫度依賴性。實例 13 將LC混合物B-8 (1.99 g)、十六烷(101 mg)、二甲基丙烯酸伸乙基酯(657 mg)、甲基丙烯酸2-羥基乙基酯(74 mg)及甲基丙烯酸甲基酯(170 mg)稱重至250 ml高燒杯中。 將Brij L23 (300 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為132 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.2 µm。 經量測之光電參數V50 係33 V,且經量測之光電參數V90 係66 V。實例 14 將LC混合物B-1 (1.00 g)、十六烷(175 mg)、乙二醇二甲基丙烯酸酯(300 mg)、甲基丙烯酸2-羥基乙基酯(40 mg)及甲基丙烯酸甲基酯(100 mg)稱重至250 ml高燒杯中。 將Brij L23 (50 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (10 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為199 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為5.3 µm。 經量測之光電參數V50 係19 V,且經量測之光電參數V90 係42 V。實例 15 如上文實例14中所闡述處理LC混合物B-1以製備奈米膠囊、具有黏合劑之複合系統及塗覆膜,其中使用1,4-戊二醇代替十六烷。實例 16 LC混合物B-8係類似於如上文實例14中所闡述之B-1進行處理。實例 17 將LC混合物B-8 (2.01 g)、十六烷(97 mg)、二甲基丙烯酸伸乙基酯(645 mg)、甲基丙烯酸2-羥基乙基酯(166 mg)、丙烯酸1,1,1,3,3,3-六氟異丙基酯(23mg)及甲基丙烯酸甲基酯(67 mg)稱重至250 ml高燒杯中。 將Brij L23 (150 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為176 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.2 µm。 經量測之光電參數V50 係48 V,且經量測之光電參數V90 係82 V。實例 18 將LC混合物B-8 (0.99 g)、十六烷(251 mg)、甲基丙烯酸硬脂醯基酯(74 mg)及丙烯酸1,1-二氫全氟丙基酯(118 mg)稱重至250 ml高燒杯中。 將Brij L23 (301 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在Branson 超音波儀W450上以50%振幅超音波處理總共6分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (10 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為191 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。實例 19 將LC混合物B-8 (2.01 g)、丙烯酸2,2,3,3,3-五氟丙基酯(117 mg)、二甲基丙烯酸伸乙基酯(663 mg)、甲基丙烯酸2-羥基乙基酯(81 mg)及甲基丙烯酸甲基酯(167 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為191 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為5.2 µm。 經量測之光電參數V50 係80 V,且經量測之光電參數V90 係132 V。實例 20 將LC混合物B-8 (2.00 g)、丙烯酸2,2,3,3,4,4,4-七氟丁基酯(117 mg)、二甲基丙烯酸伸乙基酯(659 mg)、甲基丙烯酸2-羥基乙基酯(79 mg)及甲基丙烯酸甲基酯(170 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為147 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.9 µm。 經量測之光電參數V50 係77.5 V,且經量測之光電參數V90 係130 V。實例 21 將LC混合物B-8 (2.01 g)、丙烯酸1H,1H,2H,2H-全氟癸基酯(113 mg)、二甲基丙烯酸伸乙基酯(657 mg)、甲基丙烯酸2-羥基乙基酯(75 mg)及甲基丙烯酸甲基酯(171 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為188 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為5.3 µm。 經量測之光電參數V50 係75 V,且經量測之光電參數V90 係115 V。實例 22 將LC混合物B-8 (1.00 g)、十五氟辛醇(111 mg)、二甲基丙烯酸伸乙基酯(340 mg)及甲基丙烯酸2-羥基乙基酯(73 mg)稱重至250 ml高燒杯中。 將Brij L23 (75 mg)稱重至250 ml錐形燒瓶中並添加水(70 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為191 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為3.7 µm。 經量測之光電參數V50 係23 V,且經量測之光電參數V90 係53 V。實例 23 將LC混合物B-8 (1.01 g)、甲基丙烯酸3-參(三甲基矽氧基)矽基丙基酯(250 mg)、二甲基丙烯酸伸乙基酯(300 mg)、甲基丙烯酸2-羥基乙基酯(40 mg)及甲基丙烯酸甲基酯(100 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(75 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為124 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。實例 24 將LC混合物B-8 (2.00 g)、三氟乙酸三甲基矽基酯(100 mg)、二甲基丙烯酸伸乙基酯(660 mg)、甲基丙烯酸2-羥基乙基酯(71 mg)及甲基丙烯酸甲基酯(172 mg)稱重至250 ml高燒杯中。 將Brij L23 (300 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為271 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。實例 25 將LC混合物B-8 (2.00 g)、甲基丙烯酸參(三甲基矽氧基)矽基丙基酯(101 mg)、二甲基丙烯酸伸乙基酯(659 mg)、甲基丙烯酸2-羥基乙基酯(78 mg)及甲基丙烯酸甲基酯(165 mg)稱重至250 ml高燒杯中。 將Brij L23 (100 mg)稱重至250 ml錐形燒瓶中並添加水(100 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (20 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為214 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.5 µm。 經量測之光電參數V50 係57.5 V,且經量測之光電參數V90 係95 V。實例 26 將LC混合物B-8 (1.00 g)、甲基丙烯酸硬脂醯基酯(101 mg)、二甲基丙烯酸伸乙基酯(201 mg)、甲基丙烯酸2-羥基乙基酯(42 mg)及甲基丙烯酸甲基酯(105 mg)稱重至250 ml高燒杯中。 將Brij L23 (50 mg)稱重至250 ml錐形燒瓶中並添加水(150 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (10 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為208 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為3.1 µm。 經量測之光電參數V50 係25 V,且經量測之光電參數V90 係45.5 V。實例 27 將LC混合物B-8 (1.00 g)、辛酸甲酯(73 mg)、二甲基丙烯酸伸乙基酯(291 mg)、甲基丙烯酸2-羥基乙基酯(46 mg)及甲基丙烯酸甲基酯(98 mg)稱重至250 ml高燒杯中。 將Brij L23 (50 mg)稱重至250 ml錐形燒瓶中並添加水(150 g)。然後將此混合物音波處理5至10分鐘。 將Brij水性表面活性劑溶液直接傾倒至含有該等有機物之燒杯中。將混合物在10,000 rpm下在turrax中混合10分鐘。一旦在turrax中混合完成,則使粗製乳液在30,000 psi下循環穿過高壓均質器達8分鐘。 將混合物裝填至燒瓶中並裝配冷凝器,且在添加2,2’-偶氮雙(2-甲脒基丙烷)二鹽酸鹽(AAPH) (10 mg)之後加熱至70℃持續4小時。將反應混合物冷卻,過濾,且然後藉由Zetasizer儀器實施材料之大小分析。 所獲得膠囊之平均大小為189 nm,如藉由動態光散射(DLS)分析(Zetasizer)所測定。 所獲得樣品之一部分進一步以原樣使用。 將樣品之另一部分在進一步使用之前濃縮。此藉由離心實施。將混合物填充離心管並在6,500 rpm下離心10分鐘,收集上清液且置於新管中並在15,000 rpm下離心20分鐘。將所得沈澱再分散於1 ml上清液中並取樣用於測試。 所獲得之奈米膠囊展現有利物理及光電特性且顯示因應所施加電壓之適當切換行為。 類似於實例1製備包含所獲得之膠囊及黏合劑之複合系統及膜。所製備之膜之厚度為4.3 µm。 經量測之光電參數V50 係33 V,且經量測之光電參數V90 係64 V。Without limiting the present invention, the present invention will be described by detailed descriptions of aspects, embodiments, and specific features, and specific embodiments will be described in more detail below. The term "liquid crystal (LC)" refers to a material or medium having a liquid crystal mesophase in some temperature ranges (thermotropic LC) or in some solution concentration ranges (lyotropic LC). It contains a mesogen compound. The terms "liquid crystal compound" and "liquid crystal compound" mean containing one or more rod-shaped (rod-shaped or plate-shaped / bar-shaped) or disc-shaped (disc-shaped) mesogen groups (i.e. Phase acting ability). The LC compound or material containing the mesogen group and the mesogen compound or material itself need not necessarily exhibit a liquid crystal phase. It may also show liquid crystal phase behavior only in mixtures with other compounds. This includes low molecular weight non-reactive liquid crystal compounds, reactive or polymerizable liquid crystal compounds, and liquid crystal polymers. Rod-like mesogens usually include a mesogen core composed of one or more aromatic or non-aromatic cyclic groups connected directly to each other or via a linking group, optionally including attachment to the end of the mesogen The end groups and optionally include one or more side groups attached to the long sides of the mesogen core, where the end groups and side groups are usually selected from, for example, carbon or hydrocarbon groups, polar groups (such as halogen , Nitro, hydroxyl, etc.) or polymerizable groups. For the sake of brevity, the term "liquid crystal" material or medium is used for both the liquid crystal material or medium and the liquid crystal raw material or medium, and vice versa, the term "liquidogen" is used for the mesogen of the material. The term "non- mesogen compound or material" means a compound or material that does not contain a mesogen group as defined above. As used herein, the term "polymer" is understood to mean a molecule that encompasses the backbone of one or more different types of repeating units (the smallest building blocks of a molecule), and includes the commonly known terms "oligomer", " Copolymers, "" homopolymers, "and the like. It should also be understood that the term polymer includes, in addition to the polymer itself, residues from initiators, catalysts, and other elements that accompany the polymer synthesis, where such residues should be understood as not being covalently incorporated therein. In addition, these residues and other elements, although usually removed during the post-polymerization purification process, are usually mixed or blended with the polymer such that they are usually polymerized when the polymer is transferred between containers or between solvents or dispersion media. Keep things together. The term "(meth) acrylic polymer" as used in the present invention includes polymers obtained from acrylic monomers, polymers obtainable from methacrylic monomers, and correspondences obtainable from mixtures of these monomers. Copolymer. The term "polymerization" means a chemical process of forming a polymer by bonding together a plurality of polymerizable groups or polymer precursors (polymerizable compounds) containing such polymerizable groups. A polymerizable compound having one polymerizable group is also referred to as a "single-reactive" compound, a compound having two polymerizable groups is also referred to as a "di-reactive" compound, and a compound having two or more polymerizable groups Also known as a "multi-reactive" compound. Compounds without polymerizable groups are also referred to as "non-reactive" or "non-polymerizable" compounds. The terms "film" and "layer" include rigid or flexible, self-supporting or free-standing films or layers with more or less pronounced mechanical stability, and coatings or layers on a supporting substrate or between two substrates. Visible light is electromagnetic radiation with a wavelength in the range of about 400 nm to about 745 nm. Ultraviolet (UV) light is electromagnetic radiation with a wavelength in the range of about 200 nm to 400 nm. In a first aspect, the present invention relates to a composition for nanoencapsulation (ie, to form a nanocapsule), wherein the formed capsule shell of each capsule contains a LC medium in a nanoscale volume. The composition comprises components (i), (ii) and (iii) as defined above. In particular, among others, a mesogen is provided which comprises one or more compounds of formula I. Surprisingly, it has been found that a composition as provided according to the present invention allows the production of favorable nanocapsules containing a liquid crystal precursor medium in an advantageous process, in particular a process using in situ polymerization, particularly a process based on PIPS, wherein the composition is in the process Has favorable performance. In addition, these compositions allow obtaining nanocapsules that provide significant benefits in terms of their physical and chemical properties, especially with regard to their optoelectronic properties and their suitability in photovoltaic devices. Therefore, the composition of the present invention can be used for preparing nanocapsules. The composition may be provided by appropriately mixing or blending the components. In a preferred embodiment, the composition according to the invention accounts for the following amount of LC medium based on the overall composition: 5 to 95% by weight, more preferably 15 to 75% by weight, especially 25 to 65% by weight %. In a preferred embodiment, the composition according to the present invention further comprises one or more organic solvents. It has been found that the provision of organic solvents can provide additional benefits in the process used to prepare the nanocapsules of the present invention. In particular, one or more organic solvents may help set or adjust the solubility of the components or the miscibility separately. Solvents can be used as appropriate co-solvents, where the solvent capabilities of other organic ingredients can be enhanced or affected. In addition, the (or other) organic solvent may have a beneficial effect during phase separation induced by the polymerization of one or more polymerizable compounds. The provision of such (or other) organic solvents can help to obtain improved separation of the LC material from the prepared polymer components, and it can further affect, especially reduce, the anchoring energy at the interface. In this regard, an organic solvent can be used as an organic solvent standard. The (etc.) solvent may be selected from, for example, aliphatic hydrocarbons, halogenated aliphatic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, alcohols (including fluorinated alcohols, glycols or esters thereof), ethers, esters, Lactones, ketones and the like are more preferably selected from diols and n-alkanes. Binary, ternary or higher mixtures of the above solvents can also be used. In a preferred embodiment, the solvent is selected from one or more of the following: cyclohexane, tetrafluorofluorohexane, dodecane, tridecane, tetradecane, pentadecane, hexadecane, Perfluorohexadecane, 1,5-dimethyltetralin, 3-phenoxytoluene, heptadecan 2-isopropoxyethanol, octyldodecanol, perfluorooctanol, pentafluorooctane Alcohol, pentafluorooctanol, 1,2-ethylene glycol, 1,2-propylene glycol, 1,3-butanediol, 1,4-butanediol, pentanediol (especially 1,4-pentanediol ), Hexanediol (especially 1,6-hexanediol), heptanediol, octanediol, hydroxy-2-pentanone, triethanolamine, methyl octoate, ethyl acetate, trimethylsilyl trifluoroacetate Esters and butyl acetate. Particularly preferably, the organic solvent used comprises hexadecane, methyl octoate, ethyl acetate or 1,4-pentanediol, especially hexadecane, methyl octoate, ethyl acetate or 1,4-pentanediol. alcohol. In another embodiment, a combination comprising hexadecane and 1,4-pentanediol is used. The (etc.) organic solvent, especially hexadecane, is preferably added in an amount based on the entire composition: 0.1% to 35% by weight, more preferably 1% to 25% by weight, especially 3% to 17% by weight. %. Organic solvents can enhance solubility or dissolve or dilute other organic components individually and can help adjust viscosity. In the embodiment, an organic solvent is used as a hydrophobic agent. Adding it to the dispersed phase of a nanoemulsion or miniemulsion can affect, especially increase, the osmotic pressure in the nanodroplets. This can contribute to stabilization of "oil-in-water" emulsions by inhibiting Ostwald ripening. The preferred organic solvent used as a hydrophobic agent is less soluble in water than liquid crystals, and it is soluble in liquid crystals. In the composition according to the invention, one or more polymerizable compounds are provided as a polymeric shell or wall precursor containing or individually surrounding the LC medium. The polymerizable compound has at least one polymerizable group. The polymerizable group is preferably selected from CH2 = CW1 -COO-,,, CH2 = CW2 -(O)k1 -, CH3 -CH = CH-O-, (CH2 = CH)2 CH-OCO-, (CH2 = CH-CH2 )2 CH-OCO-, (CH2 = CH)2 CH-O-, (CH2 = CH-CH2 )2 N-, HO-CW2 W3 -, HS-CW2 W3 -, HW2 N-, HO-CW2 W3 -NH-, CH2 = CW1 -CO-NH-, CH2 = CH- (COO)k1 -Phe- (O)k2 -, Phe-CH = CH-, HOOC-, OCN-, where W1 H, Cl, CN, phenyl or alkyl having 1 to 5 C atoms, especially H, Cl or CH3 , W2 And W3 Each independently is H or an alkyl group having 1 to 5 C atoms, especially H, methyl, ethyl or n-propyl, Phe is 1,4-phenylene and k1 And k2 Each is independently 0 or 1. One or more polymerizable compounds are selected so that they have appropriate and sufficient solubility in the LC component or phase. In addition, it needs to be susceptible to polymerization conditions and the environment. In particular, the (etc.) polymerizable compound may undergo appropriate polymerization with a high conversion such that the amount of residual unreacted polymerizable compound after the reaction is advantageously low. This can provide benefits in the stability and performance of LC media. In addition, the polymerizable component is selected such that the polymer formed therefrom is phase-separated appropriately or the polymer formed therefrom is phase-separated separately to constitute a polymeric capsule shell. In particular, it is advantageous to avoid or individually minimize the solubility of the LC component in the shell polymer and the swelling or gelation of the formed polymer shell, where the amount of LC medium and the amount in the formed capsule Medium remains substantially constant. It is therefore advantageous to minimize or avoid the preferential solubility of any LC compound of the LC material in the wall. By providing a suitably tough polymer shell, swelling or even rupture of nanocapsules and undesired leakage of LC material from the capsules can be advantageously minimized or even completely avoided. The polymerization or curing time depends in particular on the reactivity and amount of the polymerizable material, the thickness of the capsule shells that have been formed, the type and amount of the polymerization initiator (if present), and the reaction temperature and / or the power of the radiation (such as UV lamps). Polymerization or curing time and conditions can be selected to obtain, for example, a fast process for polymerization or to obtain, for example, a slower process in which the completeness of polymer conversion and isolation can be beneficially affected. Therefore, it may be preferable to have a shorter polymerization and curing time, for example, less than 5 minutes, and a longer polymerization time may be better in alternative embodiments, for example, more than 1 hour or even at least 3 hours. In the examples, a non- mesogen polymerizable compound, that is, a compound containing no mesogen group is used. However, it exhibits sufficient and appropriate solubility or miscibility with the LC component individually. In a preferred embodiment, an organic solvent is additionally provided. In another aspect, a polymerizable mesogen or a liquid crystal compound (also known as a reactive mesogen (RM)) is used. These compounds contain mesogen groups and one or more polymerizable groups (ie, functional groups suitable for polymerization). Optionally, in the examples, the polymerizable compound according to the present invention contains only reactive mesogens, that is, all reactive single-system mesogens. Alternatively, the RM may be provided in combination with one or more non-liquidomer polymerizable compounds. RM can be mono-reactive or di-reactive or multi-reactive. RM can exhibit favorable solubility or miscibility with the LC medium individually. However, it is further possible to design polymers from which they are formed or individually formed from them to exhibit proper phase separation behavior. It is preferred that the polymerizable mesogen comprises at least one polymerizable group as a terminal group and the mesogen as a core group. It is further preferred that a spacer group and / or a spacer group be included between the polymerizable group and the mesogen. Linking group. In the examples, bis [4 [3 (propenyloxy) propyloxy] benzoic acid 2-methyl-1,4-phenylene ester (RM 257, Merck KGaA) was used. Alternatively or additionally, one or more of the lateral substituents of the mesogen group may also be a polymerizable group. In another embodiment, the use of mesogen polymerizable compounds is avoided. In a preferred embodiment, the one or more polymerizable compounds are selected from the group consisting of vinyl chloride, dichloroethylene, acrylonitrile, methacrylonitrile, acrylamide, methacrylamide, and tetrahydrofurfuryl acrylic acid Ester, ethyl ester, n- or third butyl ester, cyclohexyl ester, 2-ethylhexyl ester, phenyloxyethyl ester, hydroxyethyl ester, hydroxypropyl ester, 2-5 C-alkoxy Methyl ethyl ester or methyl ester, ethyl ester, n- or third butyl methacrylate, cyclohexyl ester, 2-ethylhexyl ester, phenyloxyethyl ester, hydroxyethyl ester, hydroxy Propyl ester, 2-5 C-alkoxyethyl ester, vinyl acetate, vinyl propionate, vinyl acrylate, vinyl succinate, N-vinylpyrrolidone, N-vinylcarbazole, benzene Ethylene, divinylbenzene, ethylene diacrylate, 1,6-hexanediol acrylate, bisphenol A diacrylate and bisphenol A dimethacrylate, trimethylolpropane diacrylate, triethylene glycol Methylolpropane triacrylate, neopentyl alcohol triacrylate, triethylene glycol diacrylate, ethylene glycol dimethacrylate, tripropylene glycol triacrylate New pentaerythritol tri acrylate, pentaerythritol tetraacrylate, methacrylic twenty-three propane tetraacrylate or di-pentaerythritol pentaacrylate new or di-pentaerythritol hexaacrylate new. Thiol-enes are also preferred, such as the commercial product Norland 65 (Norland Products). It is also possible to use silane-based or siloxane-based reactive monomers. The polymerizable or reactive group is preferably selected from the group consisting of vinyl, acrylate, methacrylate, fluoroacrylate, oxetanyl or epoxy groups, particularly preferably acrylic Ester group or methacrylate group. Preferably, the one or more polymerizable compounds are selected from the group consisting of acrylates, methacrylates, fluoroacrylates, and vinyl acetate, wherein the composition more preferably further comprises one or more direactive and / or trireactive The polymeric compound is preferably selected from the group consisting of diacrylate, dimethacrylate, triacrylate, and trimethacrylate. In a preferred embodiment, one or more of the polymerizable compounds is fluorinated, and particularly preferably the acrylate compound and the methacrylate compound are fluorinated acrylate and fluorinated methacrylate. In an embodiment, one or more polymerizable compounds (ii) as described above comprise a polymerizable group selected from one, two or more acrylate, methacrylate and vinyl acetate groups, wherein These compounds are preferably non- mesogen compounds. In a preferred embodiment, the composition according to the invention comprises one or more monoacrylates, which are preferably added in an amount of from 0.1% to 75% by weight, more preferably from 0.5% to 5% by weight, based on the overall composition. 50% by weight, in particular 2.5% to 25% by weight. Particularly preferred mono-reactive compounds are selected from methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, butyl acrylate, third butyl acrylate, pentyl acrylate, and hexyl acrylate Ester, nonyl acrylate, 2-ethyl-hexyl acrylate, 2-hydroxy-ethyl acrylate, 2-hydroxy-butyl acrylate, 2,3-dihydroxypropyl acrylate, hexafluoroisopropyl acrylate Ester, 1,1-dihydroperfluoropropyl acrylate, perfluorodecyl acrylate, pentafluoropropyl acrylate, heptafluorobutyl acrylate, 1H, 1H, 2H, 2H-perfluorodecyl acrylate Ester, 3-ginsyl (trimethylsiloxy) silyl acrylate, stearyl acrylate and glycidyl acrylate. Additionally or alternatively vinyl acetate may be added. In another preferred embodiment, the composition according to the present invention optionally contains one or more monomethacrylates in addition to the above monoacrylate, which is preferably added in the following amount based on the overall composition: 0.1% by weight To 75% by weight, more preferably 0.5% to 50% by weight, especially 2.5% to 25% by weight. Particularly preferred mono-reactive compounds are selected from methyl methacrylate, ethyl methacrylate, propyl methacrylate, isopropyl methacrylate, butyl methacrylate, Tributyl ester, amyl methacrylate, hexyl methacrylate, nonyl methacrylate, 2-ethyl-hexyl methacrylate, 2-hydroxy-ethyl methacrylate, methacrylic acid 2-hydroxy-butyl ester, 2,3-dihydroxypropyl methacrylate, hexafluoroisopropyl methacrylate, 1,1-dihydroperfluoropropyl methacrylate, methacrylic acid Fluorodecyl ester, pentafluoropropyl methacrylate, heptafluorobutyl methacrylate, 1H, 1H, 2H, 2H-perfluorodecyl methacrylate, 3-ginsyl methacrylate (trimethyl (Siloxy) silyl propyl, stearyl methacrylate, glycidyl methacrylate, adamantyl methacrylate, and isoamyl methacrylate. It is particularly preferred to add at least one crosslinking agent (ie, a polymerizable compound containing two or more polymerizable groups) to the composition. Cross-linking the polymeric shells in the prepared particles can provide additional benefits, especially in terms of further improving stability and containment and conditioning or individually reducing susceptibility to swelling, especially swelling caused by solvents. In this regard, di-reactive and multi-reactive compounds can be used to form their own polymer networks and / or cross-link polymer chains formed from substantially self-polymerizing mono-reactive compounds. Conventional crosslinking agents known in the art can be used. It is particularly preferred to additionally provide a di-reactive or multi-reactive acrylate and / or methacrylate, which is preferably added in an amount based on the entire composition: 0.1% to 75% by weight, more preferably 0.5% by weight To 50% by weight, in particular from 2.5 to 25% by weight. Particularly preferred compounds are selected from the group consisting of ethylene diacrylate, propyl diacrylate, butyl diacrylate, pentyl diacrylate, hexyl diacrylate, glycol diacrylate, glyceryl diacrylate , Neopentaerythritol tetraacrylate, diethyl methacrylate (also known as ethylene glycol dimethacrylate), dipropyl methacrylate, dibutyl methacrylate, di D-amyl methacrylate, D-hexyl dimethacrylate, tripropylene glycol diacrylate, glycol dimethacrylate, glycerol dimethacrylate, trimethylpropane trimethacrylate and neopentyl Alcohol triacrylate. The ratio of mono-reactive monomers to di-reactive or multi-reactive monomers can be advantageously set and adjusted to influence the polymer composition and properties of the shell. The composition according to the invention comprises one or more surfactants. In embodiments, the (or other) surfactant may be prepared or provided separately in the initial step and then added to other components. In particular, the surfactant (s) may be prepared or provided as an aqueous mixture or composition, which is then added to other components comprising a mesogen as described above and below and one or more polymerizable compounds. Particularly preferably, one or more surfactants are provided as an aqueous surfactant. The (etc.) surfactant can be used to reduce surface or interfacial tension and promote emulsification and dispersion. Conventional surfactants known in the art can be used, including anionic surfactants, such as sulfates (such as sodium lauryl sulfate), sulfonates, phosphates, and carboxylate surfactants; cationic surfactants, such as secondary or Tertiary amine and quaternary ammonium salt surfactants; zwitterionic surfactants, such as betaine, sulfobetaine, and phospholipid surfactants; and nonionic surfactants, such as long-chain alcohols and phenols, ethers, esters, or Amidine nonionic surfactant. In a preferred embodiment according to the invention, a non-ionic surfactant is used. The use of non-ionic surfactants can provide benefits during the process of preparing nanocapsules, especially in terms of dispersion formation and stabilization, and in PIPS. It is further recognized that in cases where surfactants (such as residual surfactants) are included in the formed nanocapsules, it may be advantageous to avoid charged surfactants. Therefore, in terms of the stability, reliability, and optoelectronic properties and performance of nanocapsules, it is also beneficial to use nonionic surfactants and avoid ionic surfactants in composite systems and optoelectronic devices. Particularly preferred are polyethoxylated nonionic surfactants. Preferred compounds are selected from the group consisting of polyoxyethylene glycol alkyl ether surfactants, polyoxypropylene glycol alkyl ether surfactants, glucoside alkyl ether surfactants, polyoxyethylene glycol octyl Phenol ether surfactants (e.g. Triton X-100), polyoxyethylene glycol alkyl phenol ether surfactants, glyceryl alkyl ester surfactants, polyoxyethylene glycol desorbitan alkyl ester surfactants ( For example, polysorbate), sorbitan alkyl ester surfactant, cocoamide monoethanolamine, cocoamine diethanolamine, and dodecyldimethylamine oxide. In a particularly preferred embodiment, the surfactant used is selected from polyoxyethylene glycol alkyl ether surfactants, including commercially available Brij® Reagent. The most preferred is a surfactant containing triclosan (ethylene glycol) monododecyl ether, and more preferably composed thereof. In a preferred embodiment, a commercially available Brij is used® L23 (Sigma-Aldrich), which is also known as Brij 35 or polyoxyethylene (23) lauryl ether. Preferably, the surfactant is provided in the composition in an amount based on the overall composition: less than 25% by weight, more preferably less than 20% by weight and especially less than 15% by weight. According to a preferred embodiment, when the surfactant is provided as a prepared aqueous mixture, the amount of water is not considered to account for the entire composition in terms of weight, ie, water is excluded for this purpose. In the process of preparing nanocapsules according to the present invention, polymeric surfactants or surface-active polymers or block copolymers can also be used. In certain embodiments, however, the use of such polymeric surfactants or surface-active polymers is avoided. According to aspects of the present invention, a polymerizable surfactant, that is, a surfactant containing one or more polymerizable groups can be used. This polymerizable surfactant can be used alone (i.e., as the sole surfactant provided) or in combination with a non-polymerizable surfactant. In the examples, a polymerizable surfactant is additionally provided and combined with a non-polymerizable surfactant. This optional provision of polymerizable surfactants can provide combined benefits that can help with proper droplet formation and stabilization and stabilize the formation of polymeric capsule shells. Therefore, these compounds function as both a surfactant and a polymerizable compound. Particularly preferred are polymerizable nonionic surfactants, especially nonionic surfactants which additionally have one or more acrylate and / or methacrylate groups. This embodiment including the use of a polymerizable surfactant may have the advantage that the template properties at the amphiphilic interface may be particularly well maintained during polymerization. In addition, the polymerizable surfactant can not only participate in the polymerization reaction, but can also be advantageously incorporated as a building unit into the polymer shell and better at the crust surface, so that it can favorably influence interfacial interactions. In a particularly preferred embodiment, a polysiloxane polyether acrylate, more preferably a crosslinkable polysiloxane polyether acrylate, is used as the polymerizable surfactant. Poly (ethylene glycol) methyl ether methacrylate may also be added. In a preferred embodiment, the composition according to the present invention is provided as an aqueous mixture, and more preferably, the composition comprising components (i), (ii) and (iii) is dispersed in an aqueous phase. In this regard, the surfactant (s) provided can advantageously help to form and stabilize dispersions, especially emulsions, and promote homogenization. Where an aqueous mixture is provided, the amount of water is not considered to constitute the entire composition in terms of weight, i.e. water is excluded for this purpose. Preferably, the water is provided as purified water, especially deionized water. In a particularly preferred embodiment, the composition according to the invention is provided as nano droplets dispersed in an aqueous phase. The composition may contain other compounds, such as one or more polychromic dyes (especially one or more dichroic dyes), one or more chiral compounds, and / or other conventional and suitable additives. The polychromatic dye is preferably a dichroic dye and may be selected from, for example, an azo dye and a thiadiazole dye. Appropriate chiral compounds are, for example, standard chiral dopants such as R- or S-811, R- or S-1011, R- or S-2011, R- or S-3011, R- or S-4011 , R- or S-5011 or CB 15 (all available from Merck KGaA, DaRMtadt, Germany); sorbitol as described in WO 98/00428; hydrogenated benzoin as described in GB 2,328,207; as in WO 02/94805 Chiral binaphthol as described in; chiral binaphthol acetal as described in WO 02/34739; chiral TADDOL as described in WO 02/06265; or as in WO 02/06196 or WO 02 / Chiral compounds with fluorinated linking groups as described in 06195. In addition, a substance may be added to change the dependence of the photoelectric parameters of the LC material on the dielectric anisotropy, optical anisotropy, viscosity, and / or temperature. The mesogen according to the invention comprises one or more compounds of formula I as described above. In a preferred embodiment, the liquid crystal medium is composed of 2 to 25, preferably 3 to 20 compounds, at least one of which is a compound of formula I. The medium preferably comprises one or more, more preferably two or more and most preferably three or more compounds of formula I according to the invention. The medium preferably comprises a low molecular weight liquid crystal compound selected from a nematic or a nematic substance, such as from a known category selected from the group consisting of oxazobenzene, benzylidene-aniline, biphenyl, bitriphenyl, benzoic acid Phenyl or cyclohexyl benzoate, phenyl or cyclohexyl ester of cyclohexanecarboxylic acid, phenyl or cyclohexyl ester of cyclohexylbenzoate, phenyl or cyclohexyl ester of cyclohexylcyclohexane , Cyclohexylphenyl ester of benzoic acid, cyclohexylphenyl ester of cyclohexanecarboxylic acid and cyclohexylphenyl ester of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexane, cyclohexylbiphenyl, phenylcyclohexyl ring Hexane, cyclohexylcyclohexane, cyclohexylcyclohexene, cyclohexylcyclohexylcyclohexene, 1,4-dicyclohexylbenzene, 4,4'-bicyclohexylbiphenyl, phenylpyrimidine or cyclohexylpyrimidine, benzene Pyridine or cyclohexylpyridine, phenylpyrazine or cyclohexylpyrazine, phenyldioxane or cyclohexyldioxane, phenyl-1,3-dithiane or cyclohexyl-1,3-dithiane , 1,2-diphenyl-ethane, 1,2-dicyclohexylethane, 1-phenyl-2-cyclohexylethane, 1-cyclohexyl-2- (4-phenylcyclohexyl)- Ethane, 1-cyclohexyl-2-bin -Ethane, 1-phenyl2-cyclohexyl-phenylethane, optionally halogenated stilbene, benzylphenyl ether, diphenylacetylene, substituted cinnamic acid and other types of nematic or nematic State matter. Of these compounds, 1,4-phenylene can also be monofluorinated or difluorinated laterally. Liquid crystal mixtures are preferably based on achiral compounds of this type. In a preferred embodiment, the LC host mixture is a nematic LC mixture, which preferably does not have a chiral LC phase. A suitable LC mixture may have positive dielectric anisotropy. These mixtures are described, for example, in JP 07-181 439 (A), EP 0 667 555, EP 0 673 986, DE 195 09 410, DE 195 28 106, DE 195 28 107, WO 96/23 851, WO 96 / 28 521 and WO2012 / 079676. In another embodiment, the LC medium has negative dielectric anisotropy. Such media are described in, for example, EP 1 378 557 A1. In a particularly preferred embodiment, one or more compounds of formula I are selected from one or more compounds of formulas Ia, Ib and Ic,Where R1 , R2 , R3 , R4 And R5 Independent of each other means a straight or branched alkyl or alkoxy group having 1 to 15 carbon atoms or a straight or branched alkenyl group having 2 to 15 carbon atoms, which is unsubstituted, CN or CF3 Mono- or substituted by halogen, preferably F mono- or poly-substituted, and one or more of CH2 The radicals can in each case be independent of each other in a manner such that the oxygen atoms are not directly connected to each other by -O-, -S-, -CO-, -COO-, -OCO-, -OCOO- or -C≡C -Alternative, X1 F, CF3 OCF3 Or CN, L1 , L2 , L3 And L4 It is independently H or F, i is 1 or 2, and j and k are 0 or 1 independently. The composition according to the invention as set forth above can be used in the method for preparing nanocapsules according to the invention and offers certain advantages. Surprisingly, it has been found that, in accordance with the present invention, an efficient and controlled process can be finally implemented on the nanoscale to produce nanoscale containers that are typically spherical or spheroidal encapsulated LC materials. The process utilizes dispersions, especially nanoemulsions (also known as miniemulsions), in which the nanoscale phase containing the LC material and one or more reactive polymerizable compounds is dispersed in a suitable dispersion medium. In particular, the dispersed phase exhibits poor solubility in a dispersion medium, which means that it exhibits low solubility or even is practically insoluble in a dispersion medium forming a continuous phase. Advantageously, water, water-based or aqueous solutions or mixtures are used to form a continuous or external phase. By means of dispersion, individual nanodroplets are decoupled from one another such that each droplet constitutes a separate nanoscale reaction volume for subsequent polymerization. The process conveniently utilizes in-situ polymerization. In particular, polymerization is combined with phase separation. In this regard, the size given by the nanodroplets sets the length scale or volume of these transitions or causes individual separation of polymerization-induced nanophase separations. In addition, the droplet interface can be used as a template for an encapsulated polymeric shell. The polymer chains or networks that are formed or started to form in the nano-droplets can be isolated or driven to accumulate at the interface with the water phase, where polymerization can take place and terminate to form a closed, encapsulated layer. In this regard, the polymeric shell that is being formed or has been formed separately is substantially immiscible in both the aqueous phase and the LC medium. Therefore, in the aspect of the present invention, polymerization may occur, promote, and / or continue at the interface between the aqueous phase and the phase containing the LC medium. In this regard, the interface can serve as a diffusion barrier and as a reaction site. In addition, the characteristics of the positively formed and formed interface of the capsule, especially the structure and building unit of the polymer, can affect material properties, especially LC alignment, by means of, for example, vertical anchoring, anchoring energy, and switching behavior in response to an electric field. In one embodiment, the anchoring energy or intensity is reduced to favorably affect the photoelectric switching, where, for example, the polymer surface morphology and polarity can be appropriately set and adjusted. In particular, the combined elements of the process can advantageously result in the preparation of a large number of individually, dispersed, or individually dispersible liquid nanocapsules, each of which has a polymeric shell and a core containing an LC material. In the first step of the process, an aqueous mixture is prepared or provided, which comprises a composition according to the invention. In embodiments, a surfactant solution or mixture, preferably in water, can be prepared and added to other components of the composition. The provided aqueous mixture is then agitated, especially mechanically, to obtain nano droplets comprising one or more polymerizable compounds and the LC medium according to the invention dispersed in the aqueous phase. Stirring or mixing can be performed using high shear mixing. For example, a high-performance dispersion device using the rotor-stator principle, such as the commercially available Turrax (IKA), can be used. Optionally, this high-shear mixing can be replaced by sonication. It is also possible to combine sonication and high-shear mixing, preferably sonication is performed before high-shear mixing. The combination of agitation and the provision of surfactants as set forth above may be advantageous to allow proper formation and stabilization of dispersions, especially emulsions. The use of a high-pressure homogenizer (other than the mixing described above, as appropriate and preferably) can be used by setting or adjusting and individually reducing the droplet size and also by narrowing the droplet size distribution (i.e., improving particle size) The uniformity of the diameter) further favorably affects the preparation of nanodispersions, especially nanoemulsions. This is particularly preferred when the high-pressure homogenization is repeated, especially several times (for example, three, four, or five times). For example, a commercially available Microfluidics machine can be used. The dispersed nano droplets are then subjected to a polymerization step. In particular, one or more polymerizable compounds contained in the nano droplets or individually mixed therewith are polymerized. This polymerization caused the formation of PIPS and nanocapsules with a core-shell structure as explained above and below. The nanocapsules obtained or separately obtainable are usually spherical, substantially spherical or quasi-spherical. In this regard, some asymmetrical shapes or small deformations can be beneficial, for example in terms of operating voltage. Polymerization in emulsion droplets and at the interface of each droplet can be performed using conventional methods. The polymerization can be carried out in one or more steps. In particular, the polymerization of one or more polymerizable compounds in nano droplets is preferably achieved by exposure to heat or actinic radiation, where exposure to actinic radiation means the use of light (such as UV light, visible light or (IR light), X-rays or gamma rays, or high-energy particles such as ions or electrons. In a preferred embodiment, radical polymerization is performed. The polymerization can be carried out at an appropriate temperature. In the examples, the polymerization is performed at a temperature below the clearing point of the mesogen mixture. However, in alternative embodiments, the polymerization may also be performed at or above the clarification point. In an embodiment, the polymerization is performed by heating the emulsion, that is, by thermal polymerization, for example, by thermally polymerizing one or more acrylate and / or methacrylate compounds. The most preferred is the thermally initiated free radical polymerization of reactive polymerizable precursors, resulting in nano-encapsulation of the LC material. In another embodiment, the polymerization is performed by light irradiation, that is, light, preferably UV light. As a source of actinic radiation, for example, a single UV lamp or a set of UV lamps can be used. When high lamp power is used, curing time can be shortened. Another possible source of optical radiation is laser, such as, for example, UV laser, visible laser or IR laser. Appropriate and customary thermal or photo-initiators can be added to the composition to facilitate the reaction, such as azo compounds or organic peroxides (such as Luperox-type initiators). In addition, suitable conditions for polymerization and appropriate types and amounts of initiators are known in the art and are described in the literature. For example, when polymerized by means of UV light, a photoinitiator can be used, which decomposes under UV radiation to produce free radicals or ions that initiate the polymerization reaction. For polymeric acrylate or methacrylate groups, a free radical photoinitiator is preferably used. To polymerize vinyl, epoxide or oxetanyl groups, cationic photoinitiators are preferably used. It is also possible to use thermal polymerization initiators, which decompose on heating to produce free radicals or ions that initiate polymerization. Typical free radical photoinitiators are, for example, commercially available Irgacure® or Darocure® (Ciba Geigy AG, Basel, Switzerland). A typical cationic photoinitiator is, for example, UVI 6974 (Union Carbide). In the examples, an initiator is used which is well soluble in the nano droplets but insoluble in water or at least substantially insoluble in water. For example, in the process of preparing nanocapsules, azobisisobutyronitrile (AIBN) can be used, which is further included in the composition according to the present invention in specific embodiments. Alternatively or additionally, a water-soluble starter may be provided, such as 2,2 &apos; -azobis (2-methylpropylamidamine) dihydrochloride (AIBA). In the examples, non-ionic initiators, especially non-ionic photo-initiators are particularly preferably used. Other additives can also be added. In particular, the polymerizable material may additionally include one or more additives, such as catalysts, sensitizers, stabilizers, inhibitors, and chain transfer agents. For example, the polymerizable material may also include one or more stabilizers or inhibitors to prevent unwanted spontaneous polymerization, such as, for example, the commercially available Irganox® (Ciba Geigy AG, Basel, Switzerland). By adding one or more chain transfer agents to the polymerizable material, the properties of the polymers obtained or separately obtainable can be adjusted. By using a chain transfer agent, the length of the free polymer chain in the polymer and / or the length of the polymer chain between the two crosslinks can be adjusted, where as the amount of the chain transfer agent increases, the polymer in the polymer Chain length usually decreases. The polymerization is preferably performed under an inert gas atmosphere (such as nitrogen or argon), and more preferably under a heated nitrogen atmosphere. But it can also polymerize in air. Furthermore, preferably, the polymerization is carried out in the presence of an organic solvent as explained above. The use of an organic solvent, such as hexadecane, can be advantageous in terms of adjusting the solubility of one or more reactive compounds with the LC material and stabilizing nano-droplets, and it can also be beneficial in affecting phase separation. Preferably, however, the amount of the organic solvent, if used, is generally limited to less than 25% by weight, more preferably less than 20% by weight, and especially less than 15% by weight based on the overall composition. The formed polymer shell suitably exhibits low solubility with respect to both the LC material and water, ie is substantially insoluble. Furthermore, during the manufacturing process, the coagulation or individual aggregation of the resulting nanocapsules can be suitably and advantageously restricted or even avoided. Also preferably, the polymer that is being formed in the shell or the polymer that has been formed separately is crosslinked. This cross-linking can provide benefits in forming a stable polymeric shell and giving proper containment and barrier functionality while maintaining sufficient mechanical flexibility. Therefore, the process according to the present invention provides the encapsulation and limitation of the mesogen, while maintaining the optoelectronic properties and especially the electrical reactivity of the LC material. In particular, the composition and process conditions are provided so that the stability of the LC material is maintained. Therefore, LC can exhibit favorable characteristics in the formed nanocapsules, such as a suitably high De, a suitably high Dn, a high favorable clarification point, and a low melting point. In particular, the provided LC materials may exhibit appropriate and favorable stability in the polymerization, for example, with regard to exposure to heat or UV light. In the process, it is advantageous to use water or an aqueous solution as the dispersion medium. In this regard, however, it was also observed that the provided composition and the resulting nanocapsules showed proper stability and chemical resistance to the presence of water (for example with regard to hydrolysis). In embodiments, the amount of water can be reduced or even substantially minimized by providing or adding a polar medium, preferably a non-aqueous polar medium containing, for example, formamide or ethylene glycol. As a result, properly dispersed stable nanocapsules are produced during the manufacturing process. In an optional and preferred subsequent step, the aqueous phase may be removed or the amount of water may be individually reduced or depleted, or the aqueous phase may be exchanged for another dispersion medium. In embodiments, liquid nanocapsules that are dispersed or individually dispersible, such as by filtration or centrifugation, are substantially or completely separated from the aqueous phase. Conventional filtration (such as membrane filtration), dialysis, cross-flow filtration, and especially a combination of cross-flow filtration and dialysis, and / or centrifugation techniques can be used. Filtration and / or centrifugation may provide other benefits by, for example, removing excess or undesired or even residual surfactant. Therefore, for example, by removing contaminants, impurities or unwanted ions, not only can the concentration of nanocapsules be provided, but also purification can be provided. Preferably and advantageously, the amount of surface charge of the capsule is kept to a minimum. Based on mechanical stability, nanocapsules can be relatively easily subjected to separation techniques. Nanocapsules can also be dried, where drying means removing the dispersion medium but leaving the LC material contained inside the capsule. Conventional techniques can be used, such as air drying, critical point drying and freeze drying, especially freeze drying. Advantageously, the process according to the invention provides a large number of individual nanocapsules that are dispersible and even redispersible. Therefore, it can be further easily and flexibly used and applied to various environments. Due to its stable storage, it is also possible to have a particularly long storage life before being used in various applications. However, immediate further processing is also a good option. In this regard, the capsules are suitably stable during processing, especially for coating applications. The process as described above provides a convenient method of producing nanocapsules in a controlled and adaptable manner. In particular, the particle size of the capsule can be appropriately adjusted while keeping the polydispersity low, for example, by adjusting the amount of the surfactant in the composition. Surprisingly, it has been found that an appropriately set uniform capsule size can be particularly advantageous in view of reducing the operating voltage in optoelectronic applications. In embodiments, the surfactant provided in the composition may be incorporated at least partially into the polymeric capsule shell, and especially at the interface with the LC in the interior of the capsule. These surfactant molecules incorporated at the interface can favorably affect optoelectronic performance and reduce operating voltage, especially by setting or adjusting interface properties and interactions. In one case, the surfactant can favorably affect the alignment of the LC molecules, such as promoting vertical alignment to produce a radial configuration. Additionally or alternatively, surfactant molecules can affect the morphology and physicochemical properties of the internal polymer surface, resulting in reduced anchoring strength. Therefore, the surfactant provided in the composition not only facilitates the advantageous process according to the invention, but it also provides benefits in the nanocapsules obtained. In another aspect of the present invention, a favorable nanocapsule according to the present invention is provided. In particular, these nanocapsules constitute a nanocontainer filled with an LC material with a polymeric shell that is optionally and preferably crosslinked. Capsules are individual and separate, that is, discrete and dispersible particles with a core-shell structure. Capsules can be used individually or collectively as light modulation materials. It can be applied to various environments depending on the dispersion medium and can be re-dispersed in different media. For example, it can be dispersed in water or an aqueous phase, dried, and dispersed in a binder, preferably a polymer binder. Nanocapsules are also called nano particles. In particular, the nano-particles comprise nano-grade LC material surrounded by a polymer shell. These nano-encapsulated liquid crystals may be additionally embedded in the polymeric binder as appropriate. In alternative situations where phase separation is less pronounced or less complete, a polymer network can be formed in the interior of the droplets such that a capsule exhibiting a sponge-like or porous interior is obtained in which the LC material fills the voids. In this case, the LC material fills the holes in the sponge-like structure or network, and the shell encapsulates the LC material. In another alternative scenario, the separation between the LC material and the polymer may be intermediate, where the interface or boundary between the interior of the LC and the wall is only less visible and shows a gradient behavior. However, it is preferable to obtain an efficient and complete separation of the shell polymer from the LC material, especially given a shell with a smooth internal surface. Optionally, the contained mesogen may further contain one or more chiral dopants and / or one or more polychromic dyes and / or other conventional additives. Advantageously, the nanocapsules according to the invention are obtained or obtainable from the polymerization of the composition according to the invention, and in particular from the highly efficient and controlled processes described herein. Surprisingly, in nanocapsules, shell polymers can be provided, in particular, by polymerizing one or more of the precursor compounds set forth above, which is well matched to the LC components and compatible with LC properties. Preferably, the electrical impedance of the capsule polymer is at least equal to and better than the electrical impedance of the LC material. In addition, shell polymers can be advantageous in terms of dispersibility and avoiding unwanted aggregation. In addition, shell polymers can be combined with adhesives and function well with adhesives, for example in film-forming composite systems and especially in optoelectronic applications. The capsule according to the present invention, in which the liquid crystal is encapsulated by the shell material component, is characterized in that it is nano-sized. The better are nanocapsules with an average size of not more than 400 nm. Preferably, as determined by dynamic light scattering analysis, the average size of the nanocapsules is no more than 400 nm, more preferably no more than 250 nm. Dynamic light scattering (DLS) is a well-known technique that can be used to determine the size and size distribution of particles in a sub-micron region. For example, a commercially available Zetasizer (Malvern) can be used for DLS analysis. Even better, the average size of the nanocapsules is less than 200 nm, especially not more than 150 nm, as measured preferably by DLS. In a particularly preferred embodiment, the average nanocapsule size is lower than the wavelength of visible light, especially smaller than λ / 4 of visible light. It has been found to be advantageous that a nanocapsule according to the invention in at least one state, in particular with an appropriate LC orientation or configuration, can be a very weak visible light scatterer, ie it does not or does not substantially scatter visible light. In this case, the capsule can be used to modulate the phase shift (ie, phase delay) between the two polarization components of light, while at the same time not showing or substantially showing undesired scattering of light. For optoelectronic applications, polymer encapsulated mesogens preferably exhibit the following limited sizes: 15 nm to 400 nm, more preferably 50 nm to 250 nm and especially 75 nm to 150 nm. If the size of the capsule becomes extremely small, especially close to the molecular size of the LC molecules, considering that the amount of encapsulated LC material decreases and the mobility of the LC molecules becomes more restricted, the functionality of the capsule may become less efficient. The thickness of the polymeric shell or individual ground wall selected to form discrete individual structures enables it to effectively contain and stably limit the contained LC medium, while allowing for relative flexibility and still achieving the excellent electrical reactivity of LC materials. Considering the capacitance and optoelectronic performance, the case should preferably be as thin as possible while still providing sufficient containment strength. Therefore, a typical capsule shell or wall thickness is less than 100 nm. Preferably, the thickness of the polymeric shell is less than 50 nm, more preferably less than 25 nm and especially less than 15 nm. In a preferred embodiment, the thickness of the polymeric shell is 1 nm to 15 nm, more preferably 3 nm to 10 nm and especially 5 nm to 8 nm. Microscopy techniques, especially SEM and TEM, can be used to observe the size, structure and morphology of nanocapsules. Wall thickness can be determined, for example, by TEM on a freeze fractured sample. Alternatively, neutron scattering techniques can be used. In addition, for example, AFM, NMR, elliptical polarization, and sum frequency generation techniques can be used to study the nanocapsule structure. Nanocapsules according to the present invention generally have a spherical or spheroidal shape, in which a hollow spherical or spheroidal shell is filled or individually contains an LC medium according to the present invention. Preferably, the nanocapsules are substantially free of surfactants, so that preferably even residual surfactants are kept to a minimum or even completely avoided. Accordingly, nanocapsules that are substantially free of surfactant are provided in aspects. Accordingly, the present invention provides a plurality of discrete spheres or quasi-spheroids or particles of LC, each of which is encapsulated by a polymeric shell nanometer and which can be individually and collectively operated in at least two states in an optoelectronic device. The LC component provides beneficial chemical, physical and optoelectronic properties as explained above, such as good reliability and stability and lower rotational viscosity. In a preferred embodiment, the LC medium according to the present invention has a birefringence of Dn 0.15, more preferably 0.20, and most preferably 0.25. It is even better when the LC medium according to the invention additionally has a dielectric anisotropy of De³10. Surprisingly, by appropriately providing and setting the birefringence and the dielectric anisotropy according to the present invention, even a small nano-volume LC is sufficient to efficiently and efficiently modulate light, where only a medium electric field or separately only a medium The driving voltage can be used to achieve or individually change the orientation of the LC molecules in the nanocapsule. In addition, another advantage of the present invention is that a substantially uniform capsule size can be obtained, that is, low polydispersity is achieved. This uniformity can advantageously provide the uniform optoelectronic performance of the capsule in device applications. Furthermore, the capsules obtained from the controlled and adaptable process according to the invention or individually obtainable therefrom can be adjusted and adjusted with regard to the size of the capsules, which in turn allows the optoelectronic properties to be adjusted as desired, especially based on the Kerr effect. In another aspect of the present invention, a composite system comprising a nanocapsule according to the present invention and one or more adhesives is provided. It has been found that discrete nanocapsules can be mixed with an adhesive material, wherein the mixed nanocapsules substantially maintain, preferably completely maintain, their integrity in the composite, while being combined, held, or installed in the adhesive. In this regard, the adhesive material may be the same material as the polymeric shell material or a different material. Therefore, according to the present invention, nanocapsules can be dispersed in an adhesive made from the same material as or different from the nanocapsule shell. Preferably, the adhesive is a different or at least modified material. Binders can be useful because they can disperse nanocapsules, where the amount or concentration of the capsules can be set and adjusted. Surprisingly, by providing capsules and appropriate adhesives independently, not only can the amount of capsules in the composition complex be adjusted, but very high or very low capsules can also be obtained if desired. Generally, nanocapsules are contained in the composite at a ratio of about 2% to about 95% by weight. Preferably, the composite contains nanocapsules in the range of 10% to 85% by weight, more preferably 30% to 70% by weight. In the preferred embodiment, the amount of the binder and the nanocapsule used is about the same. In addition, the adhesive material can improve or affect the coatability or printability of the capsules and the film-forming ability and performance. Preferably, the adhesive can provide mechanical support while maintaining an appropriate degree of flexibility, and it can be used as a substrate. In addition, the adhesive exhibits appropriate and sufficient transparency. In embodiments, the binder may be selected from, for example, inorganic glass monoliths or other inorganic materials as set forth in, for example, US 4,814,211. However, the adhesive is preferably a polymeric material. Suitable materials may be synthetic resins, such as epoxy resins and polyurethanes, which are, for example, heat-curable. In addition, vinyl compounds and acrylates, especially polyvinyl acrylate and polyvinyl acetate can be used. In addition, polymethyl methacrylate, polyurea, polyurethane, urea formaldehyde, melamine formaldehyde, and melamine urea formaldehyde can be used or added. It is also possible to use thiol-ene based systems, such as the commercial product Norland Optical Adhesive 65 (Norland Products). Particularly preferred are water-soluble polymers such as polyvinyl alcohol (PVA), starch, carboxymethyl cellulose, methyl cellulose, ethyl cellulose, polyvinyl pyrrolidine, gelatin, alginate, casein, gum arabic Or latex-like emulsion. In terms of setting individual hydrophobicity or hydrophilicity, for example, a binder may be selected. In a preferred embodiment, the adhesive, especially the dry adhesive, absorbs little or no water. In a particularly preferred embodiment, the one or more adhesives comprise polyvinyl alcohol, which includes partially and fully hydrolyzed PVA. Advantageously, water solubility and hydrophilicity can be adjusted by changing the degree of hydrolysis. Therefore, water absorption can be controlled or reduced. The properties of PVA, such as mechanical strength or viscosity, can be advantageously set by, for example, adjusting the molecular weight, degree of hydrolysis of PVA, or by chemical modification. Adhesive properties can also be beneficially affected by crosslinking the adhesive. Therefore, especially when PVA is provided as a binder, in embodiments, the binder is preferably cross-linked by a cross-linking agent such as dialdehyde (eg, glutaraldehyde, formaldehyde, and glyoxal). This crosslinking can, for example, advantageously reduce any tendency to undesired crack formation. The composite may further include conventional additives such as stabilizers, antioxidants, free radical scavengers, and / or plasticizers. For adhesives, especially PVA, ethylene glycol can be used as the preferred plasticizer. Glycerin can also be added to adhesives, especially PVA-based adhesives. These additives added to the adhesive, especially to PVA, can also be used to favorably influence or adjust other material properties, such as operating voltage or permittivity. In addition, in order to favorably influence the film forming properties, a film forming agent (for example, polyacrylic acid) and an antifoaming agent may be added. These reagents can be used to improve film formation and substrate wettability. Optionally, degassing and / or filtering of the coating composition may be performed to further improve the membrane properties. Likewise, setting and adjusting the viscosity of the adhesive can have a beneficial effect on the film being formed or separately formed. Binders can be provided as liquids or pastes, wherein a carrier medium or solvent (e.g. water, aqueous or organic solvent) can be e.g. from the composite, for example, during or after film formation, especially by evaporation at elevated temperatures. The mixture was removed. The adhesive is preferably well mixed and combined with the nanocapsules, while further avoiding the aggregation of the capsules, so that, for example, light leakage can be avoided or minimized, which in turn makes it possible to have an excellent dark state. In addition, the binder can be selected so that high density nanocapsules can be provided in the composite, such as in a film formed from the composite. In addition, in the composite, the structural and mechanical advantages of the adhesive can be combined with the favorable optoelectronic properties of the LC capsule. Nanocapsules according to the invention can be applied to a wide variety of different environments, in particular by (re) dispersing them. It can be advantageously dispersed in the adhesive or separately mixed with the adhesive. The adhesive can not only improve the film formation behavior but also the film properties. Among them, the adhesive can hold the capsule relative to the substrate. Generally, the capsules are randomly distributed or individually oriented randomly in the adhesive. The composite containing the binder material and its own nanocapsules may be suitably applied or laminated to the substrate. For example, the composite or nanocapsules can be applied to a substrate by conventional coating techniques, such as spin coating, blade coating, or drip coating. Alternatively, it may be applied to a substrate by conventional and known printing methods such as inkjet printing. Capsules or complexes can also be dissolved in a suitable solvent. This solution is then applied or printed onto a substrate by, for example, spin coating or printing or other known techniques, and the solvent is evaporated off. In many cases, the mixture is appropriately heated to promote evaporation of the solvent. As solvents, for example, water, aqueous mixtures or standard organic solvents can be used. Preferably, the material applied to the substrate is a composite (ie, it also contains an adhesive). Generally, a film with a thickness of less than 25 µm, preferably less than 15 µm, is formed. In a preferred embodiment, the thickness of the film made from the composite is 0.5 μm to 10 μm, preferably 1 μm to 7 μm, especially 2 μm to 5 μm. As the substrate, for example, glass, silicon, quartz flakes, or plastic film can be used. The second substrate can also be placed on top of the applied, preferably coated or printed material. Isotropic or birefringent substrates can be used. Optical coatings can also be applied, especially with optical adhesives. In a preferred embodiment, the substrate may be a flexible material. In view of the flexibility provided by the composite, a flexible system or device can be obtained as a whole. Suitable and preferred plastic substrates are, for example, polyester (e.g., polyethylene terephthalate (PET) or polyethylene naphthalate (PEN)), polyvinyl alcohol (PVA), polycarbonate ( PC) or triacetyl cellulose (TAC) film, more preferably PET or TAC film. As the birefringent substrate, for example, a uniaxially stretched plastic film can be used. PET films are available, for example, under the brand name Melinex® Commercially available from DuPont Teijin Films. The substrate can be transparent and transmissive or reflective. For optoelectronic addressability, the substrate may exhibit one or more electrodes. In a typical embodiment, a glass substrate having an ITO electrode is provided. In terms of compatibility and in view of individual applications, the electrical and optical properties of LC materials, polymeric capsule shells and adhesives are advantageously and better matched or aligned. The composites according to the present invention can provide appropriate and advantageous optoelectronic behavior and properties. In addition, excellent physical and chemical stability can be obtained by, for example, better and advantageous reduction of water absorption. In particular, good stability and resistance to thermal or mechanical stresses can be achieved while still providing proper mechanical flexibility. Preferably, the adhesive and preferably the polymer shell have a relatively large impedance in view of the electrical reactivity of the LC and an appropriate dielectric constant close to the LC material to limit the charge at the interface. It was observed that the dielectric constant of the adhesive was high enough to ensure that the electric field was effectively applied to the LC medium in the capsule. It is preferred to minimize any charge or ion content in these materials to keep the conductivity extremely low. In this regard, it has been found that the properties of the provided adhesive, preferably PVA, can be improved by purification, especially by removing or reducing the amount of impurities and charged contaminants. For example, the binder, especially PVA, can be dissolved in and washed with deionized water or alcohol, and it can be processed by dialysis or soxhlet purification. In addition, considering the best performance in the respective application, the refractive index of the LC material, the polymeric capsule shell and the adhesive are advantageously and better matched or aligned. In particular, the refractive index of the LC material is compatible with the refractive index of the adhesive. In particular, the very refractive index of LC (ne ), LC ordinary refractive index (no ) Or LC average refractive index (navg ) Set or adjust the refractive index of the adhesive and possibly the refractive index of the capsule polymer. In particular, the refractive index of the adhesive and the shell polymer can be compared with the n of the LC material.e , No Or navg Close match. In an embodiment, the nanocapsules are dispersed in a binder, wherein the capsules in the binder exhibit a random orientation relative to each other. Regardless of the non-existence or existence of the orientation or orientation of the LC material in each individual capsule, this random orientation of the capsules relative to each other can result in the LC material as a whole giving the observed average refractive index (navg ). Considering the nanometer size of the capsule and its beneficial potential as a very weak light scatterer, the application of an electric field (where the electric field forces the LC material (re) alignment) to tune the phase of transmitted or reflected light in this embodiment Shift or delay, but do not change the apparent scattering (if present). In this case, and especially when the size of the capsule is significantly smaller than the wavelength of light, the refractive index of the adhesive and preferably the polymeric capsule shell may, for example, be appropriate and advantageous relative to the n of the LC materialavg Make adjustments or matches. Therefore, nanocapsules can be used as high-efficiency nanoscale phase modulators. Considering the nanometer size of the capsule and the absence of an electric field, it can substantially suppress, and preferably completely suppress, light scattering, especially for those smaller than 400 nm. In addition, scattering and refraction can be controlled by matching or adjusting the refractive index of the LC material and one or more polymeric materials. When the capsule and the respective LC directors are randomly positioned in the adhesive, in an embodiment, for normal incident light, the phase shift may be independent of polarization. In another embodiment, the capsule is aligned or oriented in an adhesive. Especially in terms of tuning optoelectronic properties and functionality, the composite system according to the present invention advantageously allows high adaptability and allows setting and adjusting several degrees of freedom. For example, while being able to independently change the density of nano-grade LC materials in the film, the layer or film thickness can be set, debugged, or changed. In addition, the size of the nanocapsules (that is, the amount of LC material in each individual capsule) ) Can be set in advance and can therefore also be adjusted. In addition, the LC medium can be selected to have specific properties, such as suitably high De and Dn values. In the preferred embodiment, the amount of LC in the composition, nanocapsules, and composites is appropriately maximized to achieve favorable high optoelectronic performance. According to the present invention, the composite can be advantageously provided with relative ease of production and high processability, which can make good transmittance, low operating voltage, improved VHR, and good dark state possible. Surprisingly, a robust, effective and efficient system is available, which is suitable for a single substrate without any alignment layer or surface friction and which can exhibit deviations in layer thickness or external forces (such as touch) and exhibit relatively poor light leakage Sensitivity. In addition, a wide viewing angle can be obtained without providing an alignment layer or an additional retardation layer. Preferably and advantageously, the nanocapsules and composite systems provided exhibit sufficient processability to keep aggregation to a minimum during concentration and filtration of the capsules, mixing with the binder, film formation, and optional drying of the film. Nanocapsules and composites according to the present invention can be used in displays and other optical and optoelectronic applications. In particular, nanocapsules containing LC media, which are preferably mixed with binders, are suitable for the efficient control and modulation of light. It can be used, for example, in filters, tunable polarizers, and lenses and phase plates. As a phase modulator, it can be used in photonic devices, optical communication and information processing, and three-dimensional displays. Another use is in switchable smart windows or privacy windows. Therefore, the present invention advantageously provides a light modulation element and a photoelectric modulator. The elements and modulators include nanocapsules according to the present invention, wherein preferably the capsules are mixed and dispersed in an adhesive. Furthermore, optoelectronic devices, in particular optoelectronic displays, are provided which advantageously make use of nanocapsules and / or composite systems as explained above and below. In the device, a plurality of nanocapsules are provided. Many of the mesogen compounds or mixtures thereof described above and below are commercially available. All such compounds are known or can be prepared by methods known per se, such as in the literature (for example in standard works such as Houben-Weyl, Methoden der Organischen Chemie [methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart) As stated in the text, it is carried out under reaction conditions known and suitable for such reactions. Variations known per se can also be used here, but are not mentioned in more detail here. The medium according to the invention is prepared in a manner customary per se. In general, it is preferred that the components dissolve with each other at elevated temperatures. With appropriate additives, the liquid crystal phase of the present invention can be adjusted in such a way that it can be used in liquid crystal display elements. Additives of this type are known to those skilled in the art and are described in detail in the literature (H. Kelker / R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, polychromic dyes can be added to produce colored guest-host systems or substances can be added to adjust the dielectric anisotropy, viscosity, and / or nematic phase alignment. According to the invention, the term "alkyl" preferably encompasses straight-chain and branched-chain alkyl groups having 1 to 7 carbon atoms, especially the straight-chain groups methyl, ethyl, propyl, butyl, pentyl, Hexyl and heptyl. Groups having 2 to 5 carbon atoms are generally preferred. An alkoxy group may be straight or branched, and it is preferably straight and has 1, 2, 3, 4, 5, 6, or 7 carbon atoms, and is therefore preferably methoxy, ethoxy Radical, propoxy, butoxy, pentyloxy, hexyloxy or heptyloxy. According to the invention, the term "alkenyl" preferably encompasses straight-chain and branched alkenyl groups, especially straight-chain groups, having 2 to 7 carbon atoms. Eudenyl C2 -C7 -1E-alkenyl, C4 -C7 -3E-alkenyl, C5 -C7 -4E-alkenyl, C6 -C7 -5E-alkenyl and C7 -6E-alkenyl, especially C2 -C7 -1E-alkenyl, C4 -C7 -3E-alkenyl and C5 -C7 -4E-alkenyl. Examples of preferred alkenyl are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl , 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl and 6-heptenyl. Groups having up to 5 carbon atoms are generally preferred. Fluorinated alkyl or alkoxy preferably contains CF3 OCF3 CFH2 , OCFH2 CF2 H, OCF2 H, C2 F5 , OC2 F5 CFHCF3 CFHCF2 H, CFHCFH2 , CH2 CF3 , CH2 CF2 H, CH2 CFH2 CF2 CF2 H, CF2 CFH2 , OCFHCF3 , OCFHCF2 H, OCFHCFH2 , OCH2 CF3 , OCH2 CF2 H, OCH2 CFH2 OCF2 CF2 H, OCF2 CFH2 , C3 F7 Or OC3 F7 , Especially CF3 OCF3 CF2 H, OCF2 H, C2 F5 , OC2 F5 CFHCF3 CFHCF2 H, CFHCFH2 CF2 CF2 H, CF2 CFH2 , OCFHCF3 , OCFHCF2 H, OCFHCFH2 OCF2 CF2 H, OCF2 CFH2 , C3 F7 Or OC3 F7 , Especially good OCF3 Or OCF2 H. In the preferred embodiment, fluoroalkyl encompasses straight-chain groups with terminal fluorine, i.e., fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluorobutyl, 5-fluoropentyl, 6- Fluorohexyl and 7-fluoroheptyl. However, other positions of fluorine are not excluded. The oxaalkyl group preferably covers formula Cn H2n + 1 -O- (CH2 )m Is a straight-chain group in which n and m are each independently 1 to 6. Preferably, n = 1 and m is 1 to 6. The oxaalkyl group is preferably a linear 2-oxopropyl (= methoxymethyl), 2-(= ethoxymethyl) or 3-oxobutyl (= 2-methoxyethyl) ); -, 3-, 4-, 5-, 6- or 7-oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl, or 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-oxadecyl. Halogen is preferably F or Cl, especially F. If one of the groups mentioned above is one of the CH2 An alkyl group in which the group has been replaced by -CH = CH-, this group may be straight or branched. It is preferably straight-chain and has 2 to 10 carbon atoms. It is therefore especially vinyl, prop-1- or prop-2-enyl, but-1-,-2- or but-3-enyl, pent-1-,-2-,-3- or pentyl 4-alkenyl, hex-1-,-2-,-3-,-4- or hex-5-alkenyl, hept-1-,-2-,-3-,-4-,-5- Or hept-6-alkenyl, oct-1-,-2-,-3-,-4-,-5-,-6- or oct-7-alkenyl, non-1-,-2-,-3 -,-4-,-5-,-6-,-7- or non-8-alkenyl, dec-1-,-2-,-3-,-4-,-5-,-6-, -7-, -8- or dec-9-alkenyl. If one of the groups mentioned above is one of the CH2 The groups have been replaced by -O- and an alkyl group has been replaced by -CO-, these groups are preferably adjacent. Therefore, these groups contain fluorenyl-CO-O- or oxycarbonyl-O-CO-. These groups are preferably straight-chain and have 2 to 6 carbon atoms. Therefore, it is especially ethoxyl, propionyloxy, butyryloxy, pentamyloxy, hexamethyleneoxy, ethynylmethyl, propionyloxymethyl, butyloxymethyl , Pentamyloxymethyl, 2-acetamyloxyethyl, 2-propamyloxyethyl, 2-butamyloxyethyl, 3-acetamyloxypropyl, 3-propamyloxy Propyl, 4-ethoxycarbonylbutyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, pentoxycarbonyl, methoxycarbonylmethyl, ethoxycarbonylmethyl , Propoxycarbonylmethyl, butoxycarbonylmethyl, 2- (methoxycarbonyl) ethyl, 2- (ethoxycarbonyl) ethyl, 2- (propoxycarbonyl) ethyl, 3- (Methoxycarbonyl) propyl, 3- (ethoxycarbonyl) propyl or 4- (methoxycarbonyl) -butyl. If one of the groups mentioned above is one of the CH2 The group has been replaced by unsubstituted or substituted -CH = CH- and adjacent to CH2 An alkyl group in which a group has been replaced by CO, CO-O or O-CO, then this group may be straight or branched. It is preferably straight-chain and has 4 to 13 carbon atoms. Therefore, it is especially acrylfluorenyloxymethyl, 2-acrylfluorenyloxyethyl, 3-acrylfluorenyloxypropyl, 4-acrylfluorenyloxybutyl, 5-propenyloxybutyl Amyl, 6-propenylfluorenyloxyhexyl, 7-propenylfluorenyloxyheptyl, 8-propenylfluorenyloxyoctyl, 9-propenylfluorenyloxynonyl, 10-propenylfluorenyloxydecyl Methyl, methacrylfluorenyloxymethyl, 2-methacrylfluorenyloxyethyl, 3-methacrylfluorenyloxypropyl, 4-methacrylfluorenyloxybutyl, 5- Methacrylfluorenyloxypentyl, 6-methacrylfluorenyloxyhexyl, 7-methacrylfluorenyloxyheptyl, 8-methacrylfluorenyloxyoctyl, or 9-methylpropylene Fluorenyloxynonyl. If one of the groups mentioned above is by CN or CF3 Mono-substituted alkyl or alkenyl, this group is preferably straight-chain. By CN or CF3 Replacement is at any position. If one of the groups mentioned above is an alkyl or alkenyl group which is at least monosubstituted by halogen, this group is preferably a straight chain and the halogen is preferably F or Cl, more preferably F. In the case of multiple substitutions, the halogen is preferably F. The resulting groups also include perfluorinated groups. In the case of a single substitution, the fluorine or chlorine substituent may be at any desired position, but is preferably at the omega position. Compounds containing branched groups may occasionally be important due to better solubility in some conventional liquid crystal base materials. However, if it is optically active, it is particularly suitable as a chiral dopant. Branched groups of this type usually contain no more than one chain branch. Preferred branched groups are isopropyl, 2-butyl (= 1-methylpropyl), isobutyl (= 2-methylpropyl), 2-methylbutyl, isopentyl ( = 3-methylbutyl), 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl, 2-propylpentyl, isopropoxy, 2-methylpropoxy, 2 -Methylbutoxy, 3-methylbutoxy, 2-methylpentoxy, 3-methylpentoxy, 2-ethylhexyloxy, 1-methylhexyloxy, or 1-methyl Heptyloxy. If one of the groups mentioned above is two or more of them2 An alkyl group in which a group has been replaced by -O- and / or -CO-O-, then this group may be straight or branched. It is preferably branched and has 3 to 12 carbon atoms. Therefore, it is especially dicarboxymethyl, 2,2-biscarboxyethyl, 3,3-biscarboxypropyl, 4,4-biscarboxybutyl, 5,5-biscarboxypentyl, 6,6- Dicarboxyhexyl, 7,7-biscarboxyheptyl, 8,8-biscarboxyoctyl, 9,9-biscarboxynonyl, 10,10-biscarboxydecyl, bis (methoxycarbonyl) methyl, 2,2-bis (methoxycarbonyl) ethyl, 3,3-bis (methoxycarbonyl) propyl, 4,4-bis (methoxycarbonyl) butyl, 5,5-bis (methoxy) Carbonyl) pentyl, 6,6-bis (methoxycarbonyl) hexyl, 7,7-bis (methoxycarbonyl) heptyl, 8,8-bis (methoxycarbonyl) octyl, bis (ethyl (Oxycarbonyl) methyl, 2,2-bis (ethoxycarbonyl) ethyl, 3,3-bis (ethoxycarbonyl) propyl, 4,4-bis (ethoxycarbonyl) butyl or 5 , 5-bis (ethoxycarbonyl) pentyl. The LC medium according to the present invention preferably has a nematic phase range between -10 ° C and + 70 ° C. The LC medium even more preferably has a nematic phase range between -20 ° C and + 80 ° C. It is optimal when the LC medium according to the invention has a nematic phase range between -20 ° C and + 90 ° C. The LC medium according to the present invention preferably has a birefringence of Dn 0.15, more preferably 0.20, and most preferably 0.25. The LC dielectric according to the present invention preferably has a dielectric anisotropy of De³ +10, more preferably +15, and most preferably +20. The LC medium according to the present invention preferably and advantageously exhibits high reliability and high electrical resistivity (also known as specific resistivity (SR)). The SR value of the LC medium according to the present invention is preferably ³ 1 × 1013 W cm, excellent³ 1 × 1014 W cm. Unless otherwise stated, SR measurements were performed as described in G. Weber et al., Liquid Crystals 5, 1381 (1989). The LC medium according to the present invention also preferably and advantageously exhibits high voltage retention (VHR), see S. Matsumoto et al., Liquid Crystals 5, 1320 (1989); K. Niwa et al., Proc. SID Conference, San Francisco , June 1984, p. 304 (1984); T. Jacob and U. Finkenzeller, "Merck Liquid Crystals-Physical Properties of Liquid Crystals", 1997. The VHR of the LC medium according to the present invention is preferably ³90%, very good³95%. Unless otherwise stated, VHR measurements were performed as described in T. Jacob, U. Finkenzeller, "Merck Liquid Crystals-Physical Properties of Liquid Crystals", 1997. Unless expressly stated otherwise, throughout the present application, all concentrations are given in weight% and refer to the individual complete mixtures, excluding water solvents or aqueous phases as indicated above. All temperatures are given in degrees Celsius (Celsius, ° C) and all temperature differences are given in degrees Celsius. Unless explicitly stated otherwise, all physical properties and physicochemical or optoelectronic parameters are determined by commonly known methods, in particular according to "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status November 1997, Merck KGaA, Germany It is given for a temperature of 20 ° C. Above and below, Dn stands for optical anisotropy, where Dn = ne -no And Δe represents the dielectric anisotropy, where Δe = e÷÷ -e^ . The dielectric anisotropy Δe was measured at 20 ° C and 1 kHz. Optical anisotropy Dn was measured at 20 ° C and a wavelength of 589.3 nm. De and Dn values and rotational viscosity of the compounds according to the invention (γ1 ) Are obtained by linear extrapolation from liquid crystal mixtures, which are from 5% to 10% of the individual compounds according to the invention and 90% to 95% of commercially available liquid crystal mixtures ZLI-2857 or ZLI -4792 (both mixtures are from Merck KGaA). In addition to the usual and well-known abbreviations, the following abbreviations are also used: C: crystalline phase; N: nematic phase; Sm: smectic phase; I: isotropic phase. The number between these symbols shows the transition temperature of the substance of interest. In the present invention and especially in the following examples, the structure of the mesogen compound is indicated by means of an abbreviation (also known as an acronym). Among these acronyms, the chemical formulas are abbreviated as follows using the following tables A to C. All groups Cn H2n + 1 , Cm H2m + 1 And C1 H2l + 1 Or Cn H2n-1 , Cm H2m-1 And Cl H2l-1 Each represents a straight-chain alkyl or alkenyl, preferably 1E-alkenyl, each of which has n, m and l C atoms, respectively. Table A shows the codes for the ring elements used in the core structure of the compounds, while Table B shows the linking groups. Table C gives the meaning of the left-hand or right-hand end group codes. The acronym is composed of a code of a ring element having an optional link group, followed by a code of a first hyphen and a left-hand end group and a second hyphen and a code of a right-hand end group. Table D shows the illustrative structures of the compounds and their respective abbreviations.table A : Ring element table B : Linking group table C : Terminal group Where n and m each represent an integer, and the three points "..." are placeholders for other abbreviations from this table. The following table shows the illustrative structure and its respective abbreviations. These structures are shown to illustrate the meaning of the abbreviation rules. In addition, they represent compounds which can be preferably used.table D : Illustrative Structure Where n, m and l preferably represent 1 to 7 independently of each other. The following table shows illustrative compounds that can be used as other stabilizers in the mesogens according to the present invention.table E Table E shows possible stabilizers that can be added to the LC medium according to the invention, where n represents an integer from 1 to 12, preferably 1, 2, 3, 4, 5, 6, 7, or 8, the terminal methyl group is not shown Out. The LC medium preferably contains 0 to 10% by weight, especially 1 ppm to 5% by weight, particularly preferably 1 ppm to 1% by weight of a stabilizer. Table F below shows illustrative compounds that can be preferably used as chiral dopants in the mesogens according to the present invention.table F In a preferred embodiment of the present invention, the mesogen comprises one or more compounds selected from the compounds shown in Table F. The mesogen according to the present invention preferably contains two or more, preferably four or more compounds selected from the compounds shown in Tables D to F above. The LC medium according to the present invention preferably contains three or more, more preferably five or more of the compounds shown in Table D. The following examples merely illustrate the invention and should not be construed as limiting the scope of the invention in any way. Based on this disclosure, those skilled in the art will know the examples and their modified forms or other equivalent forms.Examples In the example, Vo Represents the capacitive threshold voltage [V] at 20 ℃, ne Represents the extraordinary refractive index at 20 ° C and 589 nm, no Represents the ordinary refractive index at 20 ° C and 589 nm Dn represents the optical anisotropy at 20 ° C and 589 nm, e÷÷ The dielectric permittivity parallel to the director at 20 ° C and 1 kHz, e^ Indicates the dielectric permittivity perpendicular to the director at 20 ° C and 1 kHz, De indicates the dielectric anisotropy at 20 ° C and 1 kHz, and cl.p., T (N, I) indicates the clarification point [° C ], G1 Represents the rotational viscosity [mPa × s] measured at 20 ℃, measured by the rotation method in a magnetic field, K1 Represents the elastic constant [pN] of the "unfolded" deformation at 20 ° C, K2 Elastic constant [pN], which represents the "torsional" deformation at 20 ° C, K3 Represents the elastic constant [pN] of "bending" deformation at 20 ° C. Unless otherwise specified, the term "threshold voltage" of the present invention refers to the capacitive threshold0 ) ,. In the example, the optical threshold can also be indicated as 10% relative contrast (V10 ).Reference example 1 The liquid crystal mixture B-1 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-1 Reference example 2 The liquid crystal mixture B-2 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-2 Reference example 3 The liquid crystal mixture B-3 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-3 Reference example 4 Liquid crystal mixture B-4 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-4 Reference example 5 The liquid crystal mixture B-5 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-5 Reference example 6 Liquid crystal mixture B-6 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-6 Reference example 7 Liquid crystal mixture B-7 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-7 Reference example 8 Liquid crystal mixture B-8 was prepared and characterized for its general physical properties, which have the composition and properties indicated in the following table. Basic mixture B-8 Examples 1 Preparation of Nano Capsules The LC mixture B-1 (2.66 g), hexadecane (0.66 g) and methyl methacrylate (3.30 g) were weighed into a 250 ml high beaker. Brij L23 (0.83 g) was weighed into a 250 ml Erlenmeyer flask and water (100 ml) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 5 minutes. Once mixing in the turrax was complete, the crude emulsion was passed through a high pressure homogenizer 4 times at 30,000 psi. The mixture was filled into a flask and fitted with a condenser, and heated to 70 ° C. for 3 hours after the addition of AIBN (35 mg). The reaction mixture was cooled, filtered, and material size analysis was then performed on a Zetasizer (Malvern Zetasizer Nano ZS) instrument. The average size of the obtained capsules was 85 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage.30% Solid content PVA Preparation of adhesives First, PVA (Molecular Weight of PVA Mw : 31k; 88% hydrolysis) was washed in a Sauguslite device for 3 days to remove ions. Add 46.66 g of deionized water to a 150 ml bottle, add a large magnetic stir bar and place the bottle on a 50 ° C stirrer hot plate and bring it to temperature. 20.00 g of washed 31k PVA solid was weighed into a beaker. Vortex in the bottle and gradually add 31k PVA over about 5 minutes to stop dispersing the floating PVA into the mixture. Raise the hot plate to 90 ° C and continue stirring for 2-3 hours. The bottle was placed in an oven at 80 ° C for 20 hours. The mixture was filtered while still warm with a 50 μm cloth filter at an air pressure of 0.5 bar. Replace the filter with a Millipore 5 μm SVPP filter and repeat the filtration. The solids content of the filtered adhesive was measured 3 times and the average was calculated by weighing an empty DSC pan with a DSC microbalance, adding approximately 40 mg of the adhesive mixture to the DSC pan and recording the mass. The hot plate was placed on the hot plate for 1 hour and then placed on the hot plate at 110 ° C for 10 minutes. The plate was removed from the hot plate and allowed to cool, the dry plate mass was recorded and the solid content was calculated.Preparation of composite systems The obtained nanocapsule samples were first examined by microscopy for undesired coagulation or agglomeration and also after film formation. The solid content of the concentrated nanocapsule suspension was measured. The solid content of the sample was measured 3 times and the average was calculated. Samples were weighed in an empty DSC pan using a DSC microbalance. Add approximately 40 mg of sample to the DSC dish and record the mass. The plate was placed on a 60 ° C hot plate for 1 hour and then on a 110 ° C hot plate for 10 min. Remove the pan from the hot plate and allow it to cool. Record the dry pan mass and calculate the solids content. The prepared PVA was added to a concentrated nanocapsule sample in which approximately 30% of the washed 31k PVA mixture was added to a 2.5 ml vial, and then the nanocapsule was added to the vial. Deionized water was added to bring the total solids content of approximately 0.5 g of the mixture to 20%. The mixture was stirred using a vortex stirrer and the mixture was placed on a roll overnight to disperse the PVA.Preparation of film on substrate The substrate used is IPS (In-Plane Switching) glass, which has ITO-coated interdigital electrodes, where the electrode width is 4 μm and the gap is 8 μm. The substrate is placed in a shelf and a plastic box for washing. Add deionized water and place the sample in a sonic shaker for 10 minutes. Remove the substrate from water and blot dry with a paper towel to remove excess water. Repeated washing with acetone, 2-propanol (IPA), and finally water for ion chromatography. The substrate was then dried using a compressed air gun. The substrate was treated with UV-ozone for 10 minutes. A composite system containing nanocapsules and an adhesive is then coated on the substrate. Using a coater (K Control Coater, RK PrintCoat Instruments, bar coating with k rod 1, coating speed 7), 40 μL of the mixture was coated into a film. The samples were dried on a hot plate at 60 ° C for 10 minutes, under the lid to prevent draught and prevent contaminants from falling onto the film. The appearance of the film was recorded. The prepared films were stored in a dry box between measurements. The film thickness was measured by removing the film from above the electrical contacts with a razor blade. The film thickness was measured in the area of the middle electrode using a profilometer (Dektak XT surface profiler, Bruker) with a stylus force of 5 mg, a scan length of 3000 nm, and a time of 30 s. A desired film thickness of 4.0-5.5 microns was observed.Measurement of photoelectric properties Check the appearance of the film for uniformity and defects with the eyes. Weld two electrodes to glass. The voltage-transmission curve was measured using dynamic scattering mode (DSM). Images of dark and bright states of 10% and 90% transmission were also recorded using a microscope at the required voltage. The switching speed is measured at a modulation frequency of 150 Hz at 40 ° C and 25 ° C and, if appropriate, 10 Hz. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 2 LC mixture B-1 (2.0 g), diethyl methacrylate (0.60 g), 2-hydroxyethyl methacrylate (0.07 g), methyl methacrylate (0.15 g) and ten Hexane (0.10 g) was weighed into a 250 ml high beaker. This mixture was processed and studied as set out in Example 1 above. The average size of the obtained capsules was 124 nm, as determined by DLS (Zetasizer) analysis. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. Composite systems and films comprising the obtained capsules and adhesives were prepared as set forth in Example 1 above. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 3 LC mixture B-1 (2.0 g), ethylene dimethacrylate (0.66 g), hydroxyethyl methacrylate (0.08 g), methyl methacrylate (0.16 g), and 2-iso Propoxyethanol (0.10 g) was weighed into a 250 ml high beaker. This mixture was processed and studied as set out in Example 1 above. The average size of the obtained capsules was 204 nm, as determined by DLS (Zetasizer) analysis. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. Composite systems and films comprising the obtained capsules and adhesives were prepared as set forth in Example 1 above. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 4 LC mixture B-1 (1.0 g), hexanediol diacrylate (0.03 g), hydroxyethyl methacrylate (0.03 g), isoamyl methacrylate (0.110 g), and 2-ethyl acrylate The hexyl ester (0.250 g) was weighed into a 250 ml high beaker. This mixture was processed and studied as set out in Example 1 above. The average size of the obtained capsules was 114 nm, as determined by DLS (Zetasizer) analysis. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. Composite systems and films comprising the obtained capsules and adhesives were prepared as set forth in Example 1 above. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 5 LC mixture B-2 (2.0 g), ethylene dimethacrylate (0.66 g), 2-hydroxyethyl methacrylate (0.075 g), methyl methacrylate (0.175 g) and ten Hexane (0.10 g) was weighed into a 250 ml high beaker. This mixture was processed and studied as set out in Example 1 above. The average size of the obtained capsules was 148 nm, as determined by DLS (Zetasizer) analysis. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. Composite systems and films comprising the obtained capsules and adhesives were prepared as set forth in Example 1 above. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 6 Weigh LC mixture B-3 (1.0 g), diethyl methacrylate (0.34 g), 2-hydroxyethyl methacrylate (0.07 g) and hexadecane (0.25 g) to 250 ml In a high beaker. This mixture was processed and studied as set out in Example 1 above. The average size of the obtained capsules was 145 nm, as determined by DLS (Zetasizer) analysis. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. Composite systems and films comprising the obtained capsules and adhesives were prepared as set forth in Example 1 above. The measured optical and electrical parameters of the prepared film including nanocapsules and adhesives are given in the table below. Optical parameters Examples 7 The LC mixture B-4 was processed as described in Example 2 above to prepare nanocapsules, composite systems with adhesives, and coated films.Examples 8 The LC mixture B-5 was processed as described in Example 2 above to prepare nanocapsules, composite systems with adhesives, and coated films.Examples 9 The LC mixture B-6 was processed as described in Example 2 above to prepare nanocapsules, composite systems with adhesives, and coated films.Examples 10 The LC mixture B-7 was processed as described in Example 2 above to prepare nanocapsules, composite systems with adhesives, and coated films.Examples 11 LC mixture B-1 (2.00 g), 1,4-pentanediol (102 mg), ethylene dimethacrylate (658 mg), 2-hydroxyethyl methacrylate (77 mg) and Methyl methacrylate (162 mg) was weighed into a 250 ml high beaker. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was filled into a flask and a condenser was fitted, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 180 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.6 µm. Measured photoelectric parameter V50 (That is, the gray voltage at 50% relative contrast) is 55 V. The prepared samples showed favorable performance at 24 ° C, 40 ° C and 60 ° C, exhibiting appropriate temperature dependence and stability.Examples 12 LC mixture B-1 (1.00 g), 1,4-pentanediol (175 mg), ethylene dimethacrylate (300 mg), 2-hydroxyethyl methacrylate (40 mg) and Methyl methacrylate (100 mg) was weighed into a 250 ml high beaker. Brij L23 (50 mg) was weighed into a 250 ml Erlenmeyer flask and water (150 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 10 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (10 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 175 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The samples especially showed favorable temperature dependence.Examples 13 LC mixture B-8 (1.99 g), hexadecane (101 mg), ethylene dimethacrylate (657 mg), 2-hydroxyethyl methacrylate (74 mg) and methyl methacrylate Ester (170 mg) was weighed into a 250 ml high beaker. Brij L23 (300 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 132 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.2 µm. Measured photoelectric parameter V50 33 V, measured photoelectric parameter V90 66 V.Examples 14 LC mixture B-1 (1.00 g), hexadecane (175 mg), ethylene glycol dimethacrylate (300 mg), 2-hydroxyethyl methacrylate (40 mg), and methyl methacrylate Ester (100 mg) was weighed into a 250 ml high beaker. Brij L23 (50 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (10 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 199 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 5.3 µm. Measured photoelectric parameter V50 19 V, measured photoelectric parameter V90 42 V.Examples 15 The LC mixture B-1 was processed as described in Example 14 above to prepare nanocapsules, a composite system with an adhesive, and a coating film in which 1,4-pentanediol was used instead of cetane.Examples 16 LC mixture B-8 was treated similarly to B-1 as set forth in Example 14 above.Examples 17 LC mixture B-8 (2.01 g), hexadecane (97 mg), ethylene dimethacrylate (645 mg), 2-hydroxyethyl methacrylate (166 mg), acrylic acid 1,1 , 1,3,3,3-Hexafluoroisopropyl (23 mg) and methyl methacrylate (67 mg) were weighed into 250 ml high beakers. Brij L23 (150 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 176 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.2 µm. Measured photoelectric parameter V50 48 V, measured photoelectric parameter V90 82 V.Examples 18 LC mixture B-8 (0.99 g), hexadecane (251 mg), stearyl methacrylate (74 mg) and 1,1-dihydroperfluoropropyl acrylate (118 mg) were weighed In a 250 ml high beaker. Brij L23 (301 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was subjected to a 50% amplitude ultrasonic treatment on a Branson Ultrasonic Instrument W450 for a total of 6 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (10 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 191 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1.Examples 19 LC mixture B-8 (2.01 g), 2,2,3,3,3-pentafluoropropyl acrylate (117 mg), ethylene dimethacrylate (663 mg), 2-methacrylic acid 2- Hydroxyethyl ester (81 mg) and methyl methacrylate (167 mg) were weighed into 250 ml high beakers. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 191 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 5.2 µm. Measured photoelectric parameter V50 80 V, measured photoelectric parameter V90 It is 132 V.Examples 20 LC mixture B-8 (2.00 g), acrylic acid 2,2,3,3,4,4,4-heptafluorobutyl ester (117 mg), ethyl dimethacrylate (659 mg), methyl formate 2-Hydroxyethyl acrylate (79 mg) and methyl methacrylate (170 mg) were weighed into 250 ml high beakers. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 147 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.9 µm. Measured photoelectric parameter V50 77.5 V, and measured photoelectric parameter V90 130 V.Examples twenty one LC mixture B-8 (2.01 g), 1H, 1H, 2H, 2H-perfluorodecyl acrylate (113 mg), ethyl dimethacrylate (657 mg), 2-hydroxyethyl methacrylate Ester (75 mg) and methyl methacrylate (171 mg) were weighed into 250 ml high beakers. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 188 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 5.3 µm. Measured photoelectric parameter V50 75 V, measured photoelectric parameter V90 115 V.Examples twenty two LC mixture B-8 (1.00 g), pentafluorooctanol (111 mg), n-ethyl methacrylate (340 mg) and 2-hydroxyethyl methacrylate (73 mg) were weighed to In a 250 ml high beaker. Brij L23 (75 mg) was weighed into a 250 ml Erlenmeyer flask and water (70 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 191 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 3.7 µm. Measured photoelectric parameter V50 23 V, measured photoelectric parameter V90 53 V.Examples twenty three LC mixture B-8 (1.01 g), 3-ginsyl (trimethylsiloxy) silylpropyl methacrylate (250 mg), ethyl ethyl dimethacrylate (300 mg), methyl 2-Hydroxyethyl acrylate (40 mg) and methyl methacrylate (100 mg) were weighed into 250 ml high beakers. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (75 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 124 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1.Examples twenty four LC mixture B-8 (2.00 g), trimethylsilyl trifluoroacetate (100 mg), ethyl ethyl dimethacrylate (660 mg), 2-hydroxyethyl methacrylate (71 mg ) And methyl methacrylate (172 mg) were weighed into a 250 ml high beaker. Brij L23 (300 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 271 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1.Examples 25 LC mixture B-8 (2.00 g), ginsyl (trimethylsiloxy) silyl methacrylate (101 mg), northyl dimethacrylate (659 mg), methacrylic acid 2 -Hydroxyethyl ester (78 mg) and methyl methacrylate (165 mg) were weighed into 250 ml high beakers. Brij L23 (100 mg) was weighed into a 250 ml Erlenmeyer flask and water (100 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (20 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 214 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.5 µm. Measured photoelectric parameter V50 57.5 V, and measured photoelectric parameter V90 95 V.Examples 26 LC mixture B-8 (1.00 g), stearyl methacrylate (101 mg), n-ethyl dimethacrylate (201 mg), 2-hydroxyethyl methacrylate (42 mg) And methyl methacrylate (105 mg) were weighed into a 250 ml high beaker. Brij L23 (50 mg) was weighed into a 250 ml Erlenmeyer flask and water (150 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (10 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 208 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 3.1 µm. Measured photoelectric parameter V50 25 V, measured photoelectric parameter V90 45.5 V.Examples 27 LC mixture B-8 (1.00 g), methyl octoate (73 mg), ethylene dimethacrylate (291 mg), 2-hydroxyethyl methacrylate (46 mg) and methyl methacrylate Ester (98 mg) was weighed into a 250 ml high beaker. Brij L23 (50 mg) was weighed into a 250 ml Erlenmeyer flask and water (150 g) was added. This mixture is then sonicated for 5 to 10 minutes. The Brij aqueous surfactant solution was poured directly into a beaker containing the organics. The mixture was mixed in turrax at 10,000 rpm for 10 minutes. Once mixing in the turrax was complete, the crude emulsion was circulated through a high pressure homogenizer at 30,000 psi for 8 minutes. The mixture was charged into a flask and equipped with a condenser, and heated to 70 ° C for 4 hours after adding 2,2'-azobis (2-methylamidinopropane) dihydrochloride (AAPH) (10 mg). The reaction mixture was cooled, filtered, and then size analysis of the material was performed by a Zetasizer instrument. The average size of the obtained capsules was 189 nm, as determined by dynamic light scattering (DLS) analysis (Zetasizer). A part of the obtained sample was further used as it is. The other part of the sample was concentrated before further use. This is carried out by centrifugation. The mixture was filled in a centrifuge tube and centrifuged at 6,500 rpm for 10 minutes, the supernatant was collected and placed in a new tube and centrifuged at 15,000 rpm for 20 minutes. The resulting pellet was redispersed in 1 ml of supernatant and a sample was taken for testing. The obtained nanocapsules exhibit favorable physical and optoelectronic properties and show an appropriate switching behavior in accordance with the applied voltage. A composite system and film containing the obtained capsules and adhesives were prepared similarly to Example 1. The thickness of the prepared film was 4.3 µm. Measured photoelectric parameter V50 33 V, measured photoelectric parameter V90 64 V.

no

Claims (21)

一種用於奈米膠囊化之組合物,其包含 (i) 液晶原介質,其包含一或多種式I化合物 R-A-Y-A’-R’ I 其中 R及R’ 彼此獨立地表示選自以下之基團:F、CF3 、OCF3 、CN及具有1至15個碳原子之直鏈或具支鏈烷基或烷氧基或具有2至15個碳原子之直鏈或具支鏈烯基,其未經取代、由CN或CF3 單取代或由鹵素單取代或多取代,且其中一或多個CH2 基團在每一情形下可彼此獨立地以使得氧原子彼此不直接連接之方式由-O-、-S-、-CO-、-COO-、-OCO-、-OCOO-或-C≡C-替代, A及A’ 彼此獨立地表示選自以下之基團:-Cyc-、-Phe-、-Cyc-Cyc-、-Cyc-Phe-、-Phe-Phe-、-Cyc-Cyc-Cyc-、-Cyc-Cyc-Phe-、-Cyc-Phe-Cyc-、-Cyc-Phe-Phe-、-Phe-Cyc-Phe-、-Phe-Phe-Phe-及其各別鏡像, 其中Cyc係反式-1,4-伸環己基,其中一或兩個非毗鄰CH2 基團可由O替代, 且其中Phe係1,4-伸苯基,其中一或兩個非毗鄰CH基團可由N替代且其可由一或兩個F取代,且 Y 表示單鍵、-COO-、-CH2 CH2 -、-CF2 CF2 -、-CH2 O-、-CF2 O-、-CH=CH-、-CF=CF-或-C≡C-, (ii) 一或多種可聚合化合物,及 (iii) 一或多種表面活性劑。A composition for nano-encapsulation, comprising (i) a mesogen, comprising one or more compounds of the formula I RAY-A'-R 'I, wherein R and R' independently of each other represent a group selected from the group consisting of Group: F, CF 3 , OCF 3 , CN and a straight or branched alkyl or alkoxy group having 1 to 15 carbon atoms or a straight or branched alkenyl group having 2 to 15 carbon atoms, It is unsubstituted, monosubstituted by CN or CF 3 or mono- or poly-substituted by halogen, and one or more of the CH 2 groups can in each case be independent of each other in such a way that the oxygen atoms are not directly connected to each other Substituted by -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-, or -C≡C-, A and A 'independently of each other represent a group selected from: -Cyc- , -Phe-, -Cyc-Cyc-, -Cyc-Phe-, -Phe-Phe-, -Cyc-Cyc-Cyc-, -Cyc-Cyc-Phe-, -Cyc-Phe-Cyc-, -Cyc- Phe-Phe-, -Phe-Cyc-Phe-, -Phe-Phe-Phe- and their respective mirror images, where Cyc is trans-1,4-cyclohexyl, one or two of which are not adjacent CH 2 groups The group may be substituted by O, and wherein Phe is 1,4-phenylene, and one or two non-adjacent CH groups may be substituted by N and it may be substituted by one or two F And Y represents a single bond, -COO -, - CH 2 CH 2 -, - CF 2 CF 2 -, - CH 2 O -, - CF 2 O -, - CH = CH -, - CF = CF- or -C ≡C-, (ii) one or more polymerizable compounds, and (iii) one or more surfactants. 如請求項1之組合物,其進一步包含一或多種有機溶劑。The composition of claim 1, further comprising one or more organic solvents. 如請求項1或2之組合物,其中該一或多種如請求項1中所述之可聚合化合物(ii)包含選自一種、兩種或更多種丙烯酸酯、甲基丙烯酸酯及乙酸乙烯酯基團之可聚合基團。A composition as claimed in claim 1 or 2, wherein the one or more polymerizable compounds (ii) as described in claim 1 comprise a member selected from one, two or more acrylates, methacrylates and vinyl acetate Polymerizable group of an ester group. 如請求項1至3中任一項之組合物,其中該一或多種如請求項1中所述之表面活性劑(iii)係選自非離子表面活性劑。The composition according to any one of claims 1 to 3, wherein the one or more surfactants (iii) as described in claim 1 are selected from non-ionic surfactants. 如請求項1至4中任一項之組合物,其中該一或多種表面活性劑係作為水性表面活性劑提供。The composition of any one of claims 1 to 4, wherein the one or more surfactants are provided as an aqueous surfactant. 如請求項1至5中任一項之組合物,其中該一或多種式I化合物係選自式Ia、Ib及Ic化合物 其中 R1 、R2 、R3 、R4 及R5 彼此獨立地表示具有1至15個碳原子之直鏈或具支鏈烷基或烷氧基或具有2至15個碳原子之直鏈或具支鏈烯基,其未經取代、由CN或CF3 單取代或由鹵素單取代或多取代,且其中一或多個CH2 基團在每一情形下可彼此獨立地以使得氧原子彼此不直接連接之方式由-O-、-S-、-CO-、-COO-、-OCO-、-OCOO-或-C≡C-替代, X1 表示F、CF3 、OCF3 或CN, L1 、L2 、L3 及L4 彼此獨立地係H或F, i 係1或2,且 j及k 彼此獨立地係0或1。The composition of any one of claims 1 to 5, wherein the one or more compounds of formula I are selected from compounds of formulas Ia, Ib and Ic Wherein R 1 , R 2 , R 3 , R 4 and R 5 independently of each other represent a straight chain having 1 to 15 carbon atoms or a branched alkyl or alkoxy group or a straight chain having 2 to 15 carbon atoms Or with branched alkenyl groups, which are unsubstituted, monosubstituted by CN or CF 3 or mono- or poly-substituted by halogen, and in which case one or more CH 2 groups can be independent of each other in each case such that the oxygen The way that the atoms are not directly connected to each other is replaced by -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-, or -C≡C-, X 1 represents F, CF 3 , OCF 3 or CN, L 1 , L 2 , L 3, and L 4 are independently H or F, i is 1 or 2, and j and k are 0 or 1 independently. 如請求項1至6中任一項之組合物,其中該組合物分散於水相中。The composition of any one of claims 1 to 6, wherein the composition is dispersed in an aqueous phase. 如請求項1至7中任一項之組合物,其係作為分散於水相中之奈米液滴提供。The composition according to any one of claims 1 to 7, which is provided as nano droplets dispersed in an aqueous phase. 一種如請求項1至8中任一項之組合物之用途,其用於製備奈米膠囊。Use of a composition according to any one of claims 1 to 8 for preparing nanocapsules. 一種奈米膠囊,其各別地包含 聚合殼,及 含有液晶原介質之核心,該液晶原介質包含一或多種如請求項1或6中所述之式I化合物。A nanocapsule each comprising a polymeric shell and a core containing a mesogen, the mesogen comprising one or more compounds of formula I as described in claim 1 or 6. 一種藉由聚合如請求項1至8中任一項之組合物獲得或可自其獲得之奈米膠囊。A nanocapsule obtained by polymerizing a composition as claimed in any one of claims 1 to 8 or obtainable therefrom. 如請求項10或11之奈米膠囊,其中該液晶原介質進一步包含一或多種手性摻雜劑及/或一或多種多色性染料。The nanocapsule of claim 10 or 11, wherein the mesogen is further comprised of one or more chiral dopants and / or one or more polychromic dyes. 一種製備奈米膠囊之方法,其中該方法包含 (a) 提供包含如請求項1至6中任一項之組合物之水性混合物, (b) 攪動該所提供之水性混合物以獲得分散於水相中之包含如請求項1至6中任一或多項之組合物之奈米液滴, (c) 在步驟(b)之後,將該一或多種如請求項1或3中所述之可聚合化合物聚合以獲得奈米膠囊,其每一者包含聚合殼及含有如請求項1或6中所述之液晶原介質之核心, 及視情況 (d) 將該水相耗盡、去除或交換。A method for preparing a nanocapsule, wherein the method comprises (a) providing an aqueous mixture comprising a composition as claimed in any one of claims 1 to 6, and (b) agitating the provided aqueous mixture to obtain dispersion in an aqueous phase Nano droplets comprising a composition as claimed in any one or more of claims 1 to 6, (c) after step (b), one or more of the polymerizable as described in claim 1 or 3 The compounds are polymerized to obtain nanocapsules, each of which comprises a polymeric shell and a core containing the mesogen precursor as described in claim 1 or 6, and optionally (d) the water phase is depleted, removed or exchanged. 如請求項13之方法,其中使用高壓均質器實施步驟(b)。The method of claim 13, wherein step (b) is performed using a high-pressure homogenizer. 一種藉由實施如請求項13或14之方法獲得或可自其獲得之奈米膠囊。A nanocapsule obtained or obtainable from a method as claimed in claim 13 or 14. 如請求項10至12及15中任一項之奈米膠囊,其中該等奈米膠囊之平均大小不大於400 nm、較佳不大於250 nm。For example, the nanocapsules of any one of claims 10 to 12 and 15, wherein the average size of the nanocapsules is not greater than 400 nm, preferably not greater than 250 nm. 如請求項10至12、15及16中任一項之奈米膠囊,其為乾燥的或分散於水相中。A nanocapsule as claimed in any one of claims 10 to 12, 15 and 16, which is dry or dispersed in an aqueous phase. 一種複合系統,其包含 如請求項10至12及15至17中任一項之奈米膠囊,及 一或多種黏合劑。A composite system comprising a nanocapsule as claimed in any one of claims 10 to 12 and 15 to 17, and one or more adhesives. 如請求項18之複合系統,其中該一或多種黏合劑包含聚乙烯醇。The composite system of claim 18, wherein the one or more adhesives comprise polyvinyl alcohol. 一種如請求項10至12及15至17中任一項之奈米膠囊或如請求項18或19之複合系統之用途,其用於光調變元件或光電裝置中。A nanocapsule as claimed in any of claims 10 to 12 and 15 to 17 or a composite system as claimed in claims 18 or 19 for use in a light modulating element or a photovoltaic device. 一種光電裝置,其包含如請求項10至12及15至17中任一項之奈米膠囊或如請求項18或19之複合系統。An optoelectronic device comprising a nanocapsule as in any one of claims 10 to 12 and 15 to 17 or a composite system as in claim 18 or 19.
TW106111896A 2016-04-13 2017-04-10 Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium TW201807165A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
??16165174.0 2016-04-13
EP16165174 2016-04-13
??16180292.1 2016-07-20
EP16180292 2016-07-20

Publications (1)

Publication Number Publication Date
TW201807165A true TW201807165A (en) 2018-03-01

Family

ID=58632366

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106111896A TW201807165A (en) 2016-04-13 2017-04-10 Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium

Country Status (7)

Country Link
US (1) US20190127642A1 (en)
EP (1) EP3443050B1 (en)
JP (1) JP2019515989A (en)
KR (1) KR20180130569A (en)
CN (1) CN109072081A (en)
TW (1) TW201807165A (en)
WO (1) WO2017178419A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102513511B1 (en) 2016-04-28 2023-03-22 엘지디스플레이 주식회사 Liquid Crystal Display Device And Method Of Fabricating The Same
JP2017214451A (en) * 2016-05-30 2017-12-07 Dic株式会社 Composite resin particle
KR102598480B1 (en) * 2016-10-27 2023-11-03 엘지디스플레이 주식회사 Liquid Crystal Display Device Including Liquid Crystal Capsule And Method Of Fabricating The Same
WO2018189068A1 (en) * 2017-04-10 2018-10-18 Merck Patent Gmbh Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium
KR102297989B1 (en) 2017-04-13 2021-09-02 엘지디스플레이 주식회사 Liquid Crystal Display Device And Method Of Fabricating The Same
GB2586534B (en) * 2019-04-30 2023-05-10 Merck Patent Gmbh Acousto-optical device
KR102387520B1 (en) * 2020-03-23 2022-04-18 연세대학교 산학협력단 Cosmetic composition for blocking ultraviolet rays and/or infrared rays based on polymer encapsulation technology
WO2022138418A1 (en) * 2020-12-25 2022-06-30 Dic株式会社 Polymer-dispersed liquid crystal composition, liquid crystal element, and light control element
JP7099578B1 (en) 2021-03-31 2022-07-12 凸版印刷株式会社 A dimming sheet, a dimming device, a photosensitive composition, and a method for manufacturing a dimming sheet.

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435047A (en) * 1981-09-16 1984-03-06 Manchester R & D Partnership Encapsulated liquid crystal and method
KR0130554B1 (en) 1984-03-19 1998-04-11 유젠 웬닝거 Light modulating material comprising a liquid crystal disersion in a synthetic resin matrix
DE3688218T2 (en) * 1985-06-03 1993-07-22 Taliq Corp Encapsulated liquid crystal with a smectic phase.
US4814211A (en) 1987-04-10 1989-03-21 Hoechst Celanese Corporation Liquid crystalline composites
JPH07181439A (en) 1993-12-24 1995-07-21 Hitachi Ltd Active matrix liquid crystal display device
JP3543351B2 (en) 1994-02-14 2004-07-14 株式会社日立製作所 Active matrix type liquid crystal display
TW262553B (en) 1994-03-17 1995-11-11 Hitachi Seisakusyo Kk
DE19528106A1 (en) 1995-02-03 1996-08-08 Merck Patent Gmbh In-plane-switching electro=optical LCD with short switching times
DE19528107B4 (en) 1995-03-17 2010-01-21 Merck Patent Gmbh Liquid-crystalline medium and its use in an electro-optical liquid crystal display
US5993691A (en) 1995-02-03 1999-11-30 Merck Patent Gesellschaft Mit Electro-optical liquid crystal display
DE19509410A1 (en) 1995-03-15 1996-09-19 Merck Patent Gmbh Electro-optical liquid crystal display
US6217792B1 (en) 1996-07-01 2001-04-17 Merck Patent Gmbh Chiral dopants
DE19834162A1 (en) 1997-08-13 1999-02-18 Merck Patent Gmbh Chiral connections
DE60132456T2 (en) 2000-07-13 2009-01-08 Merck Patent Gmbh CHIRAL COMPOUNDS I
US7041345B2 (en) 2000-07-13 2006-05-09 Merck Patent Gmbh Chiral compounds III
EP1299335B1 (en) 2000-07-13 2007-09-05 MERCK PATENT GmbH Chiral compounds ii
DE60104014T2 (en) 2000-10-20 2005-08-11 Merck Patent Gmbh CHIRAL BINAPHTOL COMPOUNDS
KR100920912B1 (en) 2001-05-21 2009-10-12 메르크 파텐트 게엠베하 Chiral compounds
ATE354623T1 (en) 2002-07-06 2007-03-15 Merck Patent Gmbh LIQUID CRYSTALLINE MEDIUM
NO20030185D0 (en) * 2003-01-14 2003-01-14 Polydisplay Asa Method for encapsulating liquid crystals where the capsules have narrow size distribution
JP5241853B2 (en) 2007-12-28 2013-07-17 ダウ グローバル テクノロジーズ エルエルシー Micro functional materials
JP2010202799A (en) * 2009-03-04 2010-09-16 Fujifilm Corp Liquid crystal composition and reflection type display element
US8988642B2 (en) 2010-11-09 2015-03-24 Samsung Display Co., Ltd. Liquid crystal display devices and methods of manufacturing liquid crystal display devices
KR20120049796A (en) * 2010-11-09 2012-05-17 삼성모바일디스플레이주식회사 Liquid crystal display and method of manufacturing liquid crystal display device
DE102011118786A1 (en) 2010-12-17 2012-06-21 Merck Patent Gmbh Liquid crystalline medium
CN103597402B (en) * 2011-10-28 2017-02-15 利美智Lab株式会社 Transverse electric field-type liquid crystal display device comprising a nanoscale liquid crystal layer
WO2013110564A1 (en) * 2012-01-23 2013-08-01 Vlyte Innovations Limited A method for microencapsulating electro-optical fluid
US9366920B2 (en) * 2013-01-02 2016-06-14 Lg Display Co., Ltd. Liquid crystal display device and fabricating method thereof
KR102124904B1 (en) * 2013-10-23 2020-06-22 엘지디스플레이 주식회사 Liquid crystal display device including nano capsule liquid crystal
KR102279865B1 (en) * 2014-02-13 2021-07-22 메르크 파텐트 게엠베하 Reactive mesogen based polymer particles
WO2015130104A1 (en) * 2014-02-26 2015-09-03 주식회사 엘지화학 Method for preparing liquid crystal capsule
WO2016035453A1 (en) * 2014-09-02 2016-03-10 Jnc株式会社 Liquid crystal capsule and method for producing same
CN104267523B (en) * 2014-09-30 2017-09-12 江苏和成显示科技股份有限公司 Microcapsules liquid crystal and its microcapsules liquid crystal display device
CN104297974B (en) * 2014-09-30 2017-08-11 江苏和成显示科技股份有限公司 Microcapsules liquid crystal and its microcapsules liquid crystal display device
WO2016148431A1 (en) * 2015-03-16 2016-09-22 이미지랩(주) Panel structure having light transmittance adjustment function, and smart window and display device using same
KR20190039639A (en) * 2017-10-05 2019-04-15 메르크 파텐트 게엠베하 Compositions comprising functionalized polyvinyl alcohol and nanocapsules containing a liquid-crystalline medium

Also Published As

Publication number Publication date
EP3443050A1 (en) 2019-02-20
WO2017178419A1 (en) 2017-10-19
JP2019515989A (en) 2019-06-13
CN109072081A (en) 2018-12-21
EP3443050B1 (en) 2020-01-29
US20190127642A1 (en) 2019-05-02
KR20180130569A (en) 2018-12-07

Similar Documents

Publication Publication Date Title
TW201807165A (en) Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium
TW201833305A (en) Nanocapsules comprising a liquid-crystalline medium
KR101567066B1 (en) Polymerisable compounds
EP3467074B1 (en) Compositions comprising functionalized polyvinyl alcohol and nanocapsules containing a liquid-crystalline medium
TWI613279B (en) Liquid-crystal displays and liquid-crystalline media having homeotropic alignment
KR101649088B1 (en) Liquid crystal display
US9556382B2 (en) Polymerisable mixtures and the use thereof in liquid crystal displays
CN105121599B (en) Layer or product comprising cholesteric polymers particle
TWI686462B (en) Liquid-crystal medium
TW201900854A (en) Composition for nanoencapsulation and nanocapsules comprising a liquid-crystalline medium
DE102009022309A1 (en) liquid-crystal display
EP3234689A1 (en) Light modulation element
EP3215892A1 (en) Light modulation element
EP3248060A1 (en) Light modulation element
GB2589659A (en) Compositions comprising polymerizable oligoethyleneglycol derivatives and nanocapsules containing a liquid-crystalline medium
GB2587254A (en) Compositions comprising waterborne polyurethane dispersion and nanocapsules containing a liquid-crystalline medium
TWI737728B (en) Liquid crystal composition, mixture, liquid crystal composite material, optical element and its use
CN108611103B (en) Liquid crystal composition containing polymerizable compound and application thereof